US20050075713A1 - Minimally invasive valve replacement system - Google Patents
Minimally invasive valve replacement system Download PDFInfo
- Publication number
- US20050075713A1 US20050075713A1 US10/680,728 US68072803A US2005075713A1 US 20050075713 A1 US20050075713 A1 US 20050075713A1 US 68072803 A US68072803 A US 68072803A US 2005075713 A1 US2005075713 A1 US 2005075713A1
- Authority
- US
- United States
- Prior art keywords
- valve
- anchoring structure
- inflow
- sinus
- outflow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2418—Scaffolds therefor, e.g. support stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2/013—Distal protection devices, i.e. devices placed distally in combination with another endovascular procedure, e.g. angioplasty or stenting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
- A61F2/243—Deployment by mechanical expansion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
- A61F2/2439—Expansion controlled by filaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2496—Devices for determining the dimensions of the prosthetic valve to be implanted, e.g. templates, sizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
- A61F2210/0019—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at only one temperature whilst inside or touching the human body, e.g. constrained in a non-operative shape during surgery, another temperature only occurring before the operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
- A61F2210/0023—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at different temperatures whilst inside or touching the human body, heated or cooled by external energy source or cold supply
- A61F2210/0028—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at different temperatures whilst inside or touching the human body, heated or cooled by external energy source or cold supply cooled
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0008—Fixation appliances for connecting prostheses to the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0008—Fixation appliances for connecting prostheses to the body
- A61F2220/0016—Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/005—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0066—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements stapled
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0075—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/0054—V-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0059—Additional features; Implant or prostheses properties not otherwise provided for temporary
Definitions
- the present invention relates to devices and systems for the replacement of physiological valves.
- valves The transport of vital fluids in the human body is largely regulated by valves.
- Physiological valves are designed to prevent the backflow of bodily fluids, such as blood, lymph, urine, bile, etc., thereby keeping the body's fluid dynamics unidirectional for proper homeostasis.
- bodily fluids such as blood, lymph, urine, bile, etc.
- venous valves maintain the upward flow of blood, particularly from the lower extremities, back toward the heart
- lymphatic valves prevent the backflow of lymph within the lymph vessels, particularly those of the limbs.
- valves Because of their common function, valves share certain anatomical features despite variations in relative size.
- the cardiac valves are among the largest valves in the body with diameters that may exceed 30 mm, while valves of the smaller veins may have diameters no larger than a fraction of a millimeter. Regardless of their size, however, many physiological valves are situated in specialized anatomical structures known as sinuses.
- Valve sinuses can be described as dilations or bulges in the vessel wall that houses the valve.
- the geometry of the sinus has a function in the operation and fluid dynamics of the valve. One function is to guide fluid flow so as to create eddy currents that prevent the valve leaflets from adhering to the wall of the vessel at the peak of flow velocity, such as during systole.
- Another function of the sinus geometry is to generate currents that facilitate the precise closing of the leaflets at the beginning of backflow pressure.
- the sinus geometry is also important in reducing the stress exerted by differential fluid flow pressure on the valve leaflets or
- the eddy currents occurring within the sinuses of Valsalva in the natural aortic root have been shown to be important in creating smooth, gradual and gentle closure of the aortic valve at the end of systole. Blood is permitted to travel along the curved contour of the sinus and onto the valve leaflets to effect their closure, thereby reducing the pressure that would otherwise be exerted by direct fluid flow onto the valve leaflets.
- the sinuses of Valsalva also contain the coronary ostia, which are outflow openings of the arteries that feed the heart muscle. When valve sinuses contain such outflow openings, they serve the additional purpose of providing blood flow to such vessels throughout the cardiac cycle.
- valves When valves exhibit abnormal anatomy and function as a result of valve disease or injury, the unidirectional flow of the physiological fluid they are designed to regulate is disrupted, resulting in increased hydrostatic pressure.
- venous valvular dysfunction leads to blood flowing back and pooling in the lower legs, resulting in pain, swelling and edema, changes in skin color, and skin ulcerations that can be extremely difficult to treat. Lymphatic valve insufficiency can result in lymphedema with tissue fibrosis and gross distention of the affected body part.
- Cardiac valvular disease may lead to pulmonary hypertension and edema, atrial fibrillation, and right heart failure in the case of mitral and tricuspid valve stenosis; or pulmonary congestion, left ventricular contractile impairment and congestive heart failure in the case of mitral regurgitation and aortic stenosis.
- all valvular diseases result in either stenosis, in which the valve does not open properly, impeding fluid flow across it and causing a rise in fluid pressure, or insufficiency/regurgitation, in which the valve does not close properly and the fluid leaks back across the valve, creating backflow.
- Some valves are afflicted with both stenosis and insufficiency, in which case the valve neither opens fully nor closes completely.
- valve replacement surgery is becoming a widely used medical procedure, described and illustrated in numerous books and articles.
- the diseased or abnormal valve is typically cut out and replaced with either a mechanical or tissue valve.
- a conventional heart valve replacement surgery involves accessing the heart in a patient's thoracic cavity through a longitudinal incision in the chest. For example, a median sternotomy requires cutting through the sternum and forcing the two opposite halves of the rib cage to be spread apart, allowing access to the thoracic cavity and the heart within. The patient is then placed on cardiopulmonary bypass, which involves stopping the heart to permit access to the internal chambers.
- Such open heart surgery is particularly invasive and involves a lengthy and difficult recovery period. Reducing or eliminating the time a patient spends in surgery is thus a goal of foremost clinical priority.
- valve assemblies that allow implantation with minimal or no sutures would be greatly advantageous.
- devices have been developed for the endovascular implantation of replacement valves, including collapsing, delivering, and then expanding the valve, such devices do not configure the valve in a manner that takes advantage of the natural compartments formed by the valve sinuses for optimal fluid dynamics and valve performance.
- such valve constructs are configured such that the tissue leaflets of the support valve come into contact with the support structure, either during the collapsed or expanded state, or both.
- Such contact is capable of contributing undesired stress on the valve leaflet.
- support structures are not configured to properly support a tissue valve having a scalloped inflow annulus such as that disclosed in the U.S. patent application Ser. No. 09/772,526 which is incorporated by reference herein in its entirety.
- a valve replacement system comprising a collapsible and expandable valve assembly that is capable of being secured into position with minimal or no suturing; facilitating an anatomically optimal position of the valve; maintaining an open pathway for other vessel openings of vessels that may be located in the valvular sinuses; and minimizing or reducing stress to the tissue valve leaflets.
- the valves of the present invention may comprise a plurality of joined leaflets with a corresponding number of commissural tabs. Generally, however, the desired valve will contain two to four leaflets and commissural tabs. Examples of other suitable valves are disclosed in U.S. patent application Ser. Nos. 09/772,526, 09/853,463, 09/924,970, 10/121,208, 10/122,035, 10/153,286, 10/153,290, the disclosures of all of which are incorporated by reference in their entirety herein.
- the present invention provides systems and devices for the replacement of physiological valves.
- the replacement valve assemblies are adapted to fit substantially within the valve sinuses. Because the devices and procedures provided by the present invention eliminate or reduce the need for suturing, time spent in surgery is significantly decreased, and the risks associated with surgery are minimized. Further, the devices of the present invention are suitable for delivery by cannula or catheter.
- a valve anchoring structure is provided that is dimensioned to be placed substantially within the valve sinus.
- the valve anchoring structure extends substantially across the length of the valve sinus region.
- a valve assembly comprising a valve and anchoring structure, in which the valve comprises a body having a proximal end and a distal end, an inlet at the proximal end, and an outlet at the distal end.
- the inlet comprises an inflow annulus, preferably with either a scalloped or straight edge.
- the outlet comprises a plurality of tabs that are supported by the anchoring means at the distal end. In preferred embodiments of the invention, the plurality of tabs are spaced evenly around the circumference of the valve.
- a valve assembly is provided in which there is minimal or no contact between the valve and anchoring structure.
- a valve assembly in which the valve is capable of achieving full opening and full closure without contacting the anchoring structure.
- a valve assembly in which the vertical components of the anchoring structure are limited to the commissural posts between sinus cavities, thereby minimizing contact between mechanical components and fluid, as well as providing flow to vessels located in the valve sinus.
- a valve is provided that firmly attaches to the valve sinus, obviating the need for suturing to secure the valve placement.
- a valve assembly in which the anchoring structure may be collapsed to at least fifty percent of its maximum diameter.
- an expansion and contraction device is provided to facilitate implantation of the valve and anchoring structure.
- the present invention provides adhesive means for securing the valve assembly in a valve sinus.
- a valve sizing apparatus for the noninvasive determination of native valve size.
- the present invention also provides cutting means to remove the native diseased valve.
- One aspect of the cutting means comprises a plurality ofjaw elements, each jaw element having a sharp end enabling the jaw element to cut through at least a portion of the native valve.
- Another aspect of the cutting means comprises a plurality of electrode elements, wherein radiofrequency energy is delivered to each electrode element enabling the electrode element to cut through at least a portion of the native valve.
- a further aspect of the cutting means comprises a plurality of ultrasound transducer elements, wherein ultrasound energy is delivered to each transducer element enabling the transducer element to cut through at least a portion of the native valve.
- the present invention provides a temporary two-way valve and distal protection filter assembly.
- FIG. 1 shows an exemplary valve during operation.
- FIG. 1A shows the valve in the open position during peak flow.
- FIG. 1B shows the valve in closed position to prevent backflow of the fluid across the valve.
- FIG. 2 shows a preferred embodiment of the valve of the present invention. This valve features commissural tabs and a scalloped inflow annulus.
- FIGS. 3A , B and C are representations of a typical valve sinus. These figures illustrate the anatomy of the sinus cavities, commissural posts, leaflets and inflow/outflow annuli.
- FIG. 4 is a schematic representation of the geometry and relative dimensions of the valve sinus region.
- FIG. 5 shows a valve anchoring structure, in accordance with a preferred embodiment of the present invention, that is lodged inside a vessel.
- FIGS. 6A and B are schematics of a valve assembly comprising a valve and an anchoring structure in which the anchoring structure features an additional cloth ring along the valve inflow edge that serves as a gasket.
- FIG. 6C shows a valve anchoring structure according to one preferred embodiment of the present invention featuring a two-ring inflow rim.
- FIG. 7 is a diagrammatic representation of a flat pattern of a preferred embodiment of an anchoring structure in the expanded state.
- FIG. 8 is a diagrammatic representation of a flat pattern of a preferred embodiment of an anchoring structure in the compressed state.
- FIG. 9 shows a flat valve leaflet of a preferred valve to which the anchoring structure dimensions can be fitted.
- FIG. 10 illustrates the relative dimensions of a preferred embodiment of an anchoring structure of the present invention.
- FIG. 11 shows a flared anchoring structure dimensioned to lodge inside the sinus cavities.
- FIG. 12 shows a different view of the flared anchoring structure.
- FIG. 13 shows a preferred embodiment of an anchoring structure lacking an outflow ring, and having support posts dimensioned to lodge in the sinus commissural posts, providing cantilevered support for the valve outflow end.
- FIG. 14 shows a preferred embodiment of an anchoring structure with flared in- and outflow ends and support posts for lodging in the commissural posts with attachment windows capable of deflecting inward at back flow pressure.
- FIG. 15A shows a top view of a preferred embodiment of a valve assembly comprising a valve and an anchoring structure made of elliptical segments joined together.
- FIG. 15B shows a lateral view of the preferred anchoring structure without valve.
- FIG. 16A shows the valve assembly comprising a valve and elliptical segment anchoring structure in expanded form.
- FIG. 16B shows the same in compressed form
- FIG. 17 shows the lodging of an elliptical anchoring structure inside the valve sinus cavities.
- FIG. 18A shows how the elliptical segments of the anchoring structure may be joined by a double crimp.
- FIG. 18B shows how the valve is positioned inside the anchoring structure.
- FIG. 19A shows a double crimp uniquely designed to flexibly join the elliptical segments.
- FIG. 19B shows a modified double crimp.
- FIG. 20A shows how the elliptical segments may be assembled into the double crimp.
- FIG. 20B shows the final assembly.
- FIGS. 21 A-G show different views of an elliptical segment anchoring structure further comprising cloth covering including a gasket cloth cuff at the inflow rim.
- FIGS. 22A and B show different views of an elliptical segment anchoring structure made from a single piece of tubing.
- FIGS. 23A through D show an elliptical segment anchoring structure in which the upper segments have been removed and the ends of the junctions are formed into prongs.
- FIG. 24 shows a preferred valve assembly of the present invention with an anchoring structure comprising a ring incorporated into the valve inflow rim.
- FIG. 25A shows an anchoring structure comprising two undulating rings with inverse wave patterns.
- FIG. 25B shows an anchoring structure comprising two such rings connected by vertical elements.
- FIG. 26 shows a valve assembly comprising an anchoring structure in which the inflow ring and outflow ring are structurally unconnected.
- FIG. 27A -C show a tubular anchoring structure.
- FIGS. 28 A-D show an anchoring structure comprising an inflow ring and an outflow ring connected by vertical posts that slide across one another upon compression.
- FIGS. 29A and B show an anchoring structure comprising an inflow and outflow ring connected by vertical posts that join to form a single vertical element upon compression.
- FIGS. 30A and B shows an anchoring structure comprising a three-member spring aided frame.
- FIGS. 31A and B show a preferred embodiment of an expansion and contraction device.
- FIGS. 32A and B more particularly shows the angled wires of the device.
- FIG. 33 shows the positioning of an anchoring structure on the expansion and contraction device.
- FIG. 34 shows another preferred embodiment of an expansion and contraction device featuring a wire-spindle mechanism.
- FIG. 35 shows a different perspective of the wire-spindle expansion and contraction device.
- FIGS. 36A and B show another preferred embodiment of an expansion and contraction device for self-expanding valve assemblies.
- FIG. 37A shows a further preferred embodiment of an expansion and contraction device featuring a rotating plate mechanism.
- FIGS. 37B and C more particularly shows the spiral-shaped rotating plate.
- FIGS. 38A and B show the expansion and contraction device expanding an anchoring frame.
- FIG. 39 shows another preferred embodiment of an expansion and contraction device featuring a groove-pin mechanism.
- FIG. 40 shows one preferred embodiment of a valve having an outer circumferential reservoir containing a sealable fixation means for securely fixing the valve prosthesis at a desired location within a vessel or body cavity.
- FIGS. 41A and B show another embodiment of a valve having an outer circumferential reservoir, wherein the sealabe fixation means comprises a two component biological adhesive.
- FIG. 42 illustrates a reservoir with thin spots adapted to rupture when the reservoir is under pressure, thereby releasing the contents of the reservoir.
- FIG. 43 is a cross-sectional view of the reservoir showing the thin spots.
- FIG. 44 is a cross-sectional view of a valve reservoir having two concentric component compartments.
- FIGS. 45A and B depict a minimally-invasive valve replacement sizer.
- FIG. 46 is a cross-sectional view of a minimally-invasive valve replacement sizer comprising a guidewire, an intravascular ultrasound (IVUS) catheter having a transducer, and a balloon catheter, all positioned within the central lumen of the catheter.
- IVUS intravascular ultrasound
- FIG. 47 shows a balloon catheter comprising a balloon that circumferentially surrounds a portion of the catheter at its distal portion.
- FIG. 48 shows a cross-sectional view of an inflated balloon with curves forming leaflets to enable fluid to pass.
- FIG. 49 shows one preferred embodiment of a minimally-invasive valve replacement sizer, wherein the balloon is inflated with saline.
- FIG. 50 shows a preferred embodiment of a minimally-invasive valve replacement sizer system, wherein the transducer emits an ultrasonic signal in a perpendicular direction to an intravascular ultrasound catheter (IVUS), which is reflected off the outer wall of the balloon and then received by the transducer and wherein the radius and diameter of the body cavity is determined by the auxiliary processor.
- IVUS intravascular ultrasound catheter
- FIG. 51 shows an anchoring structure of the present invention having ultrasound cutting means.
- FIG. 52 shows an anchoring structure of the present invention having radiofrequency cutting means.
- FIG. 53 shows an anchoring structure having sharp edge cutting means.
- FIG. 54 is a partial view of the valve assembly with cutting means on a partially inflated balloon catheter.
- FIGS. 55 A-C show a temporary two-way valve for distal protection.
- a valve ( 1 ) comprises a distal or outflow end ( 2 ), leaflets ( 3 ) and a proximal or inflow end ( 4 ).
- a typical valve functions similar to a collapsible tube in that it opens widely during systole or in response to muscular contraction, to enable unobstructed forward flow across the valvular orifice ( FIG. 1A ).
- FIG. 1B At the end of systole or contraction, as illustrated in FIG. 1B , as forward flow decelerates, the walls of the tube are forced centrally between the sites of attachment to the vessel wall and the valve closes completely.
- a preferred valve ( 5 ) for use with the systems and devices of the present invention is illustrated in FIG. 2 and is comprised of a body having a proximal end or inflow ring ( 6 ) and a distal end or outflow ring ( 7 ).
- the body is comprised of multiple leaflets of valve tissue joined by seams ( 8 ), wherein each seam is formed by a junction of two leaflets.
- a commissural tab region ( 9 ) extends from each seam at the distal end of the valve body.
- the proximal end ( 6 ) has an inflow ring with a peripheral edge that can be scalloped or straight.
- the inflow ring ( 6 ) of the valve can further comprise a reinforcement structure ( 10 ) that can be stitched to it.
- valve replacement systems and devices of the present invention are not limited, however, to the specific valve illustrated in FIG. 2 .
- An important consideration in the design of valve replacement systems and devices that has received insufficient attention in previous approaches is the architecture of valve sinus.
- Valve sinuses are dilations of the vessel wall that surround the natural valve leaflets.
- each natural valve leaflet has a separate sinus bulge or cavity that allows for maximal opening of the leaflet at peak flow without permitting contact between the leaflet and the vessel wall.
- a two-leaflet valve is surrounded by two sinus bulges, a three-leaflet valve by three, and a four-leaflet valve by four sinus cavities.
- FIGS. 3A and B illustrate the reduced curvature of the commissural posts ( 11 ) compared with the curvature of the sinus cavities ( 12 ).
- FIG. 3C shows a view from outside the vessel of a commissural post ( 11 ) between two sinus cavities ( 12 ), while FIG. 3A shows a cross sectional view from the top of a closed valve within a valve sinus.
- the areas between the bulges define the commissural posts ( 11 ) and as can be clearly seen in FIG. 3B , the commissural posts serve as the sites of attachment for the valve leaflets to the vessel wall ( 13 ).
- FIGS. 3B and C also show the narrowing diameter of the sinus region at both its inflow end ( 14 ) and outflow end ( 15 ) to form the inflow and outflow annuli of the sinus region.
- the valve sinuses form a natural compartment to support the operation of the valve by preventing contact between the leaflets and the vessel wall, which, in turn, may lead to adherence of the leaflets and/or result in detrimental wear and tear of the leaflets.
- the valve sinuses are also designed to share the stress conditions imposed on the valve leaflets during closure when fluid pressure on the closed leaflets is greatest.
- the valve sinuses further create favorable fluid dynamics through currents that soften an otherwise abrupt closure of the leaflets under conditions of high backflow pressure.
- the sinuses ensure constant flow to any vessels located within the sinus cavities.
- the valve sinus region is characterized by certain relative dimensions which remain constant regardless of the actual size of the sinuses.
- the diameter of the sinus is at its largest at the center of the cavities or bulges ( 16 ), while there is pronounced narrowing of the sinus region at both the inflow annulus ( 17 ) and outflow annulus ( 18 ).
- the height of the sinus ( 19 ) i.e. the distance between the inflow and outflow annuli remains proportional to its overall dimensions. It is thus apparent that the sinus region forms an anatomical compartment with certain constant features that are uniquely adapted to house a valve.
- the systems and devices of the present invention are designed to utilize these anatomical features of the native sinus region for optimal replacement valve function and position.
- the replacement valve assembly comprises a collapsible and expandable anchoring structure adapted to support a valve distally along the commissural tab region and proximally along the inflow annulus.
- FIG. 5 shows a preferred anchoring structure adapted to support a valve such as that illustrated in FIG. 2 .
- the preferred anchoring structure has a generally tubular configuration within which the valve is secured.
- the valve is secured at its proximal (inflow) annulus by attachment to the inflow rim ( 20 ) of the anchoring structure and at its distal end via the commissural tabs that are threaded through the axially extending slots ( 21 ), which are formed in the support posts ( 22 ) that extend longitudinally from the inflow rim ( 20 ) to the outflow rim ( 23 ) of the anchoring structure.
- the distal ends ( 24 ) of the support posts contact the outflow rim ( 23 ) of the anchoring structure
- the proximal ends ( 25 ) of the support posts contact the inflow rim ( 20 ) of the anchoring structure.
- the outflow rim ( 23 ) of the anchoring structure is depicted as comprising a plurality of rings that extend between the support posts ( 22 ) generally at or above the axially extending slots ( 21 ) that reside therein.
- the plurality of rings of the outflow rim ( 23 ) are configured in an undulating or zigzag pattern forming peaks ( 26 ) and valleys ( 27 ), wherein the individual rings remain substantially parallel to one another.
- the plurality of rings of the outflow rim comprise a vertical connector element ( 28 ) positioned at the center of the valleys ( 27 ) formed by the undulating or zigzag pattern.
- This vertical connector element ( 2 o) is designed to stabilize the anchoring structure and to prevent distortion of the valve during compression and expansion of the anchoring structure comprising the valve.
- the vertical element ( 28 ) extends longitudinally in the axial direction of the cylindrical anchoring structure.
- the outflow rim ( 23 ) of the anchoring structure comprises two rings.
- the inflow rim ( 20 ) of the support structure comprises a single ring that extends between the support posts ( 22 ).
- Both the inflow ( 20 ) and outflow ( 23 ) rims of the anchoring structure are formed with an undulating or zigzag configuration, although the inflow rim ( 20 ) may have a shorter wavelength (circumferential dimension from peak to peak) and a lesser wave height (axial dimension from peak to peak) than the outflow rim ( 23 ).
- the wavelengths and wave heights of the inflow ( 20 ) and outflow ( 23 ) rims are selected to ensure uniform compression and expansion of the anchoring structure without distortion.
- the wavelength of the inflow rim ( 20 ) is further selected to support the geometry of the scalloped inflow annulus of a preferred valve of the present invention. Notably, as shown in FIG.
- the undulating or zigzag pattern that forms the inflow rim ( 20 ) of the anchoring structure is configured such that the proximal ends ( 25 ) of the vertical support posts ( 22 ) are connected to the peaks ( 29 ) of the inflow rim ( 20 ).
- the undulating or zigzag pattern that forms the outflow rim ( 23 ) of the anchoring structure is configured such that the distal ends ( 24 ) of the support posts ( 22 ) are connected to the valleys ( 27 ) of the outflow rim ( 23 ).
- Locating the distal ends ( 24 ) of the support posts at the valleys ( 27 ) of the outflow rim ( 23 ) will prevent the longitudinal extension of outflow rim ( 23 ) in the direction of the valve secured within the lumen of the anchoring structure upon compression of the valve assembly, thereby eliminating any contact between valve and anchoring structure.
- Locating the proximal ends ( 25 ) of the support posts at the peaks ( 29 ) of the inflow rim ( 20 ) will prevent longitudinal extension of the inflow rim ( 20 ) in the direction of the valve tissue.
- compression of the valve and anchoring structure does not lead to distortion of or injury to the valve.
- FIG. 5 further shows that the support posts ( 22 ) are configured generally in the shape of paddle with the axial slot ( 21 ) extending internally within the blade ( 30 ) of the paddle.
- the blade ( 30 ) of the paddle is oriented toward the outflow rim ( 23 ) of the anchoring structure and connects to the outflow rim ( 23 ) at a valley ( 27 ) of the undulating or zigzag pattern of the outflow rim ( 23 ).
- An important function of the support posts ( 22 ) is the stabilization of the valve in general, and in particular the prevention of any longitudinal extension at points of valve attachment to preclude valve stretching or distortion upon compression of the device.
- the blades ( 30 ) of the paddle-shaped support posts ( 22 ) are designed to accommodate the commissural tabs of the valve.
- the support posts ( 22 ) further comprise triangular shaped elements ( 31 ) extending on each side of the proximal end ( 25 ) of the support post.
- the triangular shaped elements ( 31 ) are designed to serve as attachments sites for the sewing cuff gasket and may be designed in different shapes without losing their function.
- the number of support posts ( 22 ) in this preferred embodiment can range from two to four, depending on the number of commissural posts present in the valve sinus.
- the anchoring structure comprises three support posts for a three-leaflet valve with a sinus that features three natural commissural posts.
- the support posts ( 22 ) of the anchoring structure are configured to coincide with the natural commissural posts of the sinus.
- FIGS. 6A and B show the preferred embodiment of FIG. 5 having a valve secured internally.
- the valve ( 32 ) is secured at its proximal (inflow) annulus ( 33 ) by attachment to the inflow rim ( 20 ) of the anchoring structure and at its outflow or distal end ( 34 ) via the commissural tabs ( 35 ) that are threaded through the axially extending slots ( 21 ), which are formed in the support posts ( 22 ) that extend longitudinally from the inflow rim ( 20 ) to the outflow rim ( 23 ) of the anchoring structure.
- the outflow rim ( 23 ) of the anchoring structure is configured to be longitudinally displaced from the distal outflow annulus ( 34 ) of the valve leaflets ( 36 ) that reside within the lumen of the tubular anchoring structure, thereby avoiding any contact between the valve leaflets ( 36 ) and the anchoring structure.
- the inflow rim ( 20 ) of the anchoring structure can be secured to the proximal inflow annulus ( 33 ) of the valve via a suitable fabric that may be wrapped around the circumferential juncture at the inflow end ( 33 ) and stitched into position to form a sewing cuff ( 37 ).
- the fabric may be made of any suitable material including but not limited to woven polyester, such as polyethylene terepthalate, polytetrafluoroethylene (PTFE), or other biocompatible material.
- the valve ( 32 ) is secured inside the anchoring structure by sewing a fabric ring ( 37 ) around the inflow rim ( 20 ) of the anchoring structure so as to create a sealing surface around the outer perimeter of valve's inflow annulus ( 33 ).
- the fabric ring ( 37 ) comprises two sewing cuff rings as shown in FIGS. 6A and B, with the second sewing cuff ring ( 38 ) having a larger diameter than the inflow annulus of the native valve sinus to ensure the firm lodging of the anchoring structure against the inflow annulus of the native valve sinus, thereby creating a tight, gasket-like seal.
- valve ( 32 ) The positioning of the valve ( 32 ) internally to the preferred anchoring structure with only the fabric of the commissural mounting tabs ( 35 ) of the valve ( 32 ) contacting the support posts ( 22 ) at the distal outflow annulus of the valve ( 34 ), while the proximal inflow annulus ( 33 ) of the valve is separated from the inflow rim ( 20 ) of the anchoring structure by the sewing cloth ( 37 ), ensures that no part of the valve ( 32 ) is contacted by the anchoring structure during operation of the valve ( 32 ), thereby eliminating wear on the valve ( 32 ) that may be occasioned by contact with mechanical elements.
- the outflow rim ( 23 ) of the anchoring structure is depicted as comprising a plurality of rings that extend between the support posts ( 22 ) generally at or above the axially extending slots ( 21 ) that reside at their distal ends ( 24 ).
- the plurality of rings of the outflow rim ( 23 ) are configured in an undulating or zigzag pattern forming peaks ( 26 ) and valleys ( 27 ), wherein the individual rings remain substantially parallel to one another.
- the plurality of rings of the outflow rim comprise a vertical connector element ( 28 ) positioned at the center of the valleys ( 27 ) formed by the undulating or zigzag pattern.
- This vertical connector element ( 28 ) is designed to stabilize the anchoring structure and to prevent distortion of the valve during compression and expansion of the anchoring structure containing the valve within.
- the vertical element ( 28 ) extends longitudinally in the axial direction of the cylindrical anchoring structure.
- the outflow rim of the anchoring structure comprises two rings.
- FIG. 6C shows another implementation of a preferred anchoring structure of the present invention.
- the implementation shown in FIG. 6C features an inflow rim ( 20 ) comprising two rings that are substantially parallel to each other and are connected by a vertical connector element ( 39 ) positioned at the center of the peaks ( 29 ) formed by the undulating or zigzag pattern.
- This vertical connector element ( 39 ) is designed to stabilize the anchoring structure and to prevent distortion of the valve during compression and expansion of the anchoring structure comprising the valve.
- the vertical element ( 39 ) extends longitudinally in the axial direction of the cylindrical anchoring structure.
- FIG. 6C also shows that the distal end ( 24 ) of the support post ( 22 ) may further comprise suture bores ( 41 ) to facilitate the placement of additional sutures for the securing the valve to the anchoring structure.
- the wavelengths and wave heights of the inflow ( 20 ) and outflow rims ( 23 ) are selected to ensure uniform compression and expansion of the anchoring structure without distortion, a different wavelength and height may be chosen for the inflow ring ( 20 ) of an implementation of a preferred embodiment of an anchoring structure featuring an inflow rim ( 20 ) with two substantially parallel undulating rings as shown in FIG. 6C .
- the inflow rim ( 20 ) depicted in FIG. 6C may have substantially the same wavelength and height as the outflow rim ( 23 ).
- the support posts ( 22 ) may be modified to comprise a widened proximal end ( 25 ) with an axial slot ( 40 ) extending longitudinally from the inflow rim ( 20 ) toward the distal end ( 24 ) of the support posts ( 22 ) and centrally through the triangular shaped elements ( 31 ).
- the widening of the proximal end ( 25 ) of the support posts ( 22 ) protects the triangular shaped elements ( 31 ) from distortion by the different collapsed profile of the inflow rim ( 20 ) with larger wavelength and height and ensures that no part of the valve ( 32 ) will be contacted by the anchoring structure during compression.
- FIGS. 7 and 8 show the expansion ( FIG. 7 ) and compression ( FIG. 8 ) profile of a preferred anchoring structure of the present invention.
- the anchoring structure is collapsible to at least 50% of its expanded diameter.
- the undulating or zigzag pattern that forms the inflow rim ( 20 ) of the anchoring structure is configured such that the proximal ends ( 25 ) of the vertical support posts ( 22 ) are connected to the peaks ( 29 ) of the inflow rim ( 20 ).
- the undulating or zigzag pattern that forms the outflow rim ( 23 ) of the anchoring structure is configured such that the support posts ( 22 ) are connected to the valleys ( 27 ) of the outflow rim ( 23 ). Locating the distal ends ( 24 ) of the support posts ( 22 ) at the valleys ( 27 ) of the outflow rim ( 23 ) will prevent the longitudinal extension of outflow rim ( 23 ) in the direction of the valve upon compression of the device, thereby eliminating any contact between valve and anchoring structure.
- proximal ends ( 25 ) of the support posts ( 22 ) at the peaks ( 29 ) of the inflow rim ( 20 ) prevents structural interference between the proximal ends ( 25 ) of the support posts ( 22 ), in particular the triangular shaped elements ( 31 ) designed to support the scalloped inflow annulus of the replacement valve, and the undulating pattern of the inflow rim ( 20 ), as well as longitudinal extension of the inflow rim ( 20 ) in the direction of the valve tissue.
- compression of the valve and anchoring structure does not lead to distortion of or injury to the valve.
- FIG. 8 shows that the support posts ( 22 ) connect to the outflow rim ( 23 ) at a valley ( 27 ) of the undulating or zigzag pattern and that during compression, the support posts stabilize the anchoring structure by preventing any longitudinal extension at points of valve attachment, that is at the proximal ( 25 ) and distal ( 24 ) ends of the support posts.
- the commissural mounting tabs of the valve are attached to the anchoring structure by extending through the axial slots ( 40 ) of the support posts to the exterior of the anchoring structure, while the inflow annulus of the valve is connected to the inflow rim ( 20 ) of the anchoring structure via a fabric ring.
- the number of support posts ( 22 ) in this preferred embodiment can range from two to four, depending on the number of commissural posts present in the valve sinus.
- the anchoring structure comprises three support posts ( 22 ) for a three-leaflet valve with a sinus that features three natural commissural posts.
- the support posts ( 22 ) of the anchoring structure are configured to coincide with the natural commissural posts of the sinus.
- an advantage of this arrangement is the additional option for the surgeon of suturing the valve assembly into place, wherein the anchoring structure provides the surgeon with additional guidance as to the proper anatomical positioning of the valve inside the native valve sinuses. Since the anchoring structure is dimensioned to fit precisely into the valve sinus cavities, the surgeon's positioning task is simplified to a visual determination of the location of the commissural posts of the native sinuses and their alignment with the support posts ( 22 ) of the anchoring structure of the valve. Thus, the present preferred embodiment takes advantage of the natural features of the valve sinus for the rapid orientation and attachment of the valve assembly. The ability of the anchoring structure to emulate the architecture of the valve sinus thus significantly reduces the surgeon's time spent on suturing the valve into position, should he so desire.
- the geometry of the preferred embodiment of a valve anchoring structure further naturally positions it across the entire longitudinal extension of the native valve sinus, lodging the anchoring structure firmly against the vessel walls.
- the inflow rim ( 20 ) of the anchoring structure naturally fits into the native valve sinus at a position near the inflow narrowing (annulus) of the native valve sinus against which it is designed to rest
- the outflow rim ( 23 ) of the anchoring structure fits into the sinus at a position near the outflow narrowing (annulus) of the sinus against which it is designed to rest.
- a further advantage of this preferred embodiment of the present invention is the ability of the anchoring structure to emulate the natural compartment formed by the sinus for anchoring the valve.
- the anchoring structure is able to extend completely across the sinuses without placing mechanical elements into the path of fluid flow and without obstructing flow to any vessel openings that may be present in the valve sinuses.
- the anchoring structure exerts radial force against the vessel wall so as to produce a compression fit. This may be accomplished by oversizing the anchoring structure such that it permanently seeks to expand to its original size.
- both the inflow ( 20 ) and outflow ( 23 ) rims are designed to push radially against the sinus walls near the inflow and outflow annuli of the sinus.
- the undulating or zigzag pattern formed by the inflow ( 20 ) and outflow ( 23 ) rings further serves to provide tire-like traction against the sinus wall for anchoring.
- the combination of compression fit, traction and sewing cuff rings ( 37 and 38 ) of the anchoring structure provides a firm anchor for the replacement valve and an optimal configuration in the native valve sinus.
- the anchoring structure comprises a material that is expandable from a compressed configuration illustrated in FIG. 8 into the configuration depicted in FIG. 7 .
- the anchoring structure may be non-self expanding, i.e. capable of being expanded from a compressed state using mechanical means, such as a balloon inflated from within the radial center of the anchoring structure, or using the expansion and compression devices disclosed herein.
- the anchoring structure comprises vertical tab support posts ( 22 ) which are designed to prevent inelastic deformation when the anchoring structure is collapsed prior to implantation.
- FIG. 9 shows a representative flat valve leaflet ( 36 ) before it is sewn together with a desired number of additional leaflets ( 36 ) to form a three-dimensional replacement valve.
- the flat pattern of the leaflet ( 36 ) can be used to dimension the anchoring structure shown in FIG.
- commissural tabs ( 35 ) of the valve ( 36 ) will coincide with the axial slots ( 21 ) at the distal ends ( 24 ) of the support posts ( 22 ) and the proximal edges ( 42 ) at which the leaflets will be stitched or otherwise attached to each other to form the inflow annulus of the valve can be attached to the proximal ends ( 25 ) of the support posts ( 22 ) of the anchoring structure via the triangular shaped elements ( 31 ).
- FIGS. 9 and 10 also show how an anchoring structure and valve may be scaled to fit different sizes of valve sinuses while retaining the proportional dimensions of the valve sinus. For example, if the width ( 43 ) of the leaflet ( 36 ) shown in FIG. 9 is chosen for a certain valve size, then the distance ( 44 ) between support posts ( 22 ) of the anchoring structure shown in FIG. 10 will be determined accordingly. Likewise, the height ( 45 ) of the leaflet ( 36 ) in FIG. 9 will determine the length ( 46 ) of the support posts ( 22 ) of the anchoring structure in FIG. 10 . In this manner, a person of skill in the art can dimension both the valve and anchoring structure to fit any size of valve sinus.
- FIGS. 11 and 12 Another preferred embodiment of the present invention, illustrated in FIGS. 11 and 12 , comprises a valve supported by a flared anchoring structure.
- the flared anchoring structure preferably comprises flared-out sections located at both the inflow ( 47 ) and outflow rims ( 48 ) to anchor it firmly against the narrowed inflow and outflow annuli of the valve sinuses.
- the flared distal end ( 48 ) of the anchoring structure is adapted to support the tab regions of the valve while the flared proximal end ( 47 ) supports the valve inflow annulus ( 33 ).
- the flared-out feature prevents contact between the valve tissue and the anchoring structure if the outflow rim ( 48 ) is positioned below the upper edges of the valve leaflets ( 36 ) in the open position, while also allowing the anchoring structure to secure itself in a sinus cavity of the vascular passageway.
- the outflow rim ( 48 ) of the anchoring structure is comprised of diamond ( 49 ) and hexagon ( 50 ) shaped structures which facilitate collapsibility and dynamic compliance.
- the commissural tabs ( 35 ) of the valve ( 32 ) can be stitched directly to the hexagon shaped elements ( 50 ) of the outflow ring, rather than being secured via slots.
- the flared inflow rim ( 47 ) of the anchoring structure preferably comprises a single ring in the form of an undulating or zigzag pattern to which the valve's fabric ring ( 37 ) can be sewn.
- the inflow ring ( 47 ) of the anchoring structure is connected to the outflow rim ( 48 ) through vertical elements ( 51 ) that are positioned to coincide with the commissural posts of the native sinus region.
- the exemplary embodiment of FIGS. 11 and 12 comprises three vertical connecting elements ( 51 ) for a three-leaflet valve ( 32 ).
- the number of vertical connecting elements ( 51 ) is meant to be adapted to the number of native commissural posts present in the particular sinus region.
- the area between vertical connector elements ( 51 ) is thus left free of any structural elements for the accommodation of vessel openings that may be present in the particular valve sinus.
- a valve is supported by an anchoring structure comprising a plurality of posts ( 52 ) with a single ring ( 53 ) at the inflow rim.
- the ring ( 53 ) is configured in an undulating or zigzag pattern.
- the plurality of posts ( 52 ) number three for a three-leaflet valve sinus region.
- the three posts ( 52 ) extend in the distal direction from the single ring ( 53 ) located at the inflow end of the anchoring structure.
- the proximal end ( 33 ) of the valve is attached to the ring ( 53 ) portion of the anchoring structure so that the ring ( 53 ) provides support to the inflow annulus ( 33 ) of the valve.
- the inflow ring ( 53 ) comprises an undulating or zigzag pattern for tire-like traction against the vessel wall.
- the anchoring structure portion surrounding the proximal end ( 33 ) of the valve is preferably flared in an outward direction to improve anchoring forces against the vascular wall.
- the three posts ( 52 ) extend from the proximal end ( 33 ) to the distal end ( 34 ) of the valve and provide cantilevered support to the tab regions ( 35 ) of the valve at the distal end ( 34 ).
- the three posts ( 52 ) are designed to be sufficiently flexible so that they may deflect inwardly in a controlled motion at back flow pressures to optimize the fatigue life of the anchoring structure.
- the posts ( 52 ) comprise a distal end ( 54 ) for the attachment of the valve commissural tabs ( 35 ). Below the distal end ( 54 ), the posts ( 52 ) comprise a diamond-shaped element ( 55 ) for enhanced structural stability and valve support.
- the design according to the present embodiment creates open space between the proximal ( 33 ) and distal ends of the valve ( 34 ). This also ensures that there is no direct contact between the valve and the anchoring structure and that vessel openings located within the particular sinus remain unencumbered.
- the support posts ( 52 ) are configured to spatially coincide with the commissural posts of the valve sinuses for ease of positioning and anatomical optimization.
- the anchoring structure embodiment illustrated in FIG. 14 comprises a valve supported by a multi-operational anchoring structure ( 56 ).
- the multi-operational anchoring structure ( 56 ) comprises a proximal end ( 57 ), a distal end ( 58 ), posts ( 59 ) extending from the proximal end ( 57 ) to the distal end ( 58 ), and a tab attachment window ( 60 ) attached to each post ( 59 ) at the distal end ( 58 ).
- the tab attachment windows ( 60 ) in the present embodiment have a triangular geometry that is designed to create an optimal interference fit between the anchoring structure and the commissural tabs.
- the post ( 59 ) and tab attachment window ( 60 ) construction of the present embodiment allows inward deflection of the post at back flow pressure, thus providing cantilevered support to the valve and greater dynamic compliance with the sinus region.
- Both the proximal ( 57 ) and distal ( 58 ) ends of the anchoring structure are flared out to better secure the valve in the valvular sinus region.
- the proximal end or inflow rim ( 57 ) of the anchoring structure also preferably possesses barbs or hooks ( 61 ) at the proximal end ( 62 ) of the post ( 59 ) for better attachment to the vascular wall and/or the valve's inflow annulus.
- the flared inflow rim ( 57 ) is depicted as featuring two undulating rings that are substantially parallel to one another, while the flared outflow rim features three undulating rings.
- FIGS. 15-21 Yet another preferred embodiment of a valve anchoring device according to the present invention is illustrated in FIGS. 15-21 .
- an elliptical segment ( 70 ) anchoring structure is used to support the valve ( 32 ) as shown in FIG. 15A .
- the elliptical segment anchoring structure ( 70 ) comprises a plurality of elliptical segments ( 71 ) that are joined together, either integrally, mechanically, or by adhesive means.
- Each elliptical segment ( 71 ) is flared outward at the proximal ( 72 ) and distal ends ( 73 ) of the anchoring structure and curved inward at the junctures ( 74 ) with the other segments ( 71 ) assuming the shape of a potato chip.
- the elliptical segments ( 71 ) form a tubular structure that is flared outward at both the inflow ( 72 ) and outflow ( 73 ) ends.
- the junctures ( 74 ) of the elliptical segments ( 71 ) are located at the center of a substantially straight area of the elliptical segments ( 71 ) that defines the longitudinal support post elements ( 75 ) of the elliptical segment anchoring structure ( 70 ) and also provides a gap location ( 75 ) near which the valve tabs ( 35 ) can be secured.
- the tab regions ( 35 ) extending from the seams of the valve can be attached to the anchoring structure using any suitable means, including, sewing, stapling, wedging or adhesive means.
- the tab regions ( 35 ) are preferably attached to the gaps ( 75 ) formed above the junctures ( 74 ) between the elliptical segments ( 71 ).
- the inflow ( 72 ) and outflow ( 73 ) rims of the anchoring structure are formed by the corresponding regions of the elliptical segments ( 71 ) that reside below and above the junctures ( 74 ).
- the inflow annulus of the valve can be secured at the inflow rim ( 72 ) via stitching to the inflow annulus fabric which also serves as a sealing gasket.
- FIG. 16A shows how both the valve ( 32 ) and anchoring structure ( 70 ) of the present embodiment can be compressed radially to facilitate implantation.
- the concave configurations of the elliptical segments ( 71 ) effectively form a radial spring that is capable of being radially collapsed under pressure for deployment and then expanded when positioned at the implant site.
- One advantageous feature of the instant design is that the region of juncture ( 74 ) between the elliptical segments ( 71 ) does not become extended upon compression of the anchoring structure.
- the valve ( 32 ) and anchoring structure ( 70 ) of the present embodiment can also be compression fit within a valve sinus cavity to exert radial force against the sinus walls.
- the anchoring structure ( 70 ) is preferably dimensioned to be lodged substantially within a valve sinus, with the regions of juncture ( 74 ) between the elliptical segments ( 71 ) being configured to reside at the location of the native commissural posts.
- the elliptical segment anchoring structure ( 70 ) is designed to expand at the proximal end ( 72 ) during peak flow and at the distal end ( 73 ) during peak backflow pressure, thereby maintaining pressure against the vascular wall.
- the valve and anchoring structure ( 70 ) of the present embodiment will remain secure in the valve sinus without sutures.
- a metal wire frame made from a metal that exhibits a high modulus of elasticity and that is biocompatible is preferred, such as Nitinol, as such materials exhibiting superior compressibility allow the anchoring structure to be self-expandable.
- FIGS. 18A and B A further preferred embodiment of a valve anchoring structure according to the present invention is illustrated in FIGS. 18A and B.
- an elliptical segment anchoring structure ( 70 ) is presented in which the elliptical segments ( 71 ) are joined together by a specialized double crimp ( 78 ).
- FIG. 18B shows that the valve tabs ( 35 ) can be secured near the double crimp ( 78 ) that joins the elliptical segments ( 71 ).
- the tab regions ( 35 ) are preferably attached to the gaps ( 75 ) between the elliptical segments ( 71 ).
- the inflow annulus of the valve ( 33 ) can be secured at the inflow rim ( 72 ) via stitching to the inflow annulus fabric which also serves as a sealing gasket.
- FIGS. 19A and B illustrate the double crimp ( 78 ) used to join the elliptical segments ( 71 ).
- the double crimp ( 78 ) comprises two hollow tubes ( 79 ), one for each elliptical segment ( 71 ) to be inserted.
- the hollow tubes ( 79 ) of the double crimp ( 78 ) are designed to allow for better motion of the individual elliptical segments ( 71 ) and to minimize material stresses during expansion and compression of the anchoring structure.
- the double crimp ( 78 ) further comprises a central portion ( 80 ) joining the two hollow tubes ( 79 ).
- This central portion ( 80 ) comprises one or more holes ( 81 ) to facilitate the attachment of the valve commissural tabs to the anchoring structure and to reduce the mass of the double crimp ( 78 ).
- the double crimp ( 78 ) also serves as an attachment site for the valve and further acts as a stop against backflow pressure on the valve leaflets.
- FIG. 20A shows the insertion of the elliptical segments ( 71 ) of the preferred anchoring structure embodiment ( 70 ) into the double crimp ( 78 ).
- the present embodiment is dimensioned to be lodged substantially within the valve sinuses, with the joined regions ( 74 ) of the elliptical segments in FIG. 20B configured to align with the commissural posts of the sinus and the flared inflow ( 72 ) and outflow ends ( 73 ) of the anchoring structure configured to rest against the sinus cavities.
- FIGS. 21A through G show how the elliptical segment anchoring structure ( 70 ) may additionally be covered with cloth ( 82 ), particularly at the inflow end ( 72 ) to provide traction and a gasket-like seal.
- this preferred embodiment of the present invention is dimensioned to follow the sinus architecture and to lodge into the sinus cavities and against the inflow and outflow annuli of the sinuses for optimal securing and positioning of the replacement valve.
- FIGS. 22A and B illustrate a further preferred embodiment the present invention.
- This figure shows an elliptical segment anchoring structure ( 90 ) made from one piece of tubing.
- the support posts ( 91 ) that form the slots ( 92 ) for the valve tabs include a series of small holes ( 93 ) on either side of the slot ( 92 ) to facilitate suture or mechanical attachment of the commissural tabs of the valve.
- this anchoring structure ( 90 ) is dimensioned to fit substantially within the valve sinuses with the support posts ( 91 ) being configured to reside in the commissural posts between the individual sinus cavities.
- the present embodiment also exerts axial force particularly at the flared inflow ( 94 ) and outflow rims ( 95 ) against the sinus walls to anchor the valve.
- FIGS. 23A through D Yet another embodiment of a valve and anchoring structure according to the present invention is illustrated in FIGS. 23A through D.
- a claw anchoring structure ( 100 ) is shown in FIG. 23A .
- This embodiment corresponds to an elliptical segment embodiment wherein the upper portions of each elliptical segment have been removed.
- the ends of the junctures ( 101 ) of the remaining elliptical segments are shaped into prongs or claws ( 102 ).
- the claw anchoring structure ( 100 ) comprises a flexible spring frame having a plurality of barbs ( 102 ), located distally just beyond where the valve leaflet tab regions meet the anchoring structure.
- the claw anchoring structure ( 100 ) preferably comprises at least one barb ( 102 ) for each valve leaflet tab included in the valve.
- the barbs ( 102 ) are designed to anchor the valve ( 32 ) and anchoring structure ( 100 ) to the vascular wall.
- an anchoring structure that lacks vertical support posts.
- the representative anchoring structure configuration comprises an inflow ring ( 110 ) that is adapted to being secured to the inflow annulus of the valve ( 33 ) via stitching to the reinforced fabric sewing ring in a manner similar to the prior representative implementations.
- the undulating or sinusoidal pattern of the ring ( 110 ) facilitates radial collapse and expansion and exerts radial force against the vessel wall.
- the anchoring structure does not support the outflow annulus ( 34 ) of the valve. Rather, the valve's commissural tabs ( 35 ) are attached to the sinus walls via mechanical means, such as sutures, staples, or wire.
- FIG. 25A Another representative embodiment of an anchoring structure is shown in FIG. 25A .
- the present embodiment comprises a dual-ring anchoring structure ( 120 ).
- the dual ring ( 120 ) of the present embodiment may, as in the previous embodiment, be secured to the inflow annulus of the valve via stitching to the reinforced fabric sewing ring.
- the undulating or sinusoidal pattern of the individual rings ( 121 ) is configured such that the peaks ( 122 ) of one ring ( 121 ) coincide with the valleys ( 123 ) of the other ring and vice versa, thereby forming a sine-cosine pattern. This pattern facilitates radial collapse and expansion and exerts radial force against the vessel wall.
- the dual ring anchoring structure ( 120 ) does not support the outflow annulus of the valve. Rather, the valve's commissural tabs are attached to the native sinus walls via mechanical means, such as sutures, staples, or wire, or additionally by the adhesive means disclosed herein.
- FIG. 25B shows another dual ring embodiment of the present invention.
- This anchoring structure is comprised of an upper (distal) dual ring ( 130 ) and a lower (proximal) dual ring ( 131 ).
- the lower dual ring ( 131 ) is connected to the proximal end of the valve at the inflow annulus while the upper dual ring ( 130 ) is connected to the distal end of the valve at the outflow annulus.
- the valve may be connected to the rings ( 130 , 131 ) via sutures, clips or any other suitable means for attachment.
- the valve and the attached proximal ( 131 ) and distal ( 130 ) rings can be collapsed and inserted via a catheter.
- each dual ring ( 130 , 131 ) comprises a wire frame with a circular cross-section and a sinusoidal pattern.
- the sinusoidal pattern may be of a sine-cosine shape with a varied frequency and amplitude.
- One or more longitudinal rods ( 132 ) may be used to connect the two dual rings ( 130 , 131 ) and maintain longitudinal separation and radial orientation. The rods ( 132 ) may be removable so that once the valve is implanted in the vascular passageway they can be removed.
- an upper single ring ( 140 ) with an undulating or zigzag pattern provides support to the tab regions ( 35 ) of the valve ( 32 ) at the distal end ( 34 ) of the valve whereas a lower single ring ( 141 ) configured in an undulating or sinusoidal pattern provides support to the inflow annulus ( 33 ) at the proximal end of the valve ( 32 ).
- the inflow ring ( 141 ) is stitched to the sewing fabric wrapped around the circumference of the inflow annulus of the valve, as described previously.
- the outflow ring ( 140 ) of the anchoring structure generally resides above the leaflets ( 36 ) to avoid leaflet contact.
- the inflow or outflow rings may comprise attachment barbs ( 142 ).
- the structural dissociation between the rings ( 140 , 141 ) provides improved dynamic compliance while retaining the benefits of a two ring design.
- FIGS. 27A through C Yet another embodiment of a valve and anchoring structure according to the present invention is illustrated in FIGS. 27A through C.
- the valve ( 32 ) is supported by a tubular anchoring structure ( 150 ).
- the tubular anchoring structure ( 150 ) is preferably made of metal or plastic.
- the tubular anchoring structure ( 150 ) is also preferably designed to be expandable.
- the anchoring structure may be designed to be self-expandable, balloon-expandable, or mechanically-expandable.
- the tab regions ( 35 ) of the valve ( 32 ) are preferably attached to the distal end ( 151 ) of the tubular anchoring structure ( 150 ) using staples, sutures, wire fasteners, or any other suitable means.
- the inflow rim ( 152 ) of the tubular anchoring structure may comprise a plurality of suture bores ( 153 ) to facilitate attachment of the valve ( 32 ).
- the tubular anchoring structure ( 150 ) also comprises vertical support posts ( 154 ) with axial slots ( 155 ) for the insertion of the valve tabs ( 35 ).
- the vertical support posts ( 154 ) extend to the distal end ( 151 ) of the tubular anchoring structure ( 150 ).
- the means of attachment is used to also attach the tab regions ( 35 ) of the valve ( 32 ) to the vascular wall thereby securing the valve ( 32 ) and tubular anchoring structure ( 150 ) in the valve sinuses.
- Such fastening means can also be optionally used at the inflow annulus to provide additional anchoring.
- FIG. 28 Another embodiment of a valve and anchoring structure according to the present invention is illustrated in FIG. 28 .
- a dual-ring anchoring structure ( 160 ) is shown, as seen in FIGS. 28C and D, with an inflow ring ( 161 ) and an outflow ring ( 162 ) connected by a vertical element ( 163 ) comprised of two posts ( 164 ).
- the anchoring structure ( 160 ) is designed to be circumferentially collapsible as can be seen in FIGS. 28A and B. As shown in FIGS. 28C and D, the anchoring structure ( 160 ) is collapsed by sliding the two posts ( 164 ) that are adjacent to each other in the expanded state ( FIG.
- the anchoring structure ( 160 ) prior to implantation the anchoring structure ( 160 ) is collapsed and, once the valve is properly positioned in the valve sinuses, the anchoring structure freely self-expands to its original dimensions.
- the self-expanding behavior of the present embodiment is due to Nitinol's relatively high modulus of elasticity, which imparts superior spring-like properties to the anchoring structure.
- the anchoring structure is constructed of a non-self expanding material, it may be mechanically collapsed and expanded using the devices disclosed herein.
- FIGS. 29A and B Another embodiment of a valve and anchoring structure according to the present invention is illustrated in FIGS. 29A and B.
- a dual-ring anchoring structure ( 170 ) is shown, with an inflow ring ( 171 ) and an outflow ring ( 172 ) connected by a vertical element ( 173 ) comprised of two posts ( 174 ).
- the inflow rim may further comprise tissue mounting posts ( 175 ).
- the anchoring structure ( 170 ) is designed to be circumferentially collapsible.
- FIG. 29A shows how the posts ( 174 ) are separated in the expanded state
- FIG. 29B shows how the posts ( 174 ) form a single vertical element ( 173 ) in the collapsed state.
- the anchoring structure prior to implantation the anchoring structure is collapsed and upon the positioning of the valve assembly in the valve sinuses, the anchoring structure ( 170 ) freely self-expands to its original dimensions.
- the self-expanding behavior of the present embodiment is a function of Nitinol's high modulus of elasticity.
- the anchoring structure is constructed of a non-self expanding material, it may be mechanically collapsed and expanded using the devices disclosed herein.
- FIGS. 30A and B A further embodiment of a valve and anchoring structure according to the present invention is illustrated in FIGS. 30A and B.
- the present embodiment comprises a spring-aided anchoring structure ( 180 ).
- the spring aided anchoring structure ( 180 ) preferably comprises three members ( 181 ) that are radially collapsible for implantation into the valve sinuses.
- the members ( 181 ) comprise peaks ( 182 ) that serve as valve attachment points and valleys ( 183 ) that serve to lodge the anchoring structure at the valve sinus inflow annulus.
- the anchoring structure ( 180 ) is expanded to its original dimensions by coil springs ( 184 ) that provide an outward radial force on each member.
- the spring aided anchoring structure ( 180 ) comprises at least one anchoring section ( 185 ) for selectively securing the anchoring structure ( 180 ) in the valve sinus at the inflow annulus.
- the present embodiment illustrates three members ( 181 ) and three coil springs ( 184 ), it should be appreciated that two or more members ( 181 ) with a corresponding number of coil springs ( 184 ) may be used.
- the anchoring structures of the present invention may be constructed from superelastic memory metal alloys, such as Nitinol, described in U.S. Pat. No. 6,451,025, incorporated herein by reference.
- Nitinol belongs to a family of intermetallic materials which contain a nearly equal mixture of nickel and titanium. Other elements can be added to adjust or modify the material properties.
- Nitinol exhibits both shape memory and superelastic properties.
- the shape memory effect of Nitinol allows for the restoration of the original shape of a plastically deformed structure by heating it. This is a result of the crystalline phase change known as thermoelastic martensitic transformation.
- Nitinol is martensitic, i.e. easily deformable.
- the valve assembly Prior to implantation, the valve assembly is chilled in sterile ice water. Upon cooling, the Nitinol anchoring structure enters its martensite phase. Once in this phase, the structure is malleable and can maintain a plastically deformed crushed configuration. When the crushed anchoring structure comprising the valve is delivered into the valve sinus, the increase in temperature results in a phase change from martensite to austenite. Through the phase change, the anchoring structure returns to its memorized shape, and thus expands back to its original size.
- the anchoring structures can also be designed to use the superelasticity properties of Nitinol. With the superelastic design, the chilling procedure would not be necessary. The anchoring structure would be crushed at room temperature. The phase change to martensite would be accomplished by means of the stress generated during the crushing process. The anchoring structure would be held in the crushed configuration using force. Force is removed once the anchoring structure is delivered to the valve sinus, resulting in a phase transformation of the Nitinol from martensite to austenite. Through the phase change, the anchoring structure returns to its memorized shape and stresses and strains generated during the crushing process are removed.
- the anchoring structures of the present invention may be composed of a non-self expanding suitable material, such as biocompatible metals, including titanium, and plastics. Whether the valve assembly is designed to be self-expandable or non-self expandable, it may be compressed (and expanded, if non-self expandable) for implantation using the expansion and contraction devices disclosed herein.
- FIGS. 31-33 A preferred embodiment of an expansion and contraction device for implanting the valve assemblies of the present invention is illustrated in FIGS. 31-33 .
- the device of the present embodiment comprises a group of bendable hollow tubes or wires ( 200 ), a grip handle ( 201 ), and a circular element ( 202 ) that holds the wires ( 200 ) together at their proximal ends ( 203 ).
- Each wire ( 200 ) comprises a proximal end ( 203 ), a distal end ( 204 ) and a hollow shaft ( 205 ) running from the proximal end ( 203 ) to the distal end ( 204 ).
- the wires ( 200 ) are attached to the grip handle ( 201 ) at their proximal ends ( 203 ) via the circular element ( 202 ) such that the wires form a circular pattern.
- the expansion and contraction device further comprises a cylinder ( 206 ) having a proximal end ( 207 ) and a distal end ( 208 ).
- the cylinder ( 206 ) has holes ( 209 ) drilled along its distal perimeter ( 208 ).
- the holes ( 209 ) in the cylinder ( 206 ) are preferably drilled at an outward angle so that by forcing the wires ( 200 ) through the angled holes ( 209 ), the distal ends ( 204 ) of the wires ( 200 ) are driven radially outward.
- the angle of the cylinder holes ( 209 ) controls the relationship between the longitudinal movement of the wires ( 200 ) and their radial dilation.
- a representative anchoring structure ( 210 ) of the present invention is attached to the distal ends ( 204 ) of the hollow wires ( 200 ).
- the cylinder ( 206 ) having a proximal end ( 207 ) and a distal end ( 208 ) has holes ( 209 ) drilled along its distal perimeter ( 208 ).
- the holes ( 209 ) in the cylinder ( 206 ) are drilled at an outward angle so that by forcing the wires ( 200 ) through the angled holes ( 209 ), the distal ends ( 204 ) of the wires ( 200 ) are driven radially outward.
- a long suture is routed from the proximal end to the distal end of the wire down its hollow shaft, looped around a segment of the anchoring structure at the distal end of the wire and then routed back to the proximal end of the wire, where it is secured.
- the anchoring structure ( 210 ) contracts and expands radially in response to the longitudinal motion of the wires ( 200 ). Pulling the grip handle ( 201 ) proximally contracts the anchoring structure ( 210 ) into a collapsed state for implantation whereas pushing the grip handle ( 201 ) distally expands the anchoring structure ( 210 ).
- the anchoring structure ( 210 ) is positioned in a desirable location in the vessel and expanded to the desired dimensions, the sutures are severed and removed from the proximal end ( 203 ) of the wires ( 200 ) in order to disconnect the anchoring structure ( 210 ) from the device. The device of the present embodiment is removed, thereby leaving the valve assembly securely situated in the valve sinus.
- the device of the present embodiment comprises a tube ( 220 ), multiple wall panels ( 221 ), springs ( 222 ) corresponding to the multiple wall panels ( 221 ), a spindle ( 223 ) and a plurality of connecting wires ( 224 ).
- the tube ( 220 ) comprises a hollow shaft ( 225 ) having a radial center ( 226 ), a proximal end ( 227 ), a distal end ( 228 ) as shown in FIG.
- the perimeter of the exterior wall ( 230 ) is surrounded by adjacent wall panels ( 221 ), only buffered by the springs ( 222 ) corresponding to the wall panels ( 221 ).
- the spindle ( 223 ) is attached to the interior wall ( 229 ) of the tube ( 220 ), preferably facing the tube's ( 220 ) radial center ( 226 ).
- a connecting wire ( 224 ) is attached to each wall panel ( 221 ) and routed through the spring ( 222 ) and the corresponding hole ( 231 ) in the tube wall ( 229 , 230 ) to meet the other connecting wires ( 224 ), preferably at the radial center ( 226 ) of the tube ( 220 ).
- the tension in the wires ( 224 ) is relieved to force the wall panels ( 221 ) outward, thereby expanding the anchoring structure and valve.
- the length of the uncompressed spring ( 222 ) determines the diameter to which the anchoring structure can be expanded.
- the anchoring structure can optionally be secured to the wall panels ( 221 ), by staples, sutures, wire fasteners, or any other suitable means, so that the valve assembly may be selectively expanded and collapsed by preferably varying the tension on the connecting wires.
- the anchoring structure ( 240 ) is composed of a shape memory metal or the like having a relatively high modulus of elasticity, and possessing an outward spring-like force when in a compressed state. Therefore, spring loaded wall panels are not necessary in the present embodiment. Instead, the wires ( 241 ) pass through sutures ( 242 ) that are threaded through holes ( 243 ) in the tube ( 244 ) wall and wrap around portions of the anchoring structure. Thus, the wires ( 241 ) keep the anchoring structure ( 240 ) compressed by pulling the sutures ( 242 ) around the anchoring structure ( 240 ) against the tube ( 244 ).
- the tube structure can be omitted with only the wires ( 241 ) and sutures ( 242 ) keeping the anchoring structure ( 240 ) in a compressed state. This would ensure that the valve within the anchoring structure is not contacted by any mechanical elements, such as a tube ( 244 ).
- the tube could be made from a cloth- or tissue-like material.
- each wall panel ( 250 ) is connected to a pin ( 251 ) which runs through the corresponding hole ( 252 ) in the tube ( 253 ) wall.
- the pin ( 251 ) protruding radially inward from the tube's interior, is preferably spring-loaded ( 254 ) toward the radial center of the tube ( 253 ).
- the wall panels ( 250 ) rest against the exterior wall of the tube ( 253 ) and the collapsed anchoring structure rests against the wall panels ( 250 ).
- the present embodiment comprises a longitudinal shaft ( 255 ) running through the radial center of the tube.
- the shaft is comprised of a proximal end ( 256 ) and a distal end ( 257 ).
- the distal end ( 257 ) is connected to a central plate ( 258 ) having spiral shaped edges ( 259 ) as shown in FIGS. 37B and C.
- the central plate ( 258 ) is located in the tube ( 253 ), parallel to the tube's cross-section and is aligned with the spring-loaded ( 254 ) pins ( 251 ).
- the plate's spiral-shaped edges ( 259 ) preferably cause the distance from the plate's perimeter to the tube's radial center to vary along the plate's ( 258 ) perimeter.
- FIGS. 38A and B show how rotation of the shaft ( 255 ) pushes the wall panels ( 250 ) radially out, thereby expanding the anchoring structure ( 260 ).
- the anchoring structure ( 260 ) is sutured to the wall panels ( 250 ) to allow expansion and contraction of the anchoring structure by alternating rotation of the shaft.
- the sutures are preferably removable from the shaft's ( 255 ) proximal end to free the valve assembly from the device following implantation in the valve sinus.
- an expansion and contraction device similar to the previous embodiment is presented.
- the present preferred embodiment utilizes a circular disk ( 270 ) with pre-cut spiral-shaped grooves ( 271 ) corresponding to the spring-loaded pins ( 272 ).
- the grooves ( 271 ) provide a track of varying depth for the pins ( 272 ) such that the pins ( 272 ) are forced radially outward upon rotation of the disk ( 270 ), thereby expanding the anchoring structure.
- the present invention provides the use of biocompatible adhesives.
- a number of adhesives may be used to seal the valve assembly to the surrounding tissue in the valve sinus. The following are examples of available adhesives and methods of use:
- U.S. Pat. No. 5,549,904 discloses a formulated biological adhesive composition
- a formulated biological adhesive composition comprising tissue transglutaminase and a pharmaceutically acceptable carrier, the tissue transglutaminase in an effective amount to promote adhesion upon treatment of tissue in the presence of a divalent metal ion, such as calcium or strontium.
- a divalent metal ion such as calcium or strontium.
- the two components are mixed to activate the sealable fixation means for securely fixing the valve assembly to tissue at a desired valve location.
- U.S. Pat. No. 5,407,671 discloses a one-component tissue adhesive containing, in aqueous solution, fibrinogen, F XIII, a thrombin inhibitor, prothrombin factors, calcium ions and, where appropriate, a plasmin inhibitor.
- This adhesive can be reconstituted from a freeze-dried form with water. It can contain all active substances in pasteurized form and is then free of the risk of transmission of hepatitis and HTLV III.
- the one-component tissue adhesive is reconstituted from a freeze-dried form with water to activate the sealable fixation means for securely fixing the valve assembly to tissue at a desired valve location.
- the fibrin monomer or noncrosslinked fibrin is converted to activate the sealable fixation means for securely fixing the valve assembly to tissue at a desired valve location.
- U.S. Pat. No. 5,744,545 discloses a method for effecting the nonsurgical attachment of a first surface to a second surface, comprising the steps of: (a) providing collagen and a multifunctionally activated synthetic hydrophilic polymer; (b) mixing the collagen and synthetic polymer to initiate crosslinking between the collagen and the synthetic polymer; (c) applying the mixture of collagen and synthetic polymer to a first surface before substantial crosslinking has occurred between the collagen and the synthetic polymer; and (d) contacting the first surface with the second surface to effect adhesion between the two surfaces.
- Each surface can be a native tissue or implant surface.
- collagen and a multifunctionally activated synthetic hydrophilic polymer are mixed to activate the sealable fixation means for securely fixing the valve assembly to tissue at a desired valve location.
- U.S. Pat. No. 6,113,9408 discloses soluble microparticles comprising fibrinogen or thrombin, in free-flowing form. These microparticles can be mixed to give a dry powder, to be used as a fibrin sealant that is activated only at a tissue site upon dissolving the soluble microparticles. In operation, soluble microparticles comprising fibrinogen or thrombin are contacted with water to activate the sealable fixation means for securely fixing the valve assembly to tissue at a desired valve location.
- thermally activatable adhesive is an adhesive which exhibits an increase in “tack” or adhesion after being warmed to a temperature at or above the activation temperature of the adhesive.
- the activation temperature of the thermally activatable adhesive is between about 28° C. and 60° C. More preferably, the activation temperature is between about 30° C. and 40° C.
- One exemplary thermally activatable adhesive is described as Example 1 in U.S. Pat. No. 5,648,167, which is incorporated by reference herein.
- FIG. 40 shows a preferred embodiment, wherein an outer circumferential reservoir ( 401 ) is located at an outermost radius of a valve anchoring structure ( 400 ) when the anchoring structure ( 400 ) is in an expanded state, wherein the reservoir is filled with a sealable fixation means for securely fixing the valve assembly ( 400 ) at a desired location within a body cavity.
- FIG. 40 further illustrates one embodiment of the reservoir ( 401 ) comprising a sealable fixation means, wherein the sealable fixation means may comprise a one-component biological adhesive.
- the sealable fixation means may be activated by exposing the biological adhesive to blood or heat.
- FIG. 41 illustrates another preferred embodiment wherein the sealable fixation means may comprise a two-component biological adhesive.
- the sealable fixation means may be activated by mixing the two components.
- the second reservoir ( 403 ) would contain the water for the activation of the microparticles.
- the reservoirs may be arranged concentrically as shown in FIG. 41B or adjacent to each other as shown in FIG. 41A .
- FIG. 42 illustrates an exemplary reservoir ( 401 ) which may be attached to the valve anchoring structure by its inner wall ( 404 ) by sutures, glue, staples or some other appropriate method.
- FIG. 42 further illustrates a thin spot ( 405 ) on the outer wall ( 406 ) of the reservoir ( 401 ).
- the thin spots ( 405 ) are areas on the reservoir ( 401 ) that are adapted to rupture when placed under certain levels of pressure. The pressure is exerted on the thin spots ( 405 ) as the reservoir ( 401 ) is expanded along with the valve anchoring structure.
- the thin spots ( 405 ) are unable to withstand the pressure and therefore rupture releasing the contents of the reservoir ( 401 ) or reservoirs.
- the reservoir ( 401 ) is made of an elastic material that expands along with the expansion of the valve anchoring structure.
- FIG. 43 illustrates a cross sectional view of the reservoir ( 401 ).
- the reservoir ( 401 ) may contain a lumen ( 407 ) which extends along at least a portion of the circumference of the reservoir.
- the reservoir ( 401 ) has one or more thin spots ( 405 ) along its outermost circumference, wherein the thin spots ( 405 ) are sized and configured to rupture when the reservoir ( 401 ) is expanded to an appropriate diameter. When the anchoring structure comprising the valve is fully expanded, the pressure exerted upon the expanded thin spots ( 405 ) causes them to rupture.
- the reservoir ( 401 ) is made of a biodegradable material adapted for erosion or rupture to release the content of the reservoir ( 401 ) and activate the sealable fixation means in a desired timeframe after implantation.
- a circumferentially outermost portion is pressure sensitive to rupture, wherein the contents of the reservoir ( 401 ) are released when the reservoir ( 401 ) is compressed against the sinus cavities during expansion and implantation of the valve assembly.
- FIG. 44 shows a cross-sectional view of another preferred embodiment, illustrating thin spots ( 405 ) on a reservoir having two concentric component compartments, an inner compartment ( 408 ) and an outer compartment ( 409 ).
- Component A in an inner compartment ( 408 ) and component B in an outer compartment ( 409 ) are to be mixed to form adhesive for sealing the valve assembly against the valve sinuses.
- the inner compartment ( 408 ) has a plurality of thin spots ( 405 ) along its outermost circumference, wherein the thin spots ( 405 ) are sized and configured to rupture when the reservoir ( 401 ) is expanded to an appropriate diameter.
- the outer compartment ( 409 ) also has a plurality of thin spots ( 405 ) along its innermost circumference.
- the thin spots ( 405 ) of the inner compartment ( 408 ) and the thin spots ( 405 ) of the outer compartment ( 409 ) may be located adjacent to each other.
- the space between the adjacent pair of thin spots ( 405 ) on the inner ( 408 ) and outer ( 409 ) compartment may comprise a piercing element that is activated to rupture the thin spot or the pair of adjacent spots when the reservoir is expanded to an appropriate diameter or a predetermined diameter.
- Other embodiments of reservoir configuration for example, two parallel compartments circumferentially or longitudinally, and suitable activation mechanism for the sealable fixation means are also within the scope of the present invention.
- the present invention further comprises methods and devices for the sizing of native valves that require replacement.
- Intravascular ultrasound uses high-frequency sound waves that are sent with a device called a transducer.
- the transducer is attached to the end of a catheter, which is threaded through a vein, artery, or other vessel lumen.
- the sound waves bounce off of the walls of the vessel and return to the transducer as echoes.
- the echoes can be converted into distances by computer.
- a preferred minimally invasive valve replacement sizer is shown in FIGS. 45A and B.
- the distal end or portion refers to the area closer to the body while the proximal end or portion refers to the area closer to the user of the valve replacement sizer.
- the device comprises a guidewire ( 500 ), an intravascular ultrasound (IVUS) catheter ( 501 ) having a transducer ( 502 ), and a balloon dilatation catheter ( 503 ) all positioned within the central lumen of a catheter.
- the transducer ( 502 ) is positioned in the IVUS sizing window ( 504 ) of the balloon catheter.
- the guide wire ( 500 ) advances and guides the catheter ( 501 ) to the appropriate location for valve sizing.
- FIG. 45A shows the catheter in deflated form, whereas in FIG. 45B the balloon dilatation catheter ( 503 ) has inflated the balloon ( 505 ).
- the catheter ( 510 ) contains multiple lumens ( 511 ) in order to house a guidewire ( 512 ), an IVUS catheter ( 513 ), and a balloon dilatation catheter ( 514 ).
- FIG. 46 illustrates a cross sectional view.
- One of the separate lumens ( 511 ) contains the guidewire ( 512 ), another contains the IVUS catheter ( 513 ), and another contains the balloon dilatation catheter ( 514 ).
- the balloon dilatation catheter ( 514 ) has a balloon ( 515 ) attached circumferentially surrounding the balloon dilatation catheter ( 514 ) as well as a portion of the catheter ( 510 ).
- FIG. 47 shows a balloon dilatation catheter ( 516 ) comprising a balloon ( 517 ) that circumferentially surrounds a portion of the catheter ( 518 ) proximal to its distal portion ( 519 ). More specifically, the balloon ( 517 ) comprises an outer wall ( 520 ) that circumferentially surrounds a portion of the catheter ( 518 ) near its distal portion ( 519 ). The balloon ( 517 ) also has a distal end ( 521 ) and a proximal end ( 522 ). In a preferred embodiment, within the area encompassed by the balloon, a transducer ( 523 ) is located on the IVUS catheter ( 524 ).
- a sizing window ( 525 ) is placed on the IVUS catheter ( 524 ) to enable signals to be transmitted and received by the transducer ( 523 ) without interference.
- the sizing window ( 525 ) is simply an empty space.
- the sizing window ( 525 ) could be made from any substance which does not interfere with the signals emitted and received by the transducer ( 523 ).
- the balloon ( 517 ) is round but other shapes are possible and contemplated for use with the valve sizing apparatus.
- FIG. 48 shows a cross section of an inflated balloon ( 530 ) with curves forming leaflets ( 531 ) to enable fluid ( 532 ) to pass through the vessel while the balloon ( 530 ) is in its inflated state and the outer edges ( 533 ) of the leaflets ( 531 ) are in contact with the vessel wall ( 534 ) to measure the diameter.
- the balloon may further be made from compliant or non-compliant material.
- FIG. 49 shows a preferred embodiment wherein the balloon ( 540 ) is inflated with saline ( 541 ).
- the saline is pumped into the balloon ( 540 ) through the balloon dilatation catheter.
- the balloon ( 540 ) may be inflated with a gas or any other suitable substance.
- the balloon ( 540 ) is inflated to a chosen pressure by the person using the valve replacement sizer. When the balloon ( 540 ) has been inflated, the outermost portion of the outer wall ( 542 ) will be in contact with the vessel wall ( 543 ) or other lumen at the location where the replacement valve is to be placed.
- the farthest radial points of the balloon's outer wall ( 542 ) will be equidistant to the center of the catheter ( 544 ). This distance is labeled as R.
- the transducer ( 545 ) may or may not be at the centermost point of the inflated balloon ( 540 ). Any deviation from the centermost point by the transducer ( 545 ) may be accounted for when calculating the diameter of the vessel lumen. However, the signal emitted by the transducer ( 545 ) preferably intersects the balloon ( 540 ) at its greatest radius.
- FIG. 50 shows a preferred embodiment, wherein a transducer ( 550 ) emits an ultrasonic signal ( 556 ) in a perpendicular direction to the IVUS catheter ( 551 ). The signal is then reflected off the outer wall ( 552 ) of the balloon ( 540 ) and received by the transducer ( 550 ). The transducer ( 550 ) then transmits the data to the auxiliary processor ( 553 ) to determine the radius and diameter of the vessel lumen. Alternatively, an infrared light may be emitted and received by the transducer ( 550 ) to determine the radius and diameter of the vessel lumen.
- the diameter is calculated by knowing the speed of the signal and the time it takes for the signal to be reflected off the balloon wall ( 552 ) back to the transducer ( 550 ). The known speed is multiplied by the time to determine the radius of the balloon ( 540 ). The radius may be adjusted if the transducer ( 550 ) was not located at the centermost point of the catheter.
- the present invention further provides devices and methods to remove the native diseased valves prior to implantation of the replacement valve assembly.
- the valve removing means is provided by the replacement valve assembly.
- the valve removing means is provided by a valve sizing device of the present invention.
- the present invention further provides valve assemblies comprising native valve removing capabilities.
- a valve anchoring structure having cutting means located at the annulus base for cutting a native valve is provided. Accordingly, when passing the valve assembly comprising the valve and anchoring structure through the vessel with the anchoring structure in a collapsed state, the cutting means can be advanced against the native valve with the anchoring structure in a partially expanded state. In this manner, the anchoring structure comprising the cutting means cuts at least a portion of the native valve by deploying the cutting means, before the valve assembly is secured to the desired valve location with the anchoring structure in the expanded state.
- the native valve removing means on the anchoring structure is selected from a group consisting of: a plurality of sharp edge elements, each sharp edge element having a sharp end enabling the element to cut through at least a portion of the native valve; a plurality of electrode elements, wherein radiofrequency energy is delivered to each electrode element enabling the electrode element to cut through at least a portion of the native valve, and a plurality of ultrasound transducer elements, wherein ultrasound energy is delivered to each transducer element enabling the transducer element to cut through at least a portion of the native valve.
- valve anchoring structure is made from a radially collapsible and re-expandable cylindrical support means for folding and expanding together with the collapsible replacement valve for implantation in the body by means of catheterization or other minimally invasive procedure.
- catheter balloon systems are well known to those of skill in the art, for example, U.S. Pat. No. 6,605,056 issued on Aug. 23, 2003.
- the anchoring structure ( 600 ) comprises at least one ultrasound transducer ( 601 ) at the distal end portion of the lower ring ( 602 ), wherein each ultrasound transducer is sized and configured with ultrasound energy as cutting means for cutting a native valve.
- Ultrasound energy is delivered through conductor means ( 603 ) to each transducer element ( 601 ) enabling the transducer element ( 601 ) to cut through at least a portion of the native valve.
- the conductor ( 603 ) passes through a delivery means and is connected to an external ultrasound energy generator.
- the ablative ultrasound delivery means and methods are well known to one skilled in the art, for example, U.S. Pat. No. 6,241,692 issued on Jun. 5, 2001.
- FIG. 52 shows another preferred embodiment of a native valve removal system comprising a valve assembly having radiofrequency cutting means.
- the anchoring structure comprises at least one radiofrequency electrode ( 610 ) at the distal end portion of the lower ring ( 602 ), wherein each radiofrequency electrode ( 610 ) is sized and configured with radiofrequency energy as cutting means for cutting a native valve.
- Radiofrequency energy is delivered through conductor means ( 611 ) to each electrode element ( 610 ) enabling the electrode element to cut through at least a portion of the native valve.
- the conductor ( 611 ) passes through delivery means and is connected to an external radiofrequency energy generator.
- the ablative radiofrequency delivery means and methods are well known to one skilled in the art, for example, U.S. Pat. No. 6,033,402 issued on Mar. 7, 2000.
- FIG. 53 shows another embodiment of an anchoring structure having sharp edge cutting means ( 620 ).
- the anchoring structure comprises a set of sharp edge cutting elements ( 621 ) at the distal end portion of the cutting means ( 620 ) of the lower ring ( 602 ) of the anchoring structure, wherein each cutting element ( 621 ) has a cutting tip ( 622 ), and wherein each cutting element ( 621 ) of the cutting means is sized and configured, optionally with radiofrequency energy, as cutting means for cutting a native valve.
- sharp edge cutting means on the delivery apparatus is rotatable, enabling the cutting element ( 621 ) to cut through at least a portion of the native valve.
- Sharp edge cutting means with optionally ablative radiofrequency delivery means and methods, are well known to one skilled in the art, for example, U.S. Pat. No. 5,980,515 issued on Nov. 9, 1999.
- FIG. 54 shows a partially inflated balloon catheter.
- a balloon catheter ( 630 ) is introduced in the vessel.
- the balloon means ( 632 ) of the balloon catheter ( 630 ) is led out of the protection cap ( 633 ) at the catheter tip ( 634 ) and is partly inflated through a fluid channel ( 635 ), which is led to the surface of the patient.
- the balloon ( 632 ) is partially expanded and the sharp end ( 636 ) of the cutting means of the valve anchoring structure ( 637 ) is advanced to cut and remove at least a portion of the native valve.
- the valve anchoring structure ( 637 ) comprises an ultrasound or radiofrequency cutting means ( 638 ).
- the support structure is expanded at about 30 to 95% of full expansion for cutting the native valve. More preferably, the support structure is expanded at about 50 to 90% of the full expansion.
- the balloon catheter ( 630 ) comprises a central channel ( 639 ) with respect to a central axial line ( 640 ) to receive a guide wire ( 641 ) which is used in a way known for viewing the introduction of the catheter through fluoroscopy.
- Some aspects of the present invention provide a method of endovascularly implanting a valve through a vessel, comprising the steps of providing a collapsibly expandable valve assembly that comprises an anchoring structure according to the present invention with an annulus base and a collapsible valve connected to the anchoring structure, the collapsible valve being configured to permit blood flow in a direction and prevent blood flow in an opposite direction, the anchoring structure having cutting means located at the annulus base for cutting a native valve, passing the valve assembly through the vessel with the anchoring structure in a collapsed state, advancing the cutting means against the native valve with the anchoring structure in a partially expanded state, cutting at least a portion of the native valve by deploying the cutting means, and securing the valve assembly to the desired valve location with the anchoring structure in the expanded shape.
- a method of implanting a valve assembly is given below: a valve assembly made of an anchoring structure of the present invention and a collapsible valve, as described above, is placed on a deflated balloon means and is compressed thereon, either manually or by use of the expansion/compression devices of the instant invention; the balloon means and the valve assembly are drawn into an insertion cover; a guide wire is inserted into a vessel through the central opening of the balloon catheter under continuous fluoroscopy; the insertion cover conveys the guide wire to a point in the channel in the immediate vicinity of the desired position of the valve assembly; the balloon means is pushed out of the protection cap and the valve assembly is positioned in the desired position if necessary by use of further imaging means to ensure accurate positioning; the balloon means is inflated partially; the valve assembly is advanced with its cutting means cutting at least a portion of the native valve; the balloon means is further inflated to position the valve at a desired site, preferably against the truncated valvular annulus; the balloon means is
- the present invention also provides for devices and methods to prevent the release of debris during removal of the native diseased valves from traveling to distant sites where such debris may cause undesirable physiological effects.
- the present invention provides for specialized filters that capture material and debris generated during valve replacement procedures.
- the distal protection devices of the present invention are also effective in trapping material that may be released during other percutaneous interventional procedures, such as balloon angioplasty or stenting procedures by providing a temporary valve and filter in the same device.
- the present invention provides for a temporary valve ( 700 ), which may be deployed at a desired location in a collapsed state and then expanded and secured to the walls of the passageway.
- the temporary valve ( 700 ) comprises two concentric one-way valves, an outer valve ( 701 ) and an inner valve ( 702 ) disposed within the outer valve ( 701 ), that open in opposite directions as shown in FIG. 55B .
- the outer valve ( 701 ) opens in response to positive fluid flow pressure, thereby regulating blood flow in substantially one direction.
- the inner valve ( 702 ) opens in the opposite direction of the outer valve ( 701 ) to facilitate the insertion of catheter based equipment ( 703 ) as shown in FIG.
- the inner valve ( 702 ) be configured or constructed to open with relatively more pressure than that required to open the outer valve.
- the outer ( 701 ) and inner valves ( 702 ) of the temporary valve ( 700 ) may be coupled together by radial support members.
- the radial support members couple the inner surface of the outer valve to the outer surface of the inner valve.
- the length of the radial support means depends upon the dimension of the blood vessel or body cavity within which the temporary valve is to be deployed.
- the temporary valve may be constructed from material that is capable of self-expanding the temporary valve, once it is deployed from the collapsed state at the desired location. Once expanded, catheter based equipment required for the particular surgical procedure may be passed through and movably operated in relation to the temporary valve.
- the temporary valve may be combined with a filter that extends distally from the temporary valve to capture debris material.
- the temporary valve-filter device is preferably configured such that the open proximal end is secured to the temporary valve and the closed distal end comprises an opening or a third valve to facilitate the passage of the catheter equipment through the distal end of the bag and out of the temporary valve. Additional valves may also be positioned in the filter to coincide with one or more branching arteries.
- the temporary valve-filter device may include one or more traps within the filter bag to trap debris material within the bag to reduce the likelihood of debris material leaving the filter when the catheter equipment is being passed through the filter bag.
- the filter traps may be comprised of one or more valves disposed within the filter bag that are configured to open with retrograde pressure.
- the traps may be comprised of flaps that extend inwardly from the perimeter of the bag to create a cupping effect that traps particulate matter and directs it outwardly toward the perimeter of the filter bag.
- the filter traps may be constructed of material that is capable of facilitating and filtering antegrade fluid flow, while retaining the debris material within the filter bag.
- the valve-filter assembly previously described may also incorporate multiple valves. In this arrangement, debris may be better and better entrapped, and thus reduces the chance of debris coming out of the valve-filter assembly.
- the present invention is particularly useful while performing an interventional procedure in vital arteries, such as the carotid arteries and the aorta, in which critical downstream blood vessels can become blocked with debris material.
- the valve-filter assembly may also include a cannulation system at the downstream end of the filter to remove particles and debris.
- the valve-filter assembly may also include a grinder for cutting up or reducing the size of the debris. This debris, in turn, may be removed by a cannulation system or be allowed to remain in the filter.
- valve-filter assembly is well-suited for use in minimally invasive surgery where the valve-filter may be placed in the aorta between the aortic valve and the innominate branch or the braciocephalic branch.
- the valve-filter may be put in place before the start of surgery and function as a valve.
- the valve-filter may further collect debris and particles during removal and clean up of the old valve.
- the valve-filter may also stay in place while the new valve is put in place and until the end of the procedure to function as protection and as a valve.
- a vascular filter system is well known to one skilled in the art, for example, U.S. Pat. No. 6,485,501 issued on Nov. 26, 2002.
- the invention may be part of a catheter.
- the invention may also be assembled onto a separate catheter.
- the valve-filter may also be part of a non-catheter device, placed directly into a blood vessel or other lumen.
- the valve-filter may be introduced into the body by the ways described in the following non-inclusive list: femoral artery, femoral vein, carotid artery, jugular vein, mouth, nose, urethra, vagina, brachial artery, subclavian vein, open sternotomies, partial sternotomies, and other places in the arterial and venous system.
- the filter mesh of the valve-filter may be of any size and shape required to trap all of the material while still providing sufficient surface area for providing satisfactory flows during the use of the filter.
- the filter may be a sheet or bag of different mesh sizes.
- the mesh size is optimized taking the following factors into consideration: flow conditions, application site, size of filter bag, rate of clotting, etc.
- Radiopaque markers and/or sonoreflective markers may be located on the catheter and/or the valve-filter assembly.
- An embodiment of the valve-filter catheter is described having an aortic transillumination system for locating and monitoring the position and deployment state of the catheter and the valve-filter assembly without fluoroscopy.
- visualization techniques including transcranial Doppler ultrasonography, transesophageal echocardiograpy, transthoracic echocardiography, epicardiac echocardiography, and transcutaneous or intravascular ultrasoneography in conjunction with the procedure may be used to ensure effective filtration.
- the material of the filter screen in each embodiment of the filter catheter may be made of or coated with an adherent material or substance to capture or hold embolic debris which comes into contact with the filter screen within the valve-filter assembly.
- adherent materials include, but are not limited to, known biocompatible adhesives and bioadhesive materials or substances, which are hemocompatible and non-thrombogenic. Such material are known to those having ordinary skill in the art and are described in, among other references, U.S. Pat. Nos. 4,768,523, 5,055,046, 5,066,709, 5,197,973, 5,225,196, 5,374,431, 5,578,310, 5,645,062, 5,648,167, 5,651,982, and 5,665,477.
- only the upstream side of the elements of the filter screen are coated with the adherent material to capture the embolic material which comes in contact with the upstream side of the filter screen after entering the filter assembly.
- Other bioactive substances for example, heparin or thrombolytic agents, may be impregnated into or coated on the surface of the filter screen material or incorporated into an adhesive coating.
- blood is filtered during cardiac surgery, in particular during percutaneous valve surgery, to protect a patient from embolization.
- the valve-filter is positioned in the aorta between the aortic valve and the inominate branch, where it filters blood before it reaches the carotid arteries, brachiocephalic trunk, and left subclavian artery.
- the valve contains the embolic material and foreign matter dislodged during the surgery and also provides a temporary valve for use during valve surgery.
- Such a method may be utilized both on and off pump.
- Such a method may also be utilized for aortic, mitral, and pulmonary valve surgery and repair.
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mechanical Engineering (AREA)
- Prostheses (AREA)
- Endoscopes (AREA)
Abstract
Methods and systems for minimally invasive replacement of a valve. The system includes a collapsible valve and anchoring structure, devices and methods for expanding the valve anchoring structure, adhesive means to seal the valve to the surrounding tissue, a catheter-based valve sizing and delivery system, native valve removal means, and a temporary valve and filter assembly to facilitate removal of debris material. The valve assembly comprises a valve and anchoring structure for the valve, dimensioned to fit substantially within the valve sinus.
Description
- The present invention relates to devices and systems for the replacement of physiological valves.
- The transport of vital fluids in the human body is largely regulated by valves. Physiological valves are designed to prevent the backflow of bodily fluids, such as blood, lymph, urine, bile, etc., thereby keeping the body's fluid dynamics unidirectional for proper homeostasis. For example, venous valves maintain the upward flow of blood, particularly from the lower extremities, back toward the heart, while lymphatic valves prevent the backflow of lymph within the lymph vessels, particularly those of the limbs.
- Because of their common function, valves share certain anatomical features despite variations in relative size. The cardiac valves are among the largest valves in the body with diameters that may exceed 30 mm, while valves of the smaller veins may have diameters no larger than a fraction of a millimeter. Regardless of their size, however, many physiological valves are situated in specialized anatomical structures known as sinuses. Valve sinuses can be described as dilations or bulges in the vessel wall that houses the valve. The geometry of the sinus has a function in the operation and fluid dynamics of the valve. One function is to guide fluid flow so as to create eddy currents that prevent the valve leaflets from adhering to the wall of the vessel at the peak of flow velocity, such as during systole. Another function of the sinus geometry is to generate currents that facilitate the precise closing of the leaflets at the beginning of backflow pressure. The sinus geometry is also important in reducing the stress exerted by differential fluid flow pressure on the valve leaflets or cusps as they open and close.
- Thus, for example, the eddy currents occurring within the sinuses of Valsalva in the natural aortic root have been shown to be important in creating smooth, gradual and gentle closure of the aortic valve at the end of systole. Blood is permitted to travel along the curved contour of the sinus and onto the valve leaflets to effect their closure, thereby reducing the pressure that would otherwise be exerted by direct fluid flow onto the valve leaflets. The sinuses of Valsalva also contain the coronary ostia, which are outflow openings of the arteries that feed the heart muscle. When valve sinuses contain such outflow openings, they serve the additional purpose of providing blood flow to such vessels throughout the cardiac cycle.
- When valves exhibit abnormal anatomy and function as a result of valve disease or injury, the unidirectional flow of the physiological fluid they are designed to regulate is disrupted, resulting in increased hydrostatic pressure. For example, venous valvular dysfunction leads to blood flowing back and pooling in the lower legs, resulting in pain, swelling and edema, changes in skin color, and skin ulcerations that can be extremely difficult to treat. Lymphatic valve insufficiency can result in lymphedema with tissue fibrosis and gross distention of the affected body part. Cardiac valvular disease may lead to pulmonary hypertension and edema, atrial fibrillation, and right heart failure in the case of mitral and tricuspid valve stenosis; or pulmonary congestion, left ventricular contractile impairment and congestive heart failure in the case of mitral regurgitation and aortic stenosis. Regardless of their etiology, all valvular diseases result in either stenosis, in which the valve does not open properly, impeding fluid flow across it and causing a rise in fluid pressure, or insufficiency/regurgitation, in which the valve does not close properly and the fluid leaks back across the valve, creating backflow. Some valves are afflicted with both stenosis and insufficiency, in which case the valve neither opens fully nor closes completely.
- Because of the potential severity of the clinical consequences of valve disease, valve replacement surgery is becoming a widely used medical procedure, described and illustrated in numerous books and articles. When replacement of a valve is necessary, the diseased or abnormal valve is typically cut out and replaced with either a mechanical or tissue valve. A conventional heart valve replacement surgery involves accessing the heart in a patient's thoracic cavity through a longitudinal incision in the chest. For example, a median sternotomy requires cutting through the sternum and forcing the two opposite halves of the rib cage to be spread apart, allowing access to the thoracic cavity and the heart within. The patient is then placed on cardiopulmonary bypass, which involves stopping the heart to permit access to the internal chambers. Such open heart surgery is particularly invasive and involves a lengthy and difficult recovery period. Reducing or eliminating the time a patient spends in surgery is thus a goal of foremost clinical priority.
- One strategy for reducing the time spent in surgery is to eliminate or reduce the need for suturing a replacement valve into position. Toward this end, valve assemblies that allow implantation with minimal or no sutures would be greatly advantageous. Furthermore, while devices have been developed for the endovascular implantation of replacement valves, including collapsing, delivering, and then expanding the valve, such devices do not configure the valve in a manner that takes advantage of the natural compartments formed by the valve sinuses for optimal fluid dynamics and valve performance. In addition, to the extent that such devices employ a support structure in conjunction with a tissue valve, such valve constructs are configured such that the tissue leaflets of the support valve come into contact with the support structure, either during the collapsed or expanded state, or both. Such contact is capable of contributing undesired stress on the valve leaflet. Moreover, such support structures are not configured to properly support a tissue valve having a scalloped inflow annulus such as that disclosed in the U.S. patent application Ser. No. 09/772,526 which is incorporated by reference herein in its entirety.
- Accordingly, there is a need for a valve replacement system comprising a collapsible and expandable valve assembly that is capable of being secured into position with minimal or no suturing; facilitating an anatomically optimal position of the valve; maintaining an open pathway for other vessel openings of vessels that may be located in the valvular sinuses; and minimizing or reducing stress to the tissue valve leaflets. The valves of the present invention may comprise a plurality of joined leaflets with a corresponding number of commissural tabs. Generally, however, the desired valve will contain two to four leaflets and commissural tabs. Examples of other suitable valves are disclosed in U.S. patent application Ser. Nos. 09/772,526, 09/853,463, 09/924,970, 10/121,208, 10/122,035, 10/153,286, 10/153,290, the disclosures of all of which are incorporated by reference in their entirety herein.
- The present invention provides systems and devices for the replacement of physiological valves. In one embodiment of the present invention, the replacement valve assemblies are adapted to fit substantially within the valve sinuses. Because the devices and procedures provided by the present invention eliminate or reduce the need for suturing, time spent in surgery is significantly decreased, and the risks associated with surgery are minimized. Further, the devices of the present invention are suitable for delivery by cannula or catheter.
- In one preferred embodiment of the present invention a valve anchoring structure is provided that is dimensioned to be placed substantially within the valve sinus. In this embodiment, the valve anchoring structure extends substantially across the length of the valve sinus region.
- In another preferred embodiment of the present invention a valve assembly is provided, comprising a valve and anchoring structure, in which the valve comprises a body having a proximal end and a distal end, an inlet at the proximal end, and an outlet at the distal end. The inlet comprises an inflow annulus, preferably with either a scalloped or straight edge. The outlet comprises a plurality of tabs that are supported by the anchoring means at the distal end. In preferred embodiments of the invention, the plurality of tabs are spaced evenly around the circumference of the valve.
- In yet another embodiment of the present invention, a valve assembly is provided in which there is minimal or no contact between the valve and anchoring structure.
- In still another embodiment of the present invention, a valve assembly is provided in which the valve is capable of achieving full opening and full closure without contacting the anchoring structure.
- In yet another embodiment of the present invention, a valve assembly is provided in which the vertical components of the anchoring structure are limited to the commissural posts between sinus cavities, thereby minimizing contact between mechanical components and fluid, as well as providing flow to vessels located in the valve sinus.
- In still another embodiment of the present invention, a valve is provided that firmly attaches to the valve sinus, obviating the need for suturing to secure the valve placement.
- In a further embodiment of the present invention, a valve assembly is provided in which the anchoring structure may be collapsed to at least fifty percent of its maximum diameter.
- In still a further embodiment of the present invention, an expansion and contraction device is provided to facilitate implantation of the valve and anchoring structure.
- In another embodiment, the present invention provides adhesive means for securing the valve assembly in a valve sinus.
- In yet another embodiment of the present invention, a valve sizing apparatus is provided for the noninvasive determination of native valve size.
- The present invention also provides cutting means to remove the native diseased valve. One aspect of the cutting means comprises a plurality ofjaw elements, each jaw element having a sharp end enabling the jaw element to cut through at least a portion of the native valve. Another aspect of the cutting means comprises a plurality of electrode elements, wherein radiofrequency energy is delivered to each electrode element enabling the electrode element to cut through at least a portion of the native valve. A further aspect of the cutting means comprises a plurality of ultrasound transducer elements, wherein ultrasound energy is delivered to each transducer element enabling the transducer element to cut through at least a portion of the native valve.
- In yet another embodiment, the present invention provides a temporary two-way valve and distal protection filter assembly.
-
FIG. 1 shows an exemplary valve during operation.FIG. 1A shows the valve in the open position during peak flow.FIG. 1B shows the valve in closed position to prevent backflow of the fluid across the valve. -
FIG. 2 shows a preferred embodiment of the valve of the present invention. This valve features commissural tabs and a scalloped inflow annulus. -
FIGS. 3A , B and C are representations of a typical valve sinus. These figures illustrate the anatomy of the sinus cavities, commissural posts, leaflets and inflow/outflow annuli. -
FIG. 4 is a schematic representation of the geometry and relative dimensions of the valve sinus region. -
FIG. 5 shows a valve anchoring structure, in accordance with a preferred embodiment of the present invention, that is lodged inside a vessel. -
FIGS. 6A and B are schematics of a valve assembly comprising a valve and an anchoring structure in which the anchoring structure features an additional cloth ring along the valve inflow edge that serves as a gasket.FIG. 6C shows a valve anchoring structure according to one preferred embodiment of the present invention featuring a two-ring inflow rim. -
FIG. 7 is a diagrammatic representation of a flat pattern of a preferred embodiment of an anchoring structure in the expanded state. -
FIG. 8 is a diagrammatic representation of a flat pattern of a preferred embodiment of an anchoring structure in the compressed state. -
FIG. 9 shows a flat valve leaflet of a preferred valve to which the anchoring structure dimensions can be fitted. -
FIG. 10 illustrates the relative dimensions of a preferred embodiment of an anchoring structure of the present invention. -
FIG. 11 shows a flared anchoring structure dimensioned to lodge inside the sinus cavities. -
FIG. 12 shows a different view of the flared anchoring structure. -
FIG. 13 shows a preferred embodiment of an anchoring structure lacking an outflow ring, and having support posts dimensioned to lodge in the sinus commissural posts, providing cantilevered support for the valve outflow end. -
FIG. 14 shows a preferred embodiment of an anchoring structure with flared in- and outflow ends and support posts for lodging in the commissural posts with attachment windows capable of deflecting inward at back flow pressure. -
FIG. 15A shows a top view of a preferred embodiment of a valve assembly comprising a valve and an anchoring structure made of elliptical segments joined together. -
FIG. 15B shows a lateral view of the preferred anchoring structure without valve. -
FIG. 16A shows the valve assembly comprising a valve and elliptical segment anchoring structure in expanded form.FIG. 16B shows the same in compressed form -
FIG. 17 shows the lodging of an elliptical anchoring structure inside the valve sinus cavities. -
FIG. 18A shows how the elliptical segments of the anchoring structure may be joined by a double crimp.FIG. 18B shows how the valve is positioned inside the anchoring structure. -
FIG. 19A shows a double crimp uniquely designed to flexibly join the elliptical segments.FIG. 19B shows a modified double crimp. -
FIG. 20A shows how the elliptical segments may be assembled into the double crimp.FIG. 20B shows the final assembly. - FIGS. 21A-G show different views of an elliptical segment anchoring structure further comprising cloth covering including a gasket cloth cuff at the inflow rim.
-
FIGS. 22A and B show different views of an elliptical segment anchoring structure made from a single piece of tubing. -
FIGS. 23A through D show an elliptical segment anchoring structure in which the upper segments have been removed and the ends of the junctions are formed into prongs. -
FIG. 24 shows a preferred valve assembly of the present invention with an anchoring structure comprising a ring incorporated into the valve inflow rim. -
FIG. 25A shows an anchoring structure comprising two undulating rings with inverse wave patterns.FIG. 25B shows an anchoring structure comprising two such rings connected by vertical elements. -
FIG. 26 shows a valve assembly comprising an anchoring structure in which the inflow ring and outflow ring are structurally unconnected. -
FIG. 27A -C show a tubular anchoring structure. - FIGS. 28A-D show an anchoring structure comprising an inflow ring and an outflow ring connected by vertical posts that slide across one another upon compression.
-
FIGS. 29A and B show an anchoring structure comprising an inflow and outflow ring connected by vertical posts that join to form a single vertical element upon compression. -
FIGS. 30A and B shows an anchoring structure comprising a three-member spring aided frame. -
FIGS. 31A and B show a preferred embodiment of an expansion and contraction device. -
FIGS. 32A and B more particularly shows the angled wires of the device. -
FIG. 33 shows the positioning of an anchoring structure on the expansion and contraction device. -
FIG. 34 shows another preferred embodiment of an expansion and contraction device featuring a wire-spindle mechanism. -
FIG. 35 shows a different perspective of the wire-spindle expansion and contraction device. -
FIGS. 36A and B show another preferred embodiment of an expansion and contraction device for self-expanding valve assemblies. -
FIG. 37A shows a further preferred embodiment of an expansion and contraction device featuring a rotating plate mechanism.FIGS. 37B and C more particularly shows the spiral-shaped rotating plate. -
FIGS. 38A and B show the expansion and contraction device expanding an anchoring frame. -
FIG. 39 shows another preferred embodiment of an expansion and contraction device featuring a groove-pin mechanism. -
FIG. 40 shows one preferred embodiment of a valve having an outer circumferential reservoir containing a sealable fixation means for securely fixing the valve prosthesis at a desired location within a vessel or body cavity. -
FIGS. 41A and B show another embodiment of a valve having an outer circumferential reservoir, wherein the sealabe fixation means comprises a two component biological adhesive. -
FIG. 42 illustrates a reservoir with thin spots adapted to rupture when the reservoir is under pressure, thereby releasing the contents of the reservoir. -
FIG. 43 is a cross-sectional view of the reservoir showing the thin spots. -
FIG. 44 is a cross-sectional view of a valve reservoir having two concentric component compartments. -
FIGS. 45A and B depict a minimally-invasive valve replacement sizer. -
FIG. 46 is a cross-sectional view of a minimally-invasive valve replacement sizer comprising a guidewire, an intravascular ultrasound (IVUS) catheter having a transducer, and a balloon catheter, all positioned within the central lumen of the catheter. -
FIG. 47 shows a balloon catheter comprising a balloon that circumferentially surrounds a portion of the catheter at its distal portion. -
FIG. 48 shows a cross-sectional view of an inflated balloon with curves forming leaflets to enable fluid to pass. -
FIG. 49 shows one preferred embodiment of a minimally-invasive valve replacement sizer, wherein the balloon is inflated with saline. -
FIG. 50 shows a preferred embodiment of a minimally-invasive valve replacement sizer system, wherein the transducer emits an ultrasonic signal in a perpendicular direction to an intravascular ultrasound catheter (IVUS), which is reflected off the outer wall of the balloon and then received by the transducer and wherein the radius and diameter of the body cavity is determined by the auxiliary processor. -
FIG. 51 shows an anchoring structure of the present invention having ultrasound cutting means. -
FIG. 52 shows an anchoring structure of the present invention having radiofrequency cutting means. -
FIG. 53 shows an anchoring structure having sharp edge cutting means. -
FIG. 54 is a partial view of the valve assembly with cutting means on a partially inflated balloon catheter. - FIGS. 55A-C show a temporary two-way valve for distal protection.
- The present invention relates to valve replacement systems and devices. As illustrated in
FIG. 1 , a valve (1) comprises a distal or outflow end (2), leaflets (3) and a proximal or inflow end (4). A typical valve functions similar to a collapsible tube in that it opens widely during systole or in response to muscular contraction, to enable unobstructed forward flow across the valvular orifice (FIG. 1A ). In contrast, at the end of systole or contraction, as illustrated inFIG. 1B , as forward flow decelerates, the walls of the tube are forced centrally between the sites of attachment to the vessel wall and the valve closes completely. - Replacement Valves
- A preferred valve (5) for use with the systems and devices of the present invention is illustrated in
FIG. 2 and is comprised of a body having a proximal end or inflow ring (6) and a distal end or outflow ring (7). The body is comprised of multiple leaflets of valve tissue joined by seams (8), wherein each seam is formed by a junction of two leaflets. A commissural tab region (9) extends from each seam at the distal end of the valve body. The proximal end (6) has an inflow ring with a peripheral edge that can be scalloped or straight. The inflow ring (6) of the valve can further comprise a reinforcement structure (10) that can be stitched to it. In preferred embodiments of the invention, the inflow edge of the valve is scalloped. The valve replacement systems and devices of the present invention are not limited, however, to the specific valve illustrated inFIG. 2 . An important consideration in the design of valve replacement systems and devices that has received insufficient attention in previous approaches is the architecture of valve sinus. Valve sinuses are dilations of the vessel wall that surround the natural valve leaflets. Typically, each natural valve leaflet has a separate sinus bulge or cavity that allows for maximal opening of the leaflet at peak flow without permitting contact between the leaflet and the vessel wall. Thus, for example, a two-leaflet valve is surrounded by two sinus bulges, a three-leaflet valve by three, and a four-leaflet valve by four sinus cavities. The individual sinus bulges or cavities are separated by vertical fibrous structures known as commissural posts. These commissural posts define longitudinal structures with lesser outward curvature than the sinus cavities, as can be seen inFIG. 3 .FIGS. 3A and B illustrate the reduced curvature of the commissural posts (11) compared with the curvature of the sinus cavities (12).FIG. 3C shows a view from outside the vessel of a commissural post (11) between two sinus cavities (12), whileFIG. 3A shows a cross sectional view from the top of a closed valve within a valve sinus. The areas between the bulges define the commissural posts (11) and as can be clearly seen inFIG. 3B , the commissural posts serve as the sites of attachment for the valve leaflets to the vessel wall (13). -
FIGS. 3B and C also show the narrowing diameter of the sinus region at both its inflow end (14) and outflow end (15) to form the inflow and outflow annuli of the sinus region. Thus, the valve sinuses form a natural compartment to support the operation of the valve by preventing contact between the leaflets and the vessel wall, which, in turn, may lead to adherence of the leaflets and/or result in detrimental wear and tear of the leaflets. The valve sinuses are also designed to share the stress conditions imposed on the valve leaflets during closure when fluid pressure on the closed leaflets is greatest. The valve sinuses further create favorable fluid dynamics through currents that soften an otherwise abrupt closure of the leaflets under conditions of high backflow pressure. Lastly, the sinuses ensure constant flow to any vessels located within the sinus cavities. - As shown in
FIG. 4 , the valve sinus region is characterized by certain relative dimensions which remain constant regardless of the actual size of the sinuses. Generally, the diameter of the sinus is at its largest at the center of the cavities or bulges (16), while there is pronounced narrowing of the sinus region at both the inflow annulus (17) and outflow annulus (18). Furthermore, the height of the sinus (19), i.e. the distance between the inflow and outflow annuli remains proportional to its overall dimensions. It is thus apparent that the sinus region forms an anatomical compartment with certain constant features that are uniquely adapted to house a valve. The systems and devices of the present invention are designed to utilize these anatomical features of the native sinus region for optimal replacement valve function and position. - Accordingly, in one preferred embodiment of the present invention, the replacement valve assembly comprises a collapsible and expandable anchoring structure adapted to support a valve distally along the commissural tab region and proximally along the inflow annulus.
FIG. 5 shows a preferred anchoring structure adapted to support a valve such as that illustrated inFIG. 2 . As seen inFIG. 5 , the preferred anchoring structure has a generally tubular configuration within which the valve is secured. The valve is secured at its proximal (inflow) annulus by attachment to the inflow rim (20) of the anchoring structure and at its distal end via the commissural tabs that are threaded through the axially extending slots (21), which are formed in the support posts (22) that extend longitudinally from the inflow rim (20) to the outflow rim (23) of the anchoring structure. Thus, the distal ends (24) of the support posts contact the outflow rim (23) of the anchoring structure, whereas the proximal ends (25) of the support posts contact the inflow rim (20) of the anchoring structure. - In
FIG. 5 the outflow rim (23) of the anchoring structure is depicted as comprising a plurality of rings that extend between the support posts (22) generally at or above the axially extending slots (21) that reside therein. The plurality of rings of the outflow rim (23) are configured in an undulating or zigzag pattern forming peaks (26) and valleys (27), wherein the individual rings remain substantially parallel to one another. The plurality of rings of the outflow rim comprise a vertical connector element (28) positioned at the center of the valleys (27) formed by the undulating or zigzag pattern. This vertical connector element (2o) is designed to stabilize the anchoring structure and to prevent distortion of the valve during compression and expansion of the anchoring structure comprising the valve. The vertical element (28) extends longitudinally in the axial direction of the cylindrical anchoring structure. In a preferred embodiment, the outflow rim (23) of the anchoring structure comprises two rings. In a preferred implementation of this embodiment shown inFIG. 5 , the inflow rim (20) of the support structure comprises a single ring that extends between the support posts (22). - Both the inflow (20) and outflow (23) rims of the anchoring structure are formed with an undulating or zigzag configuration, although the inflow rim (20) may have a shorter wavelength (circumferential dimension from peak to peak) and a lesser wave height (axial dimension from peak to peak) than the outflow rim (23). The wavelengths and wave heights of the inflow (20) and outflow (23) rims are selected to ensure uniform compression and expansion of the anchoring structure without distortion. The wavelength of the inflow rim (20) is further selected to support the geometry of the scalloped inflow annulus of a preferred valve of the present invention. Notably, as shown in
FIG. 5 , the undulating or zigzag pattern that forms the inflow rim (20) of the anchoring structure is configured such that the proximal ends (25) of the vertical support posts (22) are connected to the peaks (29) of the inflow rim (20). Similarly, the undulating or zigzag pattern that forms the outflow rim (23) of the anchoring structure is configured such that the distal ends (24) of the support posts (22) are connected to the valleys (27) of the outflow rim (23). Locating the distal ends (24) of the support posts at the valleys (27) of the outflow rim (23) will prevent the longitudinal extension of outflow rim (23) in the direction of the valve secured within the lumen of the anchoring structure upon compression of the valve assembly, thereby eliminating any contact between valve and anchoring structure. Likewise, locating the proximal ends (25) of the support posts at the peaks (29) of the inflow rim (20) will prevent longitudinal extension of the inflow rim (20) in the direction of the valve tissue. Thus, compression of the valve and anchoring structure does not lead to distortion of or injury to the valve. -
FIG. 5 further shows that the support posts (22) are configured generally in the shape of paddle with the axial slot (21) extending internally within the blade (30) of the paddle. The blade (30) of the paddle is oriented toward the outflow rim (23) of the anchoring structure and connects to the outflow rim (23) at a valley (27) of the undulating or zigzag pattern of the outflow rim (23). An important function of the support posts (22) is the stabilization of the valve in general, and in particular the prevention of any longitudinal extension at points of valve attachment to preclude valve stretching or distortion upon compression of the device. The blades (30) of the paddle-shaped support posts (22) are designed to accommodate the commissural tabs of the valve. The support posts (22) further comprise triangular shaped elements (31) extending on each side of the proximal end (25) of the support post. The triangular shaped elements (31) are designed to serve as attachments sites for the sewing cuff gasket and may be designed in different shapes without losing their function. - The number of support posts (22) in this preferred embodiment can range from two to four, depending on the number of commissural posts present in the valve sinus. Thus, in a preferred embodiment, the anchoring structure comprises three support posts for a three-leaflet valve with a sinus that features three natural commissural posts. The support posts (22) of the anchoring structure are configured to coincide with the natural commissural posts of the sinus.
-
FIGS. 6A and B show the preferred embodiment ofFIG. 5 having a valve secured internally. The valve (32) is secured at its proximal (inflow) annulus (33) by attachment to the inflow rim (20) of the anchoring structure and at its outflow or distal end (34) via the commissural tabs (35) that are threaded through the axially extending slots (21), which are formed in the support posts (22) that extend longitudinally from the inflow rim (20) to the outflow rim (23) of the anchoring structure. Notably, as can be seen inFIGS. 6A and B, in this preferred embodiment the outflow rim (23) of the anchoring structure is configured to be longitudinally displaced from the distal outflow annulus (34) of the valve leaflets (36) that reside within the lumen of the tubular anchoring structure, thereby avoiding any contact between the valve leaflets (36) and the anchoring structure. - As shown in
FIGS. 6A and B, the inflow rim (20) of the anchoring structure can be secured to the proximal inflow annulus (33) of the valve via a suitable fabric that may be wrapped around the circumferential juncture at the inflow end (33) and stitched into position to form a sewing cuff (37). The fabric may be made of any suitable material including but not limited to woven polyester, such as polyethylene terepthalate, polytetrafluoroethylene (PTFE), or other biocompatible material. Thus, the valve (32) is secured inside the anchoring structure by sewing a fabric ring (37) around the inflow rim (20) of the anchoring structure so as to create a sealing surface around the outer perimeter of valve's inflow annulus (33). In a preferred embodiment, the fabric ring (37) comprises two sewing cuff rings as shown inFIGS. 6A and B, with the second sewing cuff ring (38) having a larger diameter than the inflow annulus of the native valve sinus to ensure the firm lodging of the anchoring structure against the inflow annulus of the native valve sinus, thereby creating a tight, gasket-like seal. - The positioning of the valve (32) internally to the preferred anchoring structure with only the fabric of the commissural mounting tabs (35) of the valve (32) contacting the support posts (22) at the distal outflow annulus of the valve (34), while the proximal inflow annulus (33) of the valve is separated from the inflow rim (20) of the anchoring structure by the sewing cloth (37), ensures that no part of the valve (32) is contacted by the anchoring structure during operation of the valve (32), thereby eliminating wear on the valve (32) that may be occasioned by contact with mechanical elements.
- In
FIGS. 6A , B and C the outflow rim (23) of the anchoring structure is depicted as comprising a plurality of rings that extend between the support posts (22) generally at or above the axially extending slots (21) that reside at their distal ends (24). The plurality of rings of the outflow rim (23) are configured in an undulating or zigzag pattern forming peaks (26) and valleys (27), wherein the individual rings remain substantially parallel to one another. The plurality of rings of the outflow rim comprise a vertical connector element (28) positioned at the center of the valleys (27) formed by the undulating or zigzag pattern. This vertical connector element (28) is designed to stabilize the anchoring structure and to prevent distortion of the valve during compression and expansion of the anchoring structure containing the valve within. The vertical element (28) extends longitudinally in the axial direction of the cylindrical anchoring structure. In a preferred embodiment, the outflow rim of the anchoring structure comprises two rings. -
FIG. 6C shows another implementation of a preferred anchoring structure of the present invention. In contrast to the implementation shown inFIG. 5 , wherein the inflow rim (20) of the anchoring structure comprises a single ring that extends between the support posts (22), the implementation shown inFIG. 6C features an inflow rim (20) comprising two rings that are substantially parallel to each other and are connected by a vertical connector element (39) positioned at the center of the peaks (29) formed by the undulating or zigzag pattern. This vertical connector element (39) is designed to stabilize the anchoring structure and to prevent distortion of the valve during compression and expansion of the anchoring structure comprising the valve. The vertical element (39) extends longitudinally in the axial direction of the cylindrical anchoring structure.FIG. 6C also shows that the distal end (24) of the support post (22) may further comprise suture bores (41) to facilitate the placement of additional sutures for the securing the valve to the anchoring structure. - Because the wavelengths and wave heights of the inflow (20) and outflow rims (23) are selected to ensure uniform compression and expansion of the anchoring structure without distortion, a different wavelength and height may be chosen for the inflow ring (20) of an implementation of a preferred embodiment of an anchoring structure featuring an inflow rim (20) with two substantially parallel undulating rings as shown in
FIG. 6C . Thus, the inflow rim (20) depicted inFIG. 6C may have substantially the same wavelength and height as the outflow rim (23). Similarly, the support posts (22) may be modified to comprise a widened proximal end (25) with an axial slot (40) extending longitudinally from the inflow rim (20) toward the distal end (24) of the support posts (22) and centrally through the triangular shaped elements (31). The widening of the proximal end (25) of the support posts (22) protects the triangular shaped elements (31) from distortion by the different collapsed profile of the inflow rim (20) with larger wavelength and height and ensures that no part of the valve (32) will be contacted by the anchoring structure during compression. -
FIGS. 7 and 8 show the expansion (FIG. 7 ) and compression (FIG. 8 ) profile of a preferred anchoring structure of the present invention. In a preferred embodiment of the present invention, the anchoring structure is collapsible to at least 50% of its expanded diameter. As shown inFIGS. 7 and 8 , the undulating or zigzag pattern that forms the inflow rim (20) of the anchoring structure is configured such that the proximal ends (25) of the vertical support posts (22) are connected to the peaks (29) of the inflow rim (20). Similarly, the undulating or zigzag pattern that forms the outflow rim (23) of the anchoring structure is configured such that the support posts (22) are connected to the valleys (27) of the outflow rim (23). Locating the distal ends (24) of the support posts (22) at the valleys (27) of the outflow rim (23) will prevent the longitudinal extension of outflow rim (23) in the direction of the valve upon compression of the device, thereby eliminating any contact between valve and anchoring structure. Similarly, locating the proximal ends (25) of the support posts (22) at the peaks (29) of the inflow rim (20) prevents structural interference between the proximal ends (25) of the support posts (22), in particular the triangular shaped elements (31) designed to support the scalloped inflow annulus of the replacement valve, and the undulating pattern of the inflow rim (20), as well as longitudinal extension of the inflow rim (20) in the direction of the valve tissue. Thus, compression of the valve and anchoring structure does not lead to distortion of or injury to the valve. -
FIG. 8 shows that the support posts (22) connect to the outflow rim (23) at a valley (27) of the undulating or zigzag pattern and that during compression, the support posts stabilize the anchoring structure by preventing any longitudinal extension at points of valve attachment, that is at the proximal (25) and distal (24) ends of the support posts. The commissural mounting tabs of the valve are attached to the anchoring structure by extending through the axial slots (40) of the support posts to the exterior of the anchoring structure, while the inflow annulus of the valve is connected to the inflow rim (20) of the anchoring structure via a fabric ring. This arrangement allows firm attachment of the distal or outflow end of valve to the anchoring structure and ensures the proper positioning of the valve, with the outflow end being supported such that the leaflets are allowed to open and close with the movement of fluid across the lumen of the valve. It should be noted that the particular shapes of the individual elements of the structures disclosed herein may be modified by a person of skill in the art to achieve the advantages described without departing from the scope of the present invention. - The number of support posts (22) in this preferred embodiment can range from two to four, depending on the number of commissural posts present in the valve sinus. Thus, in a preferred embodiment, the anchoring structure comprises three support posts (22) for a three-leaflet valve with a sinus that features three natural commissural posts. The support posts (22) of the anchoring structure are configured to coincide with the natural commissural posts of the sinus.
- An advantage of this arrangement is the additional option for the surgeon of suturing the valve assembly into place, wherein the anchoring structure provides the surgeon with additional guidance as to the proper anatomical positioning of the valve inside the native valve sinuses. Since the anchoring structure is dimensioned to fit precisely into the valve sinus cavities, the surgeon's positioning task is simplified to a visual determination of the location of the commissural posts of the native sinuses and their alignment with the support posts (22) of the anchoring structure of the valve. Thus, the present preferred embodiment takes advantage of the natural features of the valve sinus for the rapid orientation and attachment of the valve assembly. The ability of the anchoring structure to emulate the architecture of the valve sinus thus significantly reduces the surgeon's time spent on suturing the valve into position, should he so desire.
- The geometry of the preferred embodiment of a valve anchoring structure further naturally positions it across the entire longitudinal extension of the native valve sinus, lodging the anchoring structure firmly against the vessel walls. Proximally, the inflow rim (20) of the anchoring structure naturally fits into the native valve sinus at a position near the inflow narrowing (annulus) of the native valve sinus against which it is designed to rest, while distally, the outflow rim (23) of the anchoring structure fits into the sinus at a position near the outflow narrowing (annulus) of the sinus against which it is designed to rest.
- Between the proximal and distal ends of the anchoring structure the only longitudinal mechanical elements of the anchoring structure are the support posts (22) which are confined to the native commissural posts between the sinuses, leaving the sinus cavities free to create the native fluid currents that support leaflet closure and valve operation in general. A further advantage of this preferred embodiment of the present invention is the ability of the anchoring structure to emulate the natural compartment formed by the sinus for anchoring the valve. Thus, the anchoring structure is able to extend completely across the sinuses without placing mechanical elements into the path of fluid flow and without obstructing flow to any vessel openings that may be present in the valve sinuses.
- In a preferred implementation of the present embodiment, the anchoring structure exerts radial force against the vessel wall so as to produce a compression fit. This may be accomplished by oversizing the anchoring structure such that it permanently seeks to expand to its original size. Thus, both the inflow (20) and outflow (23) rims are designed to push radially against the sinus walls near the inflow and outflow annuli of the sinus. The undulating or zigzag pattern formed by the inflow (20) and outflow (23) rings further serves to provide tire-like traction against the sinus wall for anchoring. Thus, the combination of compression fit, traction and sewing cuff rings (37 and 38) of the anchoring structure provides a firm anchor for the replacement valve and an optimal configuration in the native valve sinus.
- In preferred embodiments of the present invention, the anchoring structure comprises a material that is expandable from a compressed configuration illustrated in
FIG. 8 into the configuration depicted inFIG. 7 . The anchoring structure may be non-self expanding, i.e. capable of being expanded from a compressed state using mechanical means, such as a balloon inflated from within the radial center of the anchoring structure, or using the expansion and compression devices disclosed herein. The anchoring structure comprises vertical tab support posts (22) which are designed to prevent inelastic deformation when the anchoring structure is collapsed prior to implantation. -
FIG. 9 shows a representative flat valve leaflet (36) before it is sewn together with a desired number of additional leaflets (36) to form a three-dimensional replacement valve. The flat pattern of the leaflet (36) can be used to dimension the anchoring structure shown inFIG. 10 such that the commissural tabs (35) of the valve (36) will coincide with the axial slots (21) at the distal ends (24) of the support posts (22) and the proximal edges (42) at which the leaflets will be stitched or otherwise attached to each other to form the inflow annulus of the valve can be attached to the proximal ends (25) of the support posts (22) of the anchoring structure via the triangular shaped elements (31). -
FIGS. 9 and 10 also show how an anchoring structure and valve may be scaled to fit different sizes of valve sinuses while retaining the proportional dimensions of the valve sinus. For example, if the width (43) of the leaflet (36) shown inFIG. 9 is chosen for a certain valve size, then the distance (44) between support posts (22) of the anchoring structure shown inFIG. 10 will be determined accordingly. Likewise, the height (45) of the leaflet (36) in FIG. 9 will determine the length (46) of the support posts (22) of the anchoring structure inFIG. 10 . In this manner, a person of skill in the art can dimension both the valve and anchoring structure to fit any size of valve sinus. - Another preferred embodiment of the present invention, illustrated in
FIGS. 11 and 12 , comprises a valve supported by a flared anchoring structure. The flared anchoring structure preferably comprises flared-out sections located at both the inflow (47) and outflow rims (48) to anchor it firmly against the narrowed inflow and outflow annuli of the valve sinuses. The flared distal end (48) of the anchoring structure is adapted to support the tab regions of the valve while the flared proximal end (47) supports the valve inflow annulus (33). The flared-out feature prevents contact between the valve tissue and the anchoring structure if the outflow rim (48) is positioned below the upper edges of the valve leaflets (36) in the open position, while also allowing the anchoring structure to secure itself in a sinus cavity of the vascular passageway. In this embodiment, the outflow rim (48) of the anchoring structure is comprised of diamond (49) and hexagon (50) shaped structures which facilitate collapsibility and dynamic compliance. The commissural tabs (35) of the valve (32) can be stitched directly to the hexagon shaped elements (50) of the outflow ring, rather than being secured via slots. The flared inflow rim (47) of the anchoring structure preferably comprises a single ring in the form of an undulating or zigzag pattern to which the valve's fabric ring (37) can be sewn. The inflow ring (47) of the anchoring structure is connected to the outflow rim (48) through vertical elements (51) that are positioned to coincide with the commissural posts of the native sinus region. Thus, the exemplary embodiment ofFIGS. 11 and 12 comprises three vertical connecting elements (51) for a three-leaflet valve (32). However, it should be understood that the number of vertical connecting elements (51) is meant to be adapted to the number of native commissural posts present in the particular sinus region. The area between vertical connector elements (51) is thus left free of any structural elements for the accommodation of vessel openings that may be present in the particular valve sinus. - In another preferred embodiment, as illustrated in
FIG. 13 , a valve is supported by an anchoring structure comprising a plurality of posts (52) with a single ring (53) at the inflow rim. The ring (53) is configured in an undulating or zigzag pattern. In this exemplary embodiment the plurality of posts (52) number three for a three-leaflet valve sinus region. The three posts (52) extend in the distal direction from the single ring (53) located at the inflow end of the anchoring structure. The proximal end (33) of the valve is attached to the ring (53) portion of the anchoring structure so that the ring (53) provides support to the inflow annulus (33) of the valve. The inflow ring (53) comprises an undulating or zigzag pattern for tire-like traction against the vessel wall. The anchoring structure portion surrounding the proximal end (33) of the valve is preferably flared in an outward direction to improve anchoring forces against the vascular wall. - The three posts (52) extend from the proximal end (33) to the distal end (34) of the valve and provide cantilevered support to the tab regions (35) of the valve at the distal end (34). The three posts (52) are designed to be sufficiently flexible so that they may deflect inwardly in a controlled motion at back flow pressures to optimize the fatigue life of the anchoring structure. The posts (52) comprise a distal end (54) for the attachment of the valve commissural tabs (35). Below the distal end (54), the posts (52) comprise a diamond-shaped element (55) for enhanced structural stability and valve support. As with the previous embodiments of the present invention, the design according to the present embodiment creates open space between the proximal (33) and distal ends of the valve (34). This also ensures that there is no direct contact between the valve and the anchoring structure and that vessel openings located within the particular sinus remain unencumbered. Again, as in the preceding embodiments, the support posts (52) are configured to spatially coincide with the commissural posts of the valve sinuses for ease of positioning and anatomical optimization.
- The anchoring structure embodiment illustrated in
FIG. 14 comprises a valve supported by a multi-operational anchoring structure (56). The multi-operational anchoring structure (56) comprises a proximal end (57), a distal end (58), posts (59) extending from the proximal end (57) to the distal end (58), and a tab attachment window (60) attached to each post (59) at the distal end (58). The tab attachment windows (60) in the present embodiment have a triangular geometry that is designed to create an optimal interference fit between the anchoring structure and the commissural tabs The post (59) and tab attachment window (60) construction of the present embodiment allows inward deflection of the post at back flow pressure, thus providing cantilevered support to the valve and greater dynamic compliance with the sinus region. Both the proximal (57) and distal (58) ends of the anchoring structure are flared out to better secure the valve in the valvular sinus region. The proximal end or inflow rim (57) of the anchoring structure also preferably possesses barbs or hooks (61) at the proximal end (62) of the post (59) for better attachment to the vascular wall and/or the valve's inflow annulus. In this embodiment, the flared inflow rim (57) is depicted as featuring two undulating rings that are substantially parallel to one another, while the flared outflow rim features three undulating rings. - Yet another preferred embodiment of a valve anchoring device according to the present invention is illustrated in
FIGS. 15-21 . In this preferred embodiment, an elliptical segment (70) anchoring structure is used to support the valve (32) as shown inFIG. 15A . As shown inFIG. 15B , the elliptical segment anchoring structure (70) comprises a plurality of elliptical segments (71) that are joined together, either integrally, mechanically, or by adhesive means. Each elliptical segment (71) is flared outward at the proximal (72) and distal ends (73) of the anchoring structure and curved inward at the junctures (74) with the other segments (71) assuming the shape of a potato chip. When joined together side by side, the elliptical segments (71) form a tubular structure that is flared outward at both the inflow (72) and outflow (73) ends. The junctures (74) of the elliptical segments (71) are located at the center of a substantially straight area of the elliptical segments (71) that defines the longitudinal support post elements (75) of the elliptical segment anchoring structure (70) and also provides a gap location (75) near which the valve tabs (35) can be secured. The tab regions (35) extending from the seams of the valve can be attached to the anchoring structure using any suitable means, including, sewing, stapling, wedging or adhesive means. The tab regions (35) are preferably attached to the gaps (75) formed above the junctures (74) between the elliptical segments (71). The inflow (72) and outflow (73) rims of the anchoring structure are formed by the corresponding regions of the elliptical segments (71) that reside below and above the junctures (74). The inflow annulus of the valve can be secured at the inflow rim (72) via stitching to the inflow annulus fabric which also serves as a sealing gasket. - As shown in
FIG. 16A , the vertical axes (76) of the elliptical segments (71) are dimensioned to exceed the axial length (77) of the valve (32), thereby eliminating valve leaflet (36) contact with the outflow rim (73) of the anchoring structure.FIG. 16B shows how both the valve (32) and anchoring structure (70) of the present embodiment can be compressed radially to facilitate implantation. The concave configurations of the elliptical segments (71) effectively form a radial spring that is capable of being radially collapsed under pressure for deployment and then expanded when positioned at the implant site. One advantageous feature of the instant design is that the region of juncture (74) between the elliptical segments (71) does not become extended upon compression of the anchoring structure. The valve (32) and anchoring structure (70) of the present embodiment can also be compression fit within a valve sinus cavity to exert radial force against the sinus walls. - As shown in
FIG. 17 , the anchoring structure (70) is preferably dimensioned to be lodged substantially within a valve sinus, with the regions of juncture (74) between the elliptical segments (71) being configured to reside at the location of the native commissural posts. The elliptical segment anchoring structure (70) is designed to expand at the proximal end (72) during peak flow and at the distal end (73) during peak backflow pressure, thereby maintaining pressure against the vascular wall. As a result, the valve and anchoring structure (70) of the present embodiment will remain secure in the valve sinus without sutures. A metal wire frame made from a metal that exhibits a high modulus of elasticity and that is biocompatible is preferred, such as Nitinol, as such materials exhibiting superior compressibility allow the anchoring structure to be self-expandable. - A further preferred embodiment of a valve anchoring structure according to the present invention is illustrated in
FIGS. 18A and B. In the present embodiment, an elliptical segment anchoring structure (70) is presented in which the elliptical segments (71) are joined together by a specialized double crimp (78).FIG. 18B shows that the valve tabs (35) can be secured near the double crimp (78) that joins the elliptical segments (71). The tab regions (35) are preferably attached to the gaps (75) between the elliptical segments (71). The inflow annulus of the valve (33) can be secured at the inflow rim (72) via stitching to the inflow annulus fabric which also serves as a sealing gasket. -
FIGS. 19A and B illustrate the double crimp (78) used to join the elliptical segments (71). As shown inFIGS. 19A and B, the double crimp (78) comprises two hollow tubes (79), one for each elliptical segment (71) to be inserted. The hollow tubes (79) of the double crimp (78) are designed to allow for better motion of the individual elliptical segments (71) and to minimize material stresses during expansion and compression of the anchoring structure. The double crimp (78) further comprises a central portion (80) joining the two hollow tubes (79). This central portion (80) comprises one or more holes (81) to facilitate the attachment of the valve commissural tabs to the anchoring structure and to reduce the mass of the double crimp (78). Thus, the double crimp (78) also serves as an attachment site for the valve and further acts as a stop against backflow pressure on the valve leaflets. -
FIG. 20A shows the insertion of the elliptical segments (71) of the preferred anchoring structure embodiment (70) into the double crimp (78). As with the previous embodiments, the present embodiment is dimensioned to be lodged substantially within the valve sinuses, with the joined regions (74) of the elliptical segments inFIG. 20B configured to align with the commissural posts of the sinus and the flared inflow (72) and outflow ends (73) of the anchoring structure configured to rest against the sinus cavities. -
FIGS. 21A through G show how the elliptical segment anchoring structure (70) may additionally be covered with cloth (82), particularly at the inflow end (72) to provide traction and a gasket-like seal. Thus, this preferred embodiment of the present invention is dimensioned to follow the sinus architecture and to lodge into the sinus cavities and against the inflow and outflow annuli of the sinuses for optimal securing and positioning of the replacement valve. -
FIGS. 22A and B illustrate a further preferred embodiment the present invention. This figure shows an elliptical segment anchoring structure (90) made from one piece of tubing. As illustrated, the support posts (91) that form the slots (92) for the valve tabs include a series of small holes (93) on either side of the slot (92) to facilitate suture or mechanical attachment of the commissural tabs of the valve. Again, this anchoring structure (90) is dimensioned to fit substantially within the valve sinuses with the support posts (91) being configured to reside in the commissural posts between the individual sinus cavities. The present embodiment also exerts axial force particularly at the flared inflow (94) and outflow rims (95) against the sinus walls to anchor the valve. - Yet another embodiment of a valve and anchoring structure according to the present invention is illustrated in
FIGS. 23A through D. In the present embodiment, a claw anchoring structure (100) is shown inFIG. 23A . This embodiment corresponds to an elliptical segment embodiment wherein the upper portions of each elliptical segment have been removed. The ends of the junctures (101) of the remaining elliptical segments are shaped into prongs or claws (102). Thus, the claw anchoring structure (100) comprises a flexible spring frame having a plurality of barbs (102), located distally just beyond where the valve leaflet tab regions meet the anchoring structure. The claw anchoring structure (100) preferably comprises at least one barb (102) for each valve leaflet tab included in the valve. The barbs (102) are designed to anchor the valve (32) and anchoring structure (100) to the vascular wall. - In another preferred embodiment of the invention, an anchoring structure is provided that lacks vertical support posts. As shown in
FIG. 24 , the representative anchoring structure configuration comprises an inflow ring (110) that is adapted to being secured to the inflow annulus of the valve (33) via stitching to the reinforced fabric sewing ring in a manner similar to the prior representative implementations. The undulating or sinusoidal pattern of the ring (110) facilitates radial collapse and expansion and exerts radial force against the vessel wall. The anchoring structure does not support the outflow annulus (34) of the valve. Rather, the valve's commissural tabs (35) are attached to the sinus walls via mechanical means, such as sutures, staples, or wire. - Another representative embodiment of an anchoring structure is shown in
FIG. 25A . The present embodiment comprises a dual-ring anchoring structure (120). The dual ring (120) of the present embodiment may, as in the previous embodiment, be secured to the inflow annulus of the valve via stitching to the reinforced fabric sewing ring. The undulating or sinusoidal pattern of the individual rings (121) is configured such that the peaks (122) of one ring (121) coincide with the valleys (123) of the other ring and vice versa, thereby forming a sine-cosine pattern. This pattern facilitates radial collapse and expansion and exerts radial force against the vessel wall. As in the previous embodiment, the dual ring anchoring structure (120) does not support the outflow annulus of the valve. Rather, the valve's commissural tabs are attached to the native sinus walls via mechanical means, such as sutures, staples, or wire, or additionally by the adhesive means disclosed herein. -
FIG. 25B shows another dual ring embodiment of the present invention. This anchoring structure is comprised of an upper (distal) dual ring (130) and a lower (proximal) dual ring (131). The lower dual ring (131) is connected to the proximal end of the valve at the inflow annulus while the upper dual ring (130) is connected to the distal end of the valve at the outflow annulus. The valve may be connected to the rings (130, 131) via sutures, clips or any other suitable means for attachment. The valve and the attached proximal (131) and distal (130) rings can be collapsed and inserted via a catheter. Once the valve has reached its desired location in the vascular passageway, the two rings (130, 131) are expanded to secure the valve in the vascular passageway. As in the previous embodiment, each dual ring (130, 131) comprises a wire frame with a circular cross-section and a sinusoidal pattern. The sinusoidal pattern may be of a sine-cosine shape with a varied frequency and amplitude. One or more longitudinal rods (132) may be used to connect the two dual rings (130, 131) and maintain longitudinal separation and radial orientation. The rods (132) may be removable so that once the valve is implanted in the vascular passageway they can be removed. - In another preferred embodiment, illustrated in
FIG. 26 , an upper single ring (140) with an undulating or zigzag pattern provides support to the tab regions (35) of the valve (32) at the distal end (34) of the valve whereas a lower single ring (141) configured in an undulating or sinusoidal pattern provides support to the inflow annulus (33) at the proximal end of the valve (32). The inflow ring (141) is stitched to the sewing fabric wrapped around the circumference of the inflow annulus of the valve, as described previously. The outflow ring (140) of the anchoring structure generally resides above the leaflets (36) to avoid leaflet contact. To improve traction, the inflow or outflow rings may comprise attachment barbs (142). The structural dissociation between the rings (140, 141) provides improved dynamic compliance while retaining the benefits of a two ring design. - Yet another embodiment of a valve and anchoring structure according to the present invention is illustrated in
FIGS. 27A through C. In the valve anchoring structure according to the present embodiment shown inFIGS. 27A and C, the valve (32) is supported by a tubular anchoring structure (150). The tubular anchoring structure (150) is preferably made of metal or plastic. The tubular anchoring structure (150) is also preferably designed to be expandable. For example, the anchoring structure may be designed to be self-expandable, balloon-expandable, or mechanically-expandable. The tab regions (35) of the valve (32) are preferably attached to the distal end (151) of the tubular anchoring structure (150) using staples, sutures, wire fasteners, or any other suitable means. The inflow rim (152) of the tubular anchoring structure may comprise a plurality of suture bores (153) to facilitate attachment of the valve (32). The tubular anchoring structure (150) also comprises vertical support posts (154) with axial slots (155) for the insertion of the valve tabs (35). The vertical support posts (154) extend to the distal end (151) of the tubular anchoring structure (150). In a preferred implementation of the of the present embodiment, the means of attachment, or an alternative means, is used to also attach the tab regions (35) of the valve (32) to the vascular wall thereby securing the valve (32) and tubular anchoring structure (150) in the valve sinuses. Such fastening means can also be optionally used at the inflow annulus to provide additional anchoring. - Another embodiment of a valve and anchoring structure according to the present invention is illustrated in
FIG. 28 . In the present embodiment, a dual-ring anchoring structure (160) is shown, as seen inFIGS. 28C and D, with an inflow ring (161) and an outflow ring (162) connected by a vertical element (163) comprised of two posts (164). The anchoring structure (160) is designed to be circumferentially collapsible as can be seen inFIGS. 28A and B. As shown inFIGS. 28C and D, the anchoring structure (160) is collapsed by sliding the two posts (164) that are adjacent to each other in the expanded state (FIG. 28D ) past each other to decrease the circumference of the upper outflow (162) and lower inflow (161) rings (FIG. 28C ). Thus, prior to implantation the anchoring structure (160) is collapsed and, once the valve is properly positioned in the valve sinuses, the anchoring structure freely self-expands to its original dimensions. The self-expanding behavior of the present embodiment is due to Nitinol's relatively high modulus of elasticity, which imparts superior spring-like properties to the anchoring structure. Alternatively, if the anchoring structure is constructed of a non-self expanding material, it may be mechanically collapsed and expanded using the devices disclosed herein. - Another embodiment of a valve and anchoring structure according to the present invention is illustrated in
FIGS. 29A and B. In the present embodiment, a dual-ring anchoring structure (170) is shown, with an inflow ring (171) and an outflow ring (172) connected by a vertical element (173) comprised of two posts (174). The inflow rim may further comprise tissue mounting posts (175). The anchoring structure (170) is designed to be circumferentially collapsible.FIG. 29A shows how the posts (174) are separated in the expanded state andFIG. 29B shows how the posts (174) form a single vertical element (173) in the collapsed state. Thus, prior to implantation the anchoring structure is collapsed and upon the positioning of the valve assembly in the valve sinuses, the anchoring structure (170) freely self-expands to its original dimensions. As in the previous embodiment, the self-expanding behavior of the present embodiment is a function of Nitinol's high modulus of elasticity. Alternatively, if the anchoring structure is constructed of a non-self expanding material, it may be mechanically collapsed and expanded using the devices disclosed herein. - A further embodiment of a valve and anchoring structure according to the present invention is illustrated in
FIGS. 30A and B. The present embodiment comprises a spring-aided anchoring structure (180). The spring aided anchoring structure (180) preferably comprises three members (181) that are radially collapsible for implantation into the valve sinuses. The members (181) comprise peaks (182) that serve as valve attachment points and valleys (183) that serve to lodge the anchoring structure at the valve sinus inflow annulus. Following implantation, the anchoring structure (180) is expanded to its original dimensions by coil springs (184) that provide an outward radial force on each member. In a preferred embodiment, shown inFIG. 30B , the spring aided anchoring structure (180) comprises at least one anchoring section (185) for selectively securing the anchoring structure (180) in the valve sinus at the inflow annulus. Although the present embodiment illustrates three members (181) and three coil springs (184), it should be appreciated that two or more members (181) with a corresponding number of coil springs (184) may be used. - The anchoring structures of the present invention may be constructed from superelastic memory metal alloys, such as Nitinol, described in U.S. Pat. No. 6,451,025, incorporated herein by reference. Nitinol belongs to a family of intermetallic materials which contain a nearly equal mixture of nickel and titanium. Other elements can be added to adjust or modify the material properties. Nitinol exhibits both shape memory and superelastic properties. The shape memory effect of Nitinol allows for the restoration of the original shape of a plastically deformed structure by heating it. This is a result of the crystalline phase change known as thermoelastic martensitic transformation. Thus, below the transformation temperature, Nitinol is martensitic, i.e. easily deformable. Heating the material converts the material to its high strength, austenitic condition. Accordingly, prior to implantation, the valve assembly is chilled in sterile ice water. Upon cooling, the Nitinol anchoring structure enters its martensite phase. Once in this phase, the structure is malleable and can maintain a plastically deformed crushed configuration. When the crushed anchoring structure comprising the valve is delivered into the valve sinus, the increase in temperature results in a phase change from martensite to austenite. Through the phase change, the anchoring structure returns to its memorized shape, and thus expands back to its original size.
- The anchoring structures can also be designed to use the superelasticity properties of Nitinol. With the superelastic design, the chilling procedure would not be necessary. The anchoring structure would be crushed at room temperature. The phase change to martensite would be accomplished by means of the stress generated during the crushing process. The anchoring structure would be held in the crushed configuration using force. Force is removed once the anchoring structure is delivered to the valve sinus, resulting in a phase transformation of the Nitinol from martensite to austenite. Through the phase change, the anchoring structure returns to its memorized shape and stresses and strains generated during the crushing process are removed. Alternatively, the anchoring structures of the present invention may be composed of a non-self expanding suitable material, such as biocompatible metals, including titanium, and plastics. Whether the valve assembly is designed to be self-expandable or non-self expandable, it may be compressed (and expanded, if non-self expandable) for implantation using the expansion and contraction devices disclosed herein.
- Expansion and Contraction Devices
- A preferred embodiment of an expansion and contraction device for implanting the valve assemblies of the present invention is illustrated in
FIGS. 31-33 . As seen inFIGS. 31A and B, the device of the present embodiment comprises a group of bendable hollow tubes or wires (200), a grip handle (201), and a circular element (202) that holds the wires (200) together at their proximal ends (203). Each wire (200) comprises a proximal end (203), a distal end (204) and a hollow shaft (205) running from the proximal end (203) to the distal end (204). The wires (200) are attached to the grip handle (201) at their proximal ends (203) via the circular element (202) such that the wires form a circular pattern. - As shown in
FIGS. 32A and B, the expansion and contraction device further comprises a cylinder (206) having a proximal end (207) and a distal end (208). The cylinder (206) has holes (209) drilled along its distal perimeter (208). The holes (209) in the cylinder (206) are preferably drilled at an outward angle so that by forcing the wires (200) through the angled holes (209), the distal ends (204) of the wires (200) are driven radially outward. As the wires (200) are pushed further through the outwardly angled cylinder holes (209), the further the wires (200) spread radially, thereby expanding the anchoring structure that is positioned over the wires (200). Accordingly, the angle of the cylinder holes (209) controls the relationship between the longitudinal movement of the wires (200) and their radial dilation. - As shown in
FIG. 33 , a representative anchoring structure (210) of the present invention is attached to the distal ends (204) of the hollow wires (200). The cylinder (206) having a proximal end (207) and a distal end (208) has holes (209) drilled along its distal perimeter (208). The holes (209) in the cylinder (206) are drilled at an outward angle so that by forcing the wires (200) through the angled holes (209), the distal ends (204) of the wires (200) are driven radially outward. As this figure shows, when the wires (200) are pushed further through the outwardly angled cylinder holes (209), they are forced to spread radially, thereby expanding the anchoring structure (210) that is positioned over the wires (200) at their distal ends (204). In a preferred embodiment, a long suture is routed from the proximal end to the distal end of the wire down its hollow shaft, looped around a segment of the anchoring structure at the distal end of the wire and then routed back to the proximal end of the wire, where it is secured. Attached to the distal ends (204) of the hollow wires, the anchoring structure (210) contracts and expands radially in response to the longitudinal motion of the wires (200). Pulling the grip handle (201) proximally contracts the anchoring structure (210) into a collapsed state for implantation whereas pushing the grip handle (201) distally expands the anchoring structure (210). When the anchoring structure (210) is positioned in a desirable location in the vessel and expanded to the desired dimensions, the sutures are severed and removed from the proximal end (203) of the wires (200) in order to disconnect the anchoring structure (210) from the device. The device of the present embodiment is removed, thereby leaving the valve assembly securely situated in the valve sinus. - Another expansion and contraction device is illustrated in
FIGS. 34 and 35 . As shown inFIG. 34 , the device of the present embodiment comprises a tube (220), multiple wall panels (221), springs (222) corresponding to the multiple wall panels (221), a spindle (223) and a plurality of connecting wires (224). The tube (220) comprises a hollow shaft (225) having a radial center (226), a proximal end (227), a distal end (228) as shown inFIG. 35 , an interior wall (229) and an exterior wall (230), wherein a hole (231) corresponding to each wall panel (221) extends through the interior (229) and exterior wall (230) of the tube (220). In a preferred embodiment, the perimeter of the exterior wall (230) is surrounded by adjacent wall panels (221), only buffered by the springs (222) corresponding to the wall panels (221). The spindle (223) is attached to the interior wall (229) of the tube (220), preferably facing the tube's (220) radial center (226). A connecting wire (224) is attached to each wall panel (221) and routed through the spring (222) and the corresponding hole (231) in the tube wall (229, 230) to meet the other connecting wires (224), preferably at the radial center (226) of the tube (220). - As shown in
FIG. 35 , upon meeting at the radial center (226) of the tube (220), the wires (224) having been wrapped around the spindle (223), now run parallel to the tube's (220) longitudinal axis. By pulling the wires (224) proximally, the attached panels (221) compress the springs (222) against the tube's (220) exterior wall (230). In this compressed state, a collapsed valve assembly of the present invention can be placed over the panels (221). Once the device of the present embodiment, loaded with the valve assembly, is positioned at the desired location in the valve sinus, the tension in the wires (224) is relieved to force the wall panels (221) outward, thereby expanding the anchoring structure and valve. The length of the uncompressed spring (222) determines the diameter to which the anchoring structure can be expanded. The anchoring structure can optionally be secured to the wall panels (221), by staples, sutures, wire fasteners, or any other suitable means, so that the valve assembly may be selectively expanded and collapsed by preferably varying the tension on the connecting wires. - In
FIGS. 36A and B, another preferred embodiment of an expansion and contraction device of the present invention is presented. In this embodiment, the anchoring structure (240) is composed of a shape memory metal or the like having a relatively high modulus of elasticity, and possessing an outward spring-like force when in a compressed state. Therefore, spring loaded wall panels are not necessary in the present embodiment. Instead, the wires (241) pass through sutures (242) that are threaded through holes (243) in the tube (244) wall and wrap around portions of the anchoring structure. Thus, the wires (241) keep the anchoring structure (240) compressed by pulling the sutures (242) around the anchoring structure (240) against the tube (244). Alternatively, the tube structure can be omitted with only the wires (241) and sutures (242) keeping the anchoring structure (240) in a compressed state. This would ensure that the valve within the anchoring structure is not contacted by any mechanical elements, such as a tube (244). Alternatively, the tube could be made from a cloth- or tissue-like material. Once the anchoring structure (240) is positioned in the desired location in the valve sinus, the wires (241) can be retracted, allowing the anchoring structure (240) to self-expand such that the tube (244) can be withdrawn, leaving the anchoring structure (240) securely lodged at the desired location of implantation. The sutures (242), which will remain wrapped about the anchoring structure (240), can be made of biodegradable material and thus will be resorbed by the body within a matter of days. - The contraction and expansion device illustrated in
FIGS. 37 and 38 represents another preferred embodiment of the present invention. As illustrated inFIG. 37 , each wall panel (250) is connected to a pin (251) which runs through the corresponding hole (252) in the tube (253) wall. The pin (251), protruding radially inward from the tube's interior, is preferably spring-loaded (254) toward the radial center of the tube (253). In a zero energy state, the wall panels (250) rest against the exterior wall of the tube (253) and the collapsed anchoring structure rests against the wall panels (250). Instead of wires, the present embodiment comprises a longitudinal shaft (255) running through the radial center of the tube. The shaft is comprised of a proximal end (256) and a distal end (257). The distal end (257) is connected to a central plate (258) having spiral shaped edges (259) as shown inFIGS. 37B and C. The central plate (258) is located in the tube (253), parallel to the tube's cross-section and is aligned with the spring-loaded (254) pins (251). The plate's spiral-shaped edges (259) preferably cause the distance from the plate's perimeter to the tube's radial center to vary along the plate's (258) perimeter. When the shaft (255) is rotated, the edge of the plate (259) pushes against each pin (251), thereby driving the corresponding panels (250) outward and expanding the anchoring structure, asFIG. 37C shows. -
FIGS. 38A and B show how rotation of the shaft (255) pushes the wall panels (250) radially out, thereby expanding the anchoring structure (260). In a preferred embodiment, the anchoring structure (260) is sutured to the wall panels (250) to allow expansion and contraction of the anchoring structure by alternating rotation of the shaft. The sutures are preferably removable from the shaft's (255) proximal end to free the valve assembly from the device following implantation in the valve sinus. - In still another embodiment, as illustrated in
FIG. 39 , an expansion and contraction device similar to the previous embodiment is presented. Instead of a device comprising a central plate with spiral-shaped edges of varying dimensions, the present preferred embodiment utilizes a circular disk (270) with pre-cut spiral-shaped grooves (271) corresponding to the spring-loaded pins (272). Preferably, the grooves (271) provide a track of varying depth for the pins (272) such that the pins (272) are forced radially outward upon rotation of the disk (270), thereby expanding the anchoring structure. - Adhesive Means for Securing Replacement Valves
- In addition to the disclosed features and mechanisms for securing the valve assembly comprising a valve and anchoring structure into position, the present invention provides the use of biocompatible adhesives. A number of adhesives may be used to seal the valve assembly to the surrounding tissue in the valve sinus. The following are examples of available adhesives and methods of use:
- U.S. Pat. No. 5,549,904, the entire contents of which are incorporated herein by reference, discloses a formulated biological adhesive composition comprising tissue transglutaminase and a pharmaceutically acceptable carrier, the tissue transglutaminase in an effective amount to promote adhesion upon treatment of tissue in the presence of a divalent metal ion, such as calcium or strontium. In operation, the two components are mixed to activate the sealable fixation means for securely fixing the valve assembly to tissue at a desired valve location.
- U.S. Pat. No. 5,407,671, the entire contents of which are incorporated herein by reference, discloses a one-component tissue adhesive containing, in aqueous solution, fibrinogen, F XIII, a thrombin inhibitor, prothrombin factors, calcium ions and, where appropriate, a plasmin inhibitor. This adhesive can be reconstituted from a freeze-dried form with water. It can contain all active substances in pasteurized form and is then free of the risk of transmission of hepatitis and HTLV III. In operations, the one-component tissue adhesive is reconstituted from a freeze-dried form with water to activate the sealable fixation means for securely fixing the valve assembly to tissue at a desired valve location.
- U.S. Pat. No. 5,739,288, the entire contents of which are incorporated herein by reference, discloses a method for utilizing a fibrin sealant which comprises: (a) contacting a desired site with a composition comprising fibrin monomer or noncrosslinked fibrin; and (b) converting the fibrin monomer or noncrosslinked fibrin to a fibrin polymer concurrently with the contacting step, thereby forming a fibrin clot. In operation, the fibrin monomer or noncrosslinked fibrin is converted to activate the sealable fixation means for securely fixing the valve assembly to tissue at a desired valve location.
- U.S. Pat. No. 5,744,545, the entire contents of which are incorporated herein by reference, discloses a method for effecting the nonsurgical attachment of a first surface to a second surface, comprising the steps of: (a) providing collagen and a multifunctionally activated synthetic hydrophilic polymer; (b) mixing the collagen and synthetic polymer to initiate crosslinking between the collagen and the synthetic polymer; (c) applying the mixture of collagen and synthetic polymer to a first surface before substantial crosslinking has occurred between the collagen and the synthetic polymer; and (d) contacting the first surface with the second surface to effect adhesion between the two surfaces. Each surface can be a native tissue or implant surface. In operation, collagen and a multifunctionally activated synthetic hydrophilic polymer are mixed to activate the sealable fixation means for securely fixing the valve assembly to tissue at a desired valve location.
- U.S. Pat. No. 6,113,948, the entire contents of which are incorporated herein by reference, discloses soluble microparticles comprising fibrinogen or thrombin, in free-flowing form. These microparticles can be mixed to give a dry powder, to be used as a fibrin sealant that is activated only at a tissue site upon dissolving the soluble microparticles. In operation, soluble microparticles comprising fibrinogen or thrombin are contacted with water to activate the sealable fixation means for securely fixing the valve assembly to tissue at a desired valve location.
- U.S. Pat. Nos. 6,565,549, 5,387,450, 5,156,911 and 5,648,167, the entire contents of which are incorporated herein by reference, disclose a thermally activatable adhesive. A “thermally activatable” adhesive is an adhesive which exhibits an increase in “tack” or adhesion after being warmed to a temperature at or above the activation temperature of the adhesive. Preferably, the activation temperature of the thermally activatable adhesive is between about 28° C. and 60° C. More preferably, the activation temperature is between about 30° C. and 40° C. One exemplary thermally activatable adhesive is described as Example 1 in U.S. Pat. No. 5,648,167, which is incorporated by reference herein. It consists of a mixture of stearyl methacrylate (65.8 g), 2-ethylhexyl acrylate (28.2 g) and acrylic acid (6 g) monomers and a solution of catalyst BCEPC (0.2 g) in ethyl acetate (100 g) is slowly added by means of dropper funnels to ethyl acetate (50 g) heated under reflux (80 degrees C.) in a resin flask over a period of approximately 6 hours. Further ethyl acetate (50 g) is added to the mixture during the polymerization to maintain the mixture in a viscous but ungelled state. In operation, thermally activatable adhesive is heated to activate the sealable fixation means for securely fixing the valve assembly to tissue at a desired valve location.
-
FIG. 40 shows a preferred embodiment, wherein an outer circumferential reservoir (401) is located at an outermost radius of a valve anchoring structure (400) when the anchoring structure (400) is in an expanded state, wherein the reservoir is filled with a sealable fixation means for securely fixing the valve assembly (400) at a desired location within a body cavity.FIG. 40 further illustrates one embodiment of the reservoir (401) comprising a sealable fixation means, wherein the sealable fixation means may comprise a one-component biological adhesive. The sealable fixation means may be activated by exposing the biological adhesive to blood or heat. -
FIG. 41 illustrates another preferred embodiment wherein the sealable fixation means may comprise a two-component biological adhesive. The sealable fixation means may be activated by mixing the two components. Thus, for example, if one reservoir (402) contains microparticles that are activated by contact with water, the second reservoir (403) would contain the water for the activation of the microparticles. This figure also shows that the reservoirs may be arranged concentrically as shown inFIG. 41B or adjacent to each other as shown inFIG. 41A . -
FIG. 42 illustrates an exemplary reservoir (401) which may be attached to the valve anchoring structure by its inner wall (404) by sutures, glue, staples or some other appropriate method.FIG. 42 further illustrates a thin spot (405) on the outer wall (406) of the reservoir (401). The thin spots (405) are areas on the reservoir (401) that are adapted to rupture when placed under certain levels of pressure. The pressure is exerted on the thin spots (405) as the reservoir (401) is expanded along with the valve anchoring structure. The thin spots (405) are unable to withstand the pressure and therefore rupture releasing the contents of the reservoir (401) or reservoirs. In a preferred embodiment, the reservoir (401) is made of an elastic material that expands along with the expansion of the valve anchoring structure. -
FIG. 43 illustrates a cross sectional view of the reservoir (401). The reservoir (401) may contain a lumen (407) which extends along at least a portion of the circumference of the reservoir. The reservoir (401) has one or more thin spots (405) along its outermost circumference, wherein the thin spots (405) are sized and configured to rupture when the reservoir (401) is expanded to an appropriate diameter. When the anchoring structure comprising the valve is fully expanded, the pressure exerted upon the expanded thin spots (405) causes them to rupture. In still another preferred embodiment, the reservoir (401) is made of a biodegradable material adapted for erosion or rupture to release the content of the reservoir (401) and activate the sealable fixation means in a desired timeframe after implantation. In a further preferred embodiment, a circumferentially outermost portion is pressure sensitive to rupture, wherein the contents of the reservoir (401) are released when the reservoir (401) is compressed against the sinus cavities during expansion and implantation of the valve assembly. -
FIG. 44 shows a cross-sectional view of another preferred embodiment, illustrating thin spots (405) on a reservoir having two concentric component compartments, an inner compartment (408) and an outer compartment (409). Component A in an inner compartment (408) and component B in an outer compartment (409) are to be mixed to form adhesive for sealing the valve assembly against the valve sinuses. The inner compartment (408) has a plurality of thin spots (405) along its outermost circumference, wherein the thin spots (405) are sized and configured to rupture when the reservoir (401) is expanded to an appropriate diameter. The outer compartment (409) also has a plurality of thin spots (405) along its innermost circumference. The thin spots (405) of the inner compartment (408) and the thin spots (405) of the outer compartment (409) may be located adjacent to each other. In one preferred embodiment, the space between the adjacent pair of thin spots (405) on the inner (408) and outer (409) compartment may comprise a piercing element that is activated to rupture the thin spot or the pair of adjacent spots when the reservoir is expanded to an appropriate diameter or a predetermined diameter. Other embodiments of reservoir configuration, for example, two parallel compartments circumferentially or longitudinally, and suitable activation mechanism for the sealable fixation means are also within the scope of the present invention. - The present invention further comprises methods and devices for the sizing of native valves that require replacement.
- Methods and Apparatus for Valve Sizing
- Intravascular ultrasound (IVUS) uses high-frequency sound waves that are sent with a device called a transducer. The transducer is attached to the end of a catheter, which is threaded through a vein, artery, or other vessel lumen. The sound waves bounce off of the walls of the vessel and return to the transducer as echoes. The echoes can be converted into distances by computer. A preferred minimally invasive valve replacement sizer is shown in
FIGS. 45A and B. For purposes of this application, the distal end or portion refers to the area closer to the body while the proximal end or portion refers to the area closer to the user of the valve replacement sizer. The device comprises a guidewire (500), an intravascular ultrasound (IVUS) catheter (501) having a transducer (502), and a balloon dilatation catheter (503) all positioned within the central lumen of a catheter. The transducer (502) is positioned in the IVUS sizing window (504) of the balloon catheter. The guide wire (500) advances and guides the catheter (501) to the appropriate location for valve sizing.FIG. 45A shows the catheter in deflated form, whereas inFIG. 45B the balloon dilatation catheter (503) has inflated the balloon (505). - In a preferred embodiment, shown in
FIG. 46 , the catheter (510) contains multiple lumens (511) in order to house a guidewire (512), an IVUS catheter (513), and a balloon dilatation catheter (514).FIG. 46 illustrates a cross sectional view. One of the separate lumens (511) contains the guidewire (512), another contains the IVUS catheter (513), and another contains the balloon dilatation catheter (514). The balloon dilatation catheter (514) has a balloon (515) attached circumferentially surrounding the balloon dilatation catheter (514) as well as a portion of the catheter (510). -
FIG. 47 shows a balloon dilatation catheter (516) comprising a balloon (517) that circumferentially surrounds a portion of the catheter (518) proximal to its distal portion (519). More specifically, the balloon (517) comprises an outer wall (520) that circumferentially surrounds a portion of the catheter (518) near its distal portion (519). The balloon (517) also has a distal end (521) and a proximal end (522). In a preferred embodiment, within the area encompassed by the balloon, a transducer (523) is located on the IVUS catheter (524). Directly over the transducer (523) a sizing window (525) is placed on the IVUS catheter (524) to enable signals to be transmitted and received by the transducer (523) without interference. In a preferred embodiment, the sizing window (525) is simply an empty space. However, the sizing window (525) could be made from any substance which does not interfere with the signals emitted and received by the transducer (523). - Preferably, the balloon (517) is round but other shapes are possible and contemplated for use with the valve sizing apparatus. In particular,
FIG. 48 shows a cross section of an inflated balloon (530) with curves forming leaflets (531) to enable fluid (532) to pass through the vessel while the balloon (530) is in its inflated state and the outer edges (533) of the leaflets (531) are in contact with the vessel wall (534) to measure the diameter. The balloon may further be made from compliant or non-compliant material. -
FIG. 49 shows a preferred embodiment wherein the balloon (540) is inflated with saline (541). Preferably, the saline is pumped into the balloon (540) through the balloon dilatation catheter. Alternatively, the balloon (540) may be inflated with a gas or any other suitable substance. The balloon (540) is inflated to a chosen pressure by the person using the valve replacement sizer. When the balloon (540) has been inflated, the outermost portion of the outer wall (542) will be in contact with the vessel wall (543) or other lumen at the location where the replacement valve is to be placed. When the balloon (540) is completely inflated, the farthest radial points of the balloon's outer wall (542) will be equidistant to the center of the catheter (544). This distance is labeled as R. The transducer (545) may or may not be at the centermost point of the inflated balloon (540). Any deviation from the centermost point by the transducer (545) may be accounted for when calculating the diameter of the vessel lumen. However, the signal emitted by the transducer (545) preferably intersects the balloon (540) at its greatest radius. -
FIG. 50 shows a preferred embodiment, wherein a transducer (550) emits an ultrasonic signal (556) in a perpendicular direction to the IVUS catheter (551). The signal is then reflected off the outer wall (552) of the balloon (540) and received by the transducer (550). The transducer (550) then transmits the data to the auxiliary processor (553) to determine the radius and diameter of the vessel lumen. Alternatively, an infrared light may be emitted and received by the transducer (550) to determine the radius and diameter of the vessel lumen. The diameter is calculated by knowing the speed of the signal and the time it takes for the signal to be reflected off the balloon wall (552) back to the transducer (550). The known speed is multiplied by the time to determine the radius of the balloon (540). The radius may be adjusted if the transducer (550) was not located at the centermost point of the catheter. - The present invention further provides devices and methods to remove the native diseased valves prior to implantation of the replacement valve assembly. In one embodiment of the present invention, the valve removing means is provided by the replacement valve assembly. In another embodiment, the valve removing means is provided by a valve sizing device of the present invention.
- Valve Assemblies with Native Valve Removing Capabiliy
- The present invention further provides valve assemblies comprising native valve removing capabilities. Thus, in a preferred embodiment, a valve anchoring structure having cutting means located at the annulus base for cutting a native valve is provided. Accordingly, when passing the valve assembly comprising the valve and anchoring structure through the vessel with the anchoring structure in a collapsed state, the cutting means can be advanced against the native valve with the anchoring structure in a partially expanded state. In this manner, the anchoring structure comprising the cutting means cuts at least a portion of the native valve by deploying the cutting means, before the valve assembly is secured to the desired valve location with the anchoring structure in the expanded state.
- It is one object of the present invention to provide a valve assembly of the preferred embodiment having a tissue valve and an anchoring structure, which permits implantation without surgery or with minimal surgical intervention and provides native valve removing means for removing a dysfunctional native valve, followed by valve replacement. The native valve removing means on the anchoring structure is selected from a group consisting of: a plurality of sharp edge elements, each sharp edge element having a sharp end enabling the element to cut through at least a portion of the native valve; a plurality of electrode elements, wherein radiofrequency energy is delivered to each electrode element enabling the electrode element to cut through at least a portion of the native valve, and a plurality of ultrasound transducer elements, wherein ultrasound energy is delivered to each transducer element enabling the transducer element to cut through at least a portion of the native valve.
- Percutaneous implantation of a valve prosthesis is achieved according to the invention, which is characterized in that the valve anchoring structure is made from a radially collapsible and re-expandable cylindrical support means for folding and expanding together with the collapsible replacement valve for implantation in the body by means of catheterization or other minimally invasive procedure. Catheters and catheter balloon systems are well known to those of skill in the art, for example, U.S. Pat. No. 6,605,056 issued on Aug. 23, 2003.
- Accordingly, in one preferred embodiment of the invention shown in
FIG. 51 , the anchoring structure (600) comprises at least one ultrasound transducer (601) at the distal end portion of the lower ring (602), wherein each ultrasound transducer is sized and configured with ultrasound energy as cutting means for cutting a native valve. Ultrasound energy is delivered through conductor means (603) to each transducer element (601) enabling the transducer element (601) to cut through at least a portion of the native valve. In one embodiment, the conductor (603) passes through a delivery means and is connected to an external ultrasound energy generator. The ablative ultrasound delivery means and methods are well known to one skilled in the art, for example, U.S. Pat. No. 6,241,692 issued on Jun. 5, 2001. -
FIG. 52 shows another preferred embodiment of a native valve removal system comprising a valve assembly having radiofrequency cutting means. In this preferred embodiment, the anchoring structure comprises at least one radiofrequency electrode (610) at the distal end portion of the lower ring (602), wherein each radiofrequency electrode (610) is sized and configured with radiofrequency energy as cutting means for cutting a native valve. Radiofrequency energy is delivered through conductor means (611) to each electrode element (610) enabling the electrode element to cut through at least a portion of the native valve. In one embodiment, the conductor (611) passes through delivery means and is connected to an external radiofrequency energy generator. The ablative radiofrequency delivery means and methods are well known to one skilled in the art, for example, U.S. Pat. No. 6,033,402 issued on Mar. 7, 2000. -
FIG. 53 shows another embodiment of an anchoring structure having sharp edge cutting means (620). In one preferred embodiment, the anchoring structure comprises a set of sharp edge cutting elements (621) at the distal end portion of the cutting means (620) of the lower ring (602) of the anchoring structure, wherein each cutting element (621) has a cutting tip (622), and wherein each cutting element (621) of the cutting means is sized and configured, optionally with radiofrequency energy, as cutting means for cutting a native valve. In one embodiment, sharp edge cutting means on the delivery apparatus is rotatable, enabling the cutting element (621) to cut through at least a portion of the native valve. Sharp edge cutting means, with optionally ablative radiofrequency delivery means and methods, are well known to one skilled in the art, for example, U.S. Pat. No. 5,980,515 issued on Nov. 9, 1999. -
FIG. 54 shows a partially inflated balloon catheter. A balloon catheter (630) is introduced in the vessel. The balloon means (632) of the balloon catheter (630) is led out of the protection cap (633) at the catheter tip (634) and is partly inflated through a fluid channel (635), which is led to the surface of the patient. In one embodiment, the balloon (632) is partially expanded and the sharp end (636) of the cutting means of the valve anchoring structure (637) is advanced to cut and remove at least a portion of the native valve. In another embodiment, the valve anchoring structure (637) comprises an ultrasound or radiofrequency cutting means (638). In one embodiment, the support structure is expanded at about 30 to 95% of full expansion for cutting the native valve. More preferably, the support structure is expanded at about 50 to 90% of the full expansion. In another embodiment, the balloon catheter (630) comprises a central channel (639) with respect to a central axial line (640) to receive a guide wire (641) which is used in a way known for viewing the introduction of the catheter through fluoroscopy. - Some aspects of the present invention provide a method of endovascularly implanting a valve through a vessel, comprising the steps of providing a collapsibly expandable valve assembly that comprises an anchoring structure according to the present invention with an annulus base and a collapsible valve connected to the anchoring structure, the collapsible valve being configured to permit blood flow in a direction and prevent blood flow in an opposite direction, the anchoring structure having cutting means located at the annulus base for cutting a native valve, passing the valve assembly through the vessel with the anchoring structure in a collapsed state, advancing the cutting means against the native valve with the anchoring structure in a partially expanded state, cutting at least a portion of the native valve by deploying the cutting means, and securing the valve assembly to the desired valve location with the anchoring structure in the expanded shape.
- In operations, a method of implanting a valve assembly according to the present invention is given below: a valve assembly made of an anchoring structure of the present invention and a collapsible valve, as described above, is placed on a deflated balloon means and is compressed thereon, either manually or by use of the expansion/compression devices of the instant invention; the balloon means and the valve assembly are drawn into an insertion cover; a guide wire is inserted into a vessel through the central opening of the balloon catheter under continuous fluoroscopy; the insertion cover conveys the guide wire to a point in the channel in the immediate vicinity of the desired position of the valve assembly; the balloon means is pushed out of the protection cap and the valve assembly is positioned in the desired position if necessary by use of further imaging means to ensure accurate positioning; the balloon means is inflated partially; the valve assembly is advanced with its cutting means cutting at least a portion of the native valve; the balloon means is further inflated to position the valve at a desired site, preferably against the truncated valvular annulus; the balloon means is deflated; and the balloon means with entrapped tissue and debris inside the filter means, the guide wire, and the protection cap are drawn out and the opening in the channel, if any, wherein the valve prosthesis is inserted can be closed.
- The present invention also provides for devices and methods to prevent the release of debris during removal of the native diseased valves from traveling to distant sites where such debris may cause undesirable physiological effects.
- Distal Protection Assembly
- As described above, removal or manipulation of diseased valves may result in dislodgment of parts of the valve or deposits formed thereon which may be carried by the fluid to other parts of the body. Thus, the present invention provides for specialized filters that capture material and debris generated during valve replacement procedures. The distal protection devices of the present invention are also effective in trapping material that may be released during other percutaneous interventional procedures, such as balloon angioplasty or stenting procedures by providing a temporary valve and filter in the same device.
- In one preferred embodiment, shown in
FIGS. 55A and B, the present invention provides for a temporary valve (700), which may be deployed at a desired location in a collapsed state and then expanded and secured to the walls of the passageway. The temporary valve (700) comprises two concentric one-way valves, an outer valve (701) and an inner valve (702) disposed within the outer valve (701), that open in opposite directions as shown inFIG. 55B . The outer valve (701) opens in response to positive fluid flow pressure, thereby regulating blood flow in substantially one direction. The inner valve (702) opens in the opposite direction of the outer valve (701) to facilitate the insertion of catheter based equipment (703) as shown inFIG. 55C and functions as a seal through which such equipment may be passed. The pressure required to open the individual valves may be manipulated to facilitate positive fluid flow, while precluding or minimizing retrograde flow that might otherwise occur as a result of back flow pressure. Hence, it is contemplated that the inner valve (702) be configured or constructed to open with relatively more pressure than that required to open the outer valve. - The outer (701) and inner valves (702) of the temporary valve (700) may be coupled together by radial support members. In one embodiment, the radial support members couple the inner surface of the outer valve to the outer surface of the inner valve. The length of the radial support means depends upon the dimension of the blood vessel or body cavity within which the temporary valve is to be deployed.
- The temporary valve may be constructed from material that is capable of self-expanding the temporary valve, once it is deployed from the collapsed state at the desired location. Once expanded, catheter based equipment required for the particular surgical procedure may be passed through and movably operated in relation to the temporary valve.
- In another embodiment of the present invention, the temporary valve may be combined with a filter that extends distally from the temporary valve to capture debris material. In this embodiment, the temporary valve-filter device is preferably configured such that the open proximal end is secured to the temporary valve and the closed distal end comprises an opening or a third valve to facilitate the passage of the catheter equipment through the distal end of the bag and out of the temporary valve. Additional valves may also be positioned in the filter to coincide with one or more branching arteries.
- In yet another preferred embodiment of the present invention, the temporary valve-filter device may include one or more traps within the filter bag to trap debris material within the bag to reduce the likelihood of debris material leaving the filter when the catheter equipment is being passed through the filter bag. The filter traps may be comprised of one or more valves disposed within the filter bag that are configured to open with retrograde pressure. Alternatively, the traps may be comprised of flaps that extend inwardly from the perimeter of the bag to create a cupping effect that traps particulate matter and directs it outwardly toward the perimeter of the filter bag. The filter traps may be constructed of material that is capable of facilitating and filtering antegrade fluid flow, while retaining the debris material within the filter bag.
- The valve-filter assembly previously described may also incorporate multiple valves. In this arrangement, debris may be better and better entrapped, and thus reduces the chance of debris coming out of the valve-filter assembly. The present invention is particularly useful while performing an interventional procedure in vital arteries, such as the carotid arteries and the aorta, in which critical downstream blood vessels can become blocked with debris material.
- One benefit of the current invention is that it provides fast, simple, and quick deployment. One may deploy both the filter and temporary valve simultaneously. The valve-filter assembly may also include a cannulation system at the downstream end of the filter to remove particles and debris. The valve-filter assembly may also include a grinder for cutting up or reducing the size of the debris. This debris, in turn, may be removed by a cannulation system or be allowed to remain in the filter.
- The valve-filter assembly is well-suited for use in minimally invasive surgery where the valve-filter may be placed in the aorta between the aortic valve and the innominate branch or the braciocephalic branch. In such a configuration, the valve-filter may be put in place before the start of surgery and function as a valve. The valve-filter may further collect debris and particles during removal and clean up of the old valve. The valve-filter may also stay in place while the new valve is put in place and until the end of the procedure to function as protection and as a valve. A vascular filter system is well known to one skilled in the art, for example, U.S. Pat. No. 6,485,501 issued on Nov. 26, 2002.
- In all of the embodiments described above, the invention may be part of a catheter. The invention may also be assembled onto a separate catheter. The valve-filter may also be part of a non-catheter device, placed directly into a blood vessel or other lumen. In both the catheter and non-catheter embodiments, the valve-filter may be introduced into the body by the ways described in the following non-inclusive list: femoral artery, femoral vein, carotid artery, jugular vein, mouth, nose, urethra, vagina, brachial artery, subclavian vein, open sternotomies, partial sternotomies, and other places in the arterial and venous system.
- Furthermore, in all of the embodiments described above, the filter mesh of the valve-filter may be of any size and shape required to trap all of the material while still providing sufficient surface area for providing satisfactory flows during the use of the filter. The filter may be a sheet or bag of different mesh sizes. In a preferred embodiment, the mesh size is optimized taking the following factors into consideration: flow conditions, application site, size of filter bag, rate of clotting, etc.
- Radiopaque markers and/or sonoreflective markers, may be located on the catheter and/or the valve-filter assembly. An embodiment of the valve-filter catheter is described having an aortic transillumination system for locating and monitoring the position and deployment state of the catheter and the valve-filter assembly without fluoroscopy.
- Additionally, visualization techniques including transcranial Doppler ultrasonography, transesophageal echocardiograpy, transthoracic echocardiography, epicardiac echocardiography, and transcutaneous or intravascular ultrasoneography in conjunction with the procedure may be used to ensure effective filtration.
- Alternatively, or additionally, the material of the filter screen in each embodiment of the filter catheter may be made of or coated with an adherent material or substance to capture or hold embolic debris which comes into contact with the filter screen within the valve-filter assembly. Suitable adherent materials include, but are not limited to, known biocompatible adhesives and bioadhesive materials or substances, which are hemocompatible and non-thrombogenic. Such material are known to those having ordinary skill in the art and are described in, among other references, U.S. Pat. Nos. 4,768,523, 5,055,046, 5,066,709, 5,197,973, 5,225,196, 5,374,431, 5,578,310, 5,645,062, 5,648,167, 5,651,982, and 5,665,477. In one particularly preferred embodiment, only the upstream side of the elements of the filter screen are coated with the adherent material to capture the embolic material which comes in contact with the upstream side of the filter screen after entering the filter assembly. Other bioactive substances, for example, heparin or thrombolytic agents, may be impregnated into or coated on the surface of the filter screen material or incorporated into an adhesive coating.
- In a preferred method, blood is filtered during cardiac surgery, in particular during percutaneous valve surgery, to protect a patient from embolization. In this method, the valve-filter is positioned in the aorta between the aortic valve and the inominate branch, where it filters blood before it reaches the carotid arteries, brachiocephalic trunk, and left subclavian artery. The valve contains the embolic material and foreign matter dislodged during the surgery and also provides a temporary valve for use during valve surgery. Such a method may be utilized both on and off pump. Such a method may also be utilized for aortic, mitral, and pulmonary valve surgery and repair.
- Although this invention has been exemplified for purposes of illustration and description by reference to certain specific embodiments, it will be apparent to those skilled in the art that various modifications and alterations of the illustrated examples are possible. Numerous modifications, alterations, alternate embodiments, and alternate materials may be contemplated by those skilled in the art and may be utilized in accomplishing the present invention. Any such changes which derive directly from the teachings herein, and which do not depart from the spirit and scope of the invention, are deemed to be covered by this invention.
Claims (9)
1. A valve assembly comprising:
a replacement valve; and
an anchoring structure comprising one or more sinusoidal inflow rings.
2. The valve assembly of claim 1 , wherein said valve is positioned internally to said anchoring structure.
3. The valve assembly of claim 2 , wherein said valve comprises an inflow annulus, an outflow annulus, and a plurality of leaflets.
4. The valve assembly of claim 3 , wherein said inflow annulus is scalloped.
5. The valve assembly of claim 1 , wherein said inflow rings are configured in an inverse sinusoidal pattern.
6. The valve assembly of claim 1 , wherein said anchoring structure further comprises one or more sinusoidal outflow rings.
7. The valve assembly of claim 6 , wherein said sinusoidal outflow rings are configured in an inverse sinusoidal pattern.
8. The valve assembly of claim 6 , further comprising a plurality of longitudinal rods connecting the inflow and outflow rings.
9. The valve assembly of claim 6 , wherein the inflow or outflow rings further comprise attachment barbs
Priority Applications (19)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/680,733 US20050075584A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,071 US7101396B2 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,716 US20050075718A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,732 US20050075720A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,562 US20050075724A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,068 US7044966B2 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,567 US20050096738A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,075 US20050075728A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,560 US20050075717A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,728 US20050075713A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,719 US20050075712A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,069 US20050075729A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,717 US20050075719A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,070 US20050075730A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
CA2545874A CA2545874C (en) | 2003-10-06 | 2004-10-06 | Minimally invasive valve replacement system |
EP14163073.1A EP2789314B1 (en) | 2003-10-06 | 2004-10-06 | Minimally invasive valve replacement system |
EP20198702.1A EP3821852A3 (en) | 2003-10-06 | 2004-10-06 | Minimally invasive valve replacement system |
PCT/US2004/033026 WO2005046528A1 (en) | 2003-10-06 | 2004-10-06 | Minimally invasive valve replacement system |
EP04794398.0A EP1684671B1 (en) | 2003-10-06 | 2004-10-06 | Minimally invasive valve replacement system |
Applications Claiming Priority (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/680,728 US20050075713A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,732 US20050075720A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,562 US20050075724A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,068 US7044966B2 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,733 US20050075584A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,069 US20050075729A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,719 US20050075712A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,717 US20050075719A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,070 US20050075730A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,560 US20050075717A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,075 US20050075728A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,567 US20050096738A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,716 US20050075718A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,071 US7101396B2 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
Publications (1)
Publication Number | Publication Date |
---|---|
US20050075713A1 true US20050075713A1 (en) | 2005-04-07 |
Family
ID=46599162
Family Applications (14)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/680,716 Abandoned US20050075718A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,567 Abandoned US20050096738A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,070 Abandoned US20050075730A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,560 Abandoned US20050075717A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,562 Abandoned US20050075724A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,733 Abandoned US20050075584A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,068 Expired - Lifetime US7044966B2 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,075 Abandoned US20050075728A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,717 Abandoned US20050075719A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,071 Expired - Lifetime US7101396B2 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,069 Abandoned US20050075729A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,732 Abandoned US20050075720A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,719 Abandoned US20050075712A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,728 Abandoned US20050075713A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
Family Applications Before (13)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/680,716 Abandoned US20050075718A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,567 Abandoned US20050096738A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,070 Abandoned US20050075730A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,560 Abandoned US20050075717A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,562 Abandoned US20050075724A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,733 Abandoned US20050075584A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,068 Expired - Lifetime US7044966B2 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,075 Abandoned US20050075728A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,717 Abandoned US20050075719A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,071 Expired - Lifetime US7101396B2 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,069 Abandoned US20050075729A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,732 Abandoned US20050075720A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
US10/680,719 Abandoned US20050075712A1 (en) | 2003-10-06 | 2003-10-06 | Minimally invasive valve replacement system |
Country Status (2)
Country | Link |
---|---|
US (14) | US20050075718A1 (en) |
EP (1) | EP2789314B1 (en) |
Cited By (131)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040215333A1 (en) * | 2002-04-16 | 2004-10-28 | Carlos Duran | Sigmoid valve and method for its percutaneous implantation |
US20050197695A1 (en) * | 2004-03-03 | 2005-09-08 | Sorin Biomedica Cardio S.R.L. | Minimally-invasive cardiac-valve prosthesis |
US20050228494A1 (en) * | 2004-03-29 | 2005-10-13 | Salvador Marquez | Controlled separation heart valve frame |
US20060111773A1 (en) * | 2004-11-19 | 2006-05-25 | Biomedical Research Associates, Inc. | Prosthetic venous valves |
US20060122692A1 (en) * | 2004-05-10 | 2006-06-08 | Ran Gilad | Stent valve and method of using same |
US20060122693A1 (en) * | 2004-05-10 | 2006-06-08 | Youssef Biadillah | Stent valve and method of manufacturing same |
US20060122686A1 (en) * | 2004-05-10 | 2006-06-08 | Ran Gilad | Stent and method of manufacturing same |
US20060287717A1 (en) * | 2005-05-24 | 2006-12-21 | Rowe Stanton J | Methods for rapid deployment of prosthetic heart valves |
US20070021826A1 (en) * | 2003-04-24 | 2007-01-25 | Cook Incorporated | Intralumenally implantable frames |
US20070038291A1 (en) * | 2003-04-24 | 2007-02-15 | Cook Incorporated | Intralumenally-implantable frames |
US20070100435A1 (en) * | 2003-04-24 | 2007-05-03 | Cook Incorporated | Artificial prostheses with preferred geometries |
US20070254273A1 (en) * | 2006-05-01 | 2007-11-01 | Hugues Lafrance | Simulated heart valve root for training and testing |
US20080147182A1 (en) * | 2006-12-19 | 2008-06-19 | Sorin Biomedica Cardio S.R.L. | Instrument and method for in situ deployment of cardiac valve prostheses |
US20080249619A1 (en) * | 2005-02-10 | 2008-10-09 | Sorin Biomedica Cardio S.R.L. | Cardiac-valve prosthesis |
US20090030506A1 (en) * | 2007-07-24 | 2009-01-29 | Biotronik Vi Patent Ag | Endoprosthesis and method for manufacturing same |
US20090099653A1 (en) * | 2007-10-12 | 2009-04-16 | Sorin Biomedica Cardio S.R.L. | Expandable valve prosthesis with sealing mechanism |
US20090292350A1 (en) * | 2008-01-24 | 2009-11-26 | Medtronic, Inc. | Stents for Prosthetic Heart Valves |
US7670368B2 (en) | 2005-02-07 | 2010-03-02 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US20100063363A1 (en) * | 2005-02-10 | 2010-03-11 | Hamman Baron L | System, device, and method for providing access in a cardiovascular environment |
US7682385B2 (en) | 2002-04-03 | 2010-03-23 | Boston Scientific Corporation | Artificial valve |
US7722666B2 (en) | 2005-04-15 | 2010-05-25 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US7776053B2 (en) | 2000-10-26 | 2010-08-17 | Boston Scientific Scimed, Inc. | Implantable valve system |
US7780722B2 (en) | 2005-02-07 | 2010-08-24 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7780627B2 (en) | 2002-12-30 | 2010-08-24 | Boston Scientific Scimed, Inc. | Valve treatment catheter and methods |
US7799038B2 (en) | 2006-01-20 | 2010-09-21 | Boston Scientific Scimed, Inc. | Translumenal apparatus, system, and method |
US20100249920A1 (en) * | 2007-01-08 | 2010-09-30 | Millipede Llc | Reconfiguring heart features |
US20100249908A1 (en) * | 2009-03-31 | 2010-09-30 | Edwards Lifesciences Corporation | Prosthetic heart valve system with positioning markers |
US7819915B2 (en) | 2000-07-27 | 2010-10-26 | Edwards Lifesciences Corporation | Heart valve holders and handling clips therefor |
US20100292782A1 (en) * | 2009-05-13 | 2010-11-18 | Sorin Biomedica Cardio S.R.L. | Device for the in situ delivery of heart valves |
US20100292783A1 (en) * | 2009-05-13 | 2010-11-18 | Sorin Biomedica Cardio S.R.L. | Device for surgical interventions |
US20100292784A1 (en) * | 2009-05-13 | 2010-11-18 | Sorin Biomedica Cardio S.r. I. | Device for the in situ delivery of heart valves |
US7854755B2 (en) | 2005-02-01 | 2010-12-21 | Boston Scientific Scimed, Inc. | Vascular catheter, system, and method |
US7854761B2 (en) | 2003-12-19 | 2010-12-21 | Boston Scientific Scimed, Inc. | Methods for venous valve replacement with a catheter |
US7878966B2 (en) | 2005-02-04 | 2011-02-01 | Boston Scientific Scimed, Inc. | Ventricular assist and support device |
US7892276B2 (en) | 2007-12-21 | 2011-02-22 | Boston Scientific Scimed, Inc. | Valve with delayed leaflet deployment |
US20110054598A1 (en) * | 2005-07-13 | 2011-03-03 | Edwards Lifesciences Corporation | Contoured Sewing Ring for a Prosthetic Mitral Heart Valve |
US20110098602A1 (en) * | 2009-10-27 | 2011-04-28 | Edwards Lifesciences Corporation | Apparatus and Method for Measuring Body Orifice |
US7951197B2 (en) | 2005-04-08 | 2011-05-31 | Medtronic, Inc. | Two-piece prosthetic valves with snap-in connection and methods for use |
US7951189B2 (en) | 2005-09-21 | 2011-05-31 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US7959674B2 (en) | 2002-07-16 | 2011-06-14 | Medtronic, Inc. | Suture locking assembly and method of use |
US7967853B2 (en) | 2007-02-05 | 2011-06-28 | Boston Scientific Scimed, Inc. | Percutaneous valve, system and method |
US7967857B2 (en) | 2006-01-27 | 2011-06-28 | Medtronic, Inc. | Gasket with spring collar for prosthetic heart valves and methods for making and using them |
US7972377B2 (en) | 2001-12-27 | 2011-07-05 | Medtronic, Inc. | Bioprosthetic heart valve |
US7981153B2 (en) | 2002-12-20 | 2011-07-19 | Medtronic, Inc. | Biologically implantable prosthesis methods of using |
US8002824B2 (en) | 2004-09-02 | 2011-08-23 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
US8012198B2 (en) | 2005-06-10 | 2011-09-06 | Boston Scientific Scimed, Inc. | Venous valve, system, and method |
US8021421B2 (en) | 2003-08-22 | 2011-09-20 | Medtronic, Inc. | Prosthesis heart valve fixturing device |
US8038708B2 (en) | 2001-02-05 | 2011-10-18 | Cook Medical Technologies Llc | Implantable device with remodelable material and covering material |
US8057539B2 (en) | 2006-12-19 | 2011-11-15 | Sorin Biomedica Cardio S.R.L. | System for in situ positioning of cardiac valve prostheses without occluding blood flow |
US8114154B2 (en) | 2007-09-07 | 2012-02-14 | Sorin Biomedica Cardio S.R.L. | Fluid-filled delivery system for in situ deployment of cardiac valve prostheses |
US8128681B2 (en) | 2003-12-19 | 2012-03-06 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US8133270B2 (en) | 2007-01-08 | 2012-03-13 | California Institute Of Technology | In-situ formation of a valve |
US8211169B2 (en) | 2005-05-27 | 2012-07-03 | Medtronic, Inc. | Gasket with collar for prosthetic heart valves and methods for using them |
US8221492B2 (en) | 2003-04-24 | 2012-07-17 | Cook Medical Technologies | Artificial valve prosthesis with improved flow dynamics |
US8308798B2 (en) | 2008-12-19 | 2012-11-13 | Edwards Lifesciences Corporation | Quick-connect prosthetic heart valve and methods |
US8348998B2 (en) | 2009-06-26 | 2013-01-08 | Edwards Lifesciences Corporation | Unitary quick connect prosthetic heart valve and deployment system and methods |
US20130046380A1 (en) * | 2010-01-22 | 2013-02-21 | 4Tech Inc. | Tricuspid valve repair using tension |
CN103237523A (en) * | 2010-09-01 | 2013-08-07 | M阀门技术有限公司 | Cardiac valve support structure |
US8512397B2 (en) | 2009-04-27 | 2013-08-20 | Sorin Group Italia S.R.L. | Prosthetic vascular conduit |
US8603161B2 (en) | 2003-10-08 | 2013-12-10 | Medtronic, Inc. | Attachment device and methods of using the same |
US8641757B2 (en) | 2010-09-10 | 2014-02-04 | Edwards Lifesciences Corporation | Systems for rapidly deploying surgical heart valves |
US8685084B2 (en) | 2011-12-29 | 2014-04-01 | Sorin Group Italia S.R.L. | Prosthetic vascular conduit and assembly method |
US8808369B2 (en) | 2009-10-05 | 2014-08-19 | Mayo Foundation For Medical Education And Research | Minimally invasive aortic valve replacement |
US8808367B2 (en) | 2007-09-07 | 2014-08-19 | Sorin Group Italia S.R.L. | Prosthetic valve delivery system including retrograde/antegrade approach |
US8821569B2 (en) | 2006-04-29 | 2014-09-02 | Medtronic, Inc. | Multiple component prosthetic heart valve assemblies and methods for delivering them |
US8828079B2 (en) | 2007-07-26 | 2014-09-09 | Boston Scientific Scimed, Inc. | Circulatory valve, system and method |
US8834563B2 (en) | 2008-12-23 | 2014-09-16 | Sorin Group Italia S.R.L. | Expandable prosthetic valve having anchoring appendages |
US8840661B2 (en) | 2008-05-16 | 2014-09-23 | Sorin Group Italia S.R.L. | Atraumatic prosthetic heart valve prosthesis |
US8845720B2 (en) | 2010-09-27 | 2014-09-30 | Edwards Lifesciences Corporation | Prosthetic heart valve frame with flexible commissures |
US20150073543A1 (en) * | 2010-03-26 | 2015-03-12 | Thubrikar Aortic Valve, Inc. | Valve component, frame component and prosthetic valve device including the same for implantation in a body lumen |
US8986374B2 (en) | 2010-05-10 | 2015-03-24 | Edwards Lifesciences Corporation | Prosthetic heart valve |
US9078747B2 (en) | 2011-12-21 | 2015-07-14 | Edwards Lifesciences Corporation | Anchoring device for replacing or repairing a heart valve |
US9125741B2 (en) | 2010-09-10 | 2015-09-08 | Edwards Lifesciences Corporation | Systems and methods for ensuring safe and rapid deployment of prosthetic heart valves |
US9155617B2 (en) | 2004-01-23 | 2015-10-13 | Edwards Lifesciences Corporation | Prosthetic mitral valve |
US9161836B2 (en) | 2011-02-14 | 2015-10-20 | Sorin Group Italia S.R.L. | Sutureless anchoring device for cardiac valve prostheses |
EP2568925A4 (en) * | 2010-05-12 | 2015-10-21 | Edwards Lifesciences Corp | Low gradient prosthetic heart valve |
US9180005B1 (en) | 2014-07-17 | 2015-11-10 | Millipede, Inc. | Adjustable endolumenal mitral valve ring |
US9192471B2 (en) | 2007-01-08 | 2015-11-24 | Millipede, Inc. | Device for translumenal reshaping of a mitral valve annulus |
US9248017B2 (en) | 2010-05-21 | 2016-02-02 | Sorin Group Italia S.R.L. | Support device for valve prostheses and corresponding kit |
US9289289B2 (en) | 2011-02-14 | 2016-03-22 | Sorin Group Italia S.R.L. | Sutureless anchoring device for cardiac valve prostheses |
US9314334B2 (en) | 2008-11-25 | 2016-04-19 | Edwards Lifesciences Corporation | Conformal expansion of prosthetic devices to anatomical shapes |
US9333100B2 (en) | 2008-01-24 | 2016-05-10 | Medtronic, Inc. | Stents for prosthetic heart valves |
US9370418B2 (en) | 2010-09-10 | 2016-06-21 | Edwards Lifesciences Corporation | Rapidly deployable surgical heart valves |
US9370419B2 (en) | 2005-02-23 | 2016-06-21 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US9439762B2 (en) | 2000-06-01 | 2016-09-13 | Edwards Lifesciences Corporation | Methods of implant of a heart valve with a convertible sewing ring |
US9468527B2 (en) | 2013-06-12 | 2016-10-18 | Edwards Lifesciences Corporation | Cardiac implant with integrated suture fasteners |
US9504566B2 (en) | 2014-06-20 | 2016-11-29 | Edwards Lifesciences Corporation | Surgical heart valves identifiable post-implant |
US9549816B2 (en) | 2014-04-03 | 2017-01-24 | Edwards Lifesciences Corporation | Method for manufacturing high durability heart valve |
US9585752B2 (en) | 2014-04-30 | 2017-03-07 | Edwards Lifesciences Corporation | Holder and deployment system for surgical heart valves |
US9622859B2 (en) | 2005-02-01 | 2017-04-18 | Boston Scientific Scimed, Inc. | Filter system and method |
US9668859B2 (en) | 2011-08-05 | 2017-06-06 | California Institute Of Technology | Percutaneous heart valve delivery systems |
US9744037B2 (en) | 2013-03-15 | 2017-08-29 | California Institute Of Technology | Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves |
US9795480B2 (en) | 2010-08-24 | 2017-10-24 | Millipede, Inc. | Reconfiguring tissue features of a heart annulus |
US9848983B2 (en) | 2015-02-13 | 2017-12-26 | Millipede, Inc. | Valve replacement using rotational anchors |
US9907681B2 (en) | 2013-03-14 | 2018-03-06 | 4Tech Inc. | Stent with tether interface |
US9919137B2 (en) | 2013-08-28 | 2018-03-20 | Edwards Lifesciences Corporation | Integrated balloon catheter inflation system |
US9956384B2 (en) | 2014-01-24 | 2018-05-01 | Cook Medical Technologies Llc | Articulating balloon catheter and method for using the same |
US10058323B2 (en) | 2010-01-22 | 2018-08-28 | 4 Tech Inc. | Tricuspid valve repair using tension |
US10058425B2 (en) | 2013-03-15 | 2018-08-28 | Edwards Lifesciences Corporation | Methods of assembling a valved aortic conduit |
US10058313B2 (en) | 2011-05-24 | 2018-08-28 | Sorin Group Italia S.R.L. | Transapical valve replacement |
US10080653B2 (en) | 2015-09-10 | 2018-09-25 | Edwards Lifesciences Corporation | Limited expansion heart valve |
US10105224B2 (en) | 2010-09-01 | 2018-10-23 | Mvalve Technologies Ltd. | Cardiac valve support structure |
USD846122S1 (en) | 2016-12-16 | 2019-04-16 | Edwards Lifesciences Corporation | Heart valve sizer |
US10335275B2 (en) | 2015-09-29 | 2019-07-02 | Millipede, Inc. | Methods for delivery of heart valve devices using intravascular ultrasound imaging |
US10433963B2 (en) | 2010-01-22 | 2019-10-08 | 4Tech Inc. | Tissue anchor and delivery tool |
US10441415B2 (en) | 2013-09-20 | 2019-10-15 | Edwards Lifesciences Corporation | Heart valves with increased effective orifice area |
US10449050B2 (en) | 2013-01-09 | 2019-10-22 | 4 Tech Inc. | Soft tissue depth-finding tool |
US10456245B2 (en) | 2016-05-16 | 2019-10-29 | Edwards Lifesciences Corporation | System and method for applying material to a stent |
US10456246B2 (en) | 2015-07-02 | 2019-10-29 | Edwards Lifesciences Corporation | Integrated hybrid heart valves |
US10463485B2 (en) | 2017-04-06 | 2019-11-05 | Edwards Lifesciences Corporation | Prosthetic valve holders with automatic deploying mechanisms |
USD867594S1 (en) | 2015-06-19 | 2019-11-19 | Edwards Lifesciences Corporation | Prosthetic heart valve |
US10543080B2 (en) | 2011-05-20 | 2020-01-28 | Edwards Lifesciences Corporation | Methods of making encapsulated heart valves |
US10543088B2 (en) | 2012-09-14 | 2020-01-28 | Boston Scientific Scimed, Inc. | Mitral valve inversion prostheses |
US10548731B2 (en) | 2017-02-10 | 2020-02-04 | Boston Scientific Scimed, Inc. | Implantable device and delivery system for reshaping a heart valve annulus |
US10555813B2 (en) | 2015-11-17 | 2020-02-11 | Boston Scientific Scimed, Inc. | Implantable device and delivery system for reshaping a heart valve annulus |
US10667904B2 (en) | 2016-03-08 | 2020-06-02 | Edwards Lifesciences Corporation | Valve implant with integrated sensor and transmitter |
US10695170B2 (en) | 2015-07-02 | 2020-06-30 | Edwards Lifesciences Corporation | Hybrid heart valves adapted for post-implant expansion |
US10722316B2 (en) | 2013-11-06 | 2020-07-28 | Edwards Lifesciences Corporation | Bioprosthetic heart valves having adaptive seals to minimize paravalvular leakage |
US10799353B2 (en) | 2017-04-28 | 2020-10-13 | Edwards Lifesciences Corporation | Prosthetic heart valve with collapsible holder |
US10849755B2 (en) | 2012-09-14 | 2020-12-01 | Boston Scientific Scimed, Inc. | Mitral valve inversion prostheses |
USD908874S1 (en) | 2018-07-11 | 2021-01-26 | Edwards Lifesciences Corporation | Collapsible heart valve sizer |
US10912546B2 (en) | 2005-04-22 | 2021-02-09 | Laurent Schaller | Catheter-based tissue remodeling devices and methods |
US10940167B2 (en) | 2012-02-10 | 2021-03-09 | Cvdevices, Llc | Methods and uses of biological tissues for various stent and other medical applications |
US11007058B2 (en) | 2013-03-15 | 2021-05-18 | Edwards Lifesciences Corporation | Valved aortic conduits |
US11135057B2 (en) | 2017-06-21 | 2021-10-05 | Edwards Lifesciences Corporation | Dual-wireform limited expansion heart valves |
US11337805B2 (en) | 2018-01-23 | 2022-05-24 | Edwards Lifesciences Corporation | Prosthetic valve holders, systems, and methods |
US11406495B2 (en) | 2013-02-11 | 2022-08-09 | Cook Medical Technologies Llc | Expandable support frame and medical device |
US11504231B2 (en) | 2018-05-23 | 2022-11-22 | Corcym S.R.L. | Cardiac valve prosthesis |
US11554012B2 (en) | 2019-12-16 | 2023-01-17 | Edwards Lifesciences Corporation | Valve holder assembly with suture looping protection |
US11648118B2 (en) * | 2017-07-06 | 2023-05-16 | Raghuveer Basude | Tissue grasping devices and related methods |
US11690709B2 (en) | 2015-09-02 | 2023-07-04 | Edwards Lifesciences Corporation | Methods for securing a transcatheter valve to a bioprosthetic cardiac structure |
Families Citing this family (581)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6006134A (en) | 1998-04-30 | 1999-12-21 | Medtronic, Inc. | Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers |
US6530952B2 (en) | 1997-12-29 | 2003-03-11 | The Cleveland Clinic Foundation | Bioprosthetic cardiovascular valve system |
US8579966B2 (en) | 1999-11-17 | 2013-11-12 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US8016877B2 (en) | 1999-11-17 | 2011-09-13 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US7018406B2 (en) | 1999-11-17 | 2006-03-28 | Corevalve Sa | Prosthetic valve for transluminal delivery |
US8241274B2 (en) | 2000-01-19 | 2012-08-14 | Medtronic, Inc. | Method for guiding a medical device |
US7749245B2 (en) | 2000-01-27 | 2010-07-06 | Medtronic, Inc. | Cardiac valve procedure methods and devices |
US6692513B2 (en) | 2000-06-30 | 2004-02-17 | Viacor, Inc. | Intravascular filter with debris entrapment mechanism |
EP1408997A2 (en) * | 2000-06-16 | 2004-04-21 | McGILL UNIVERSITY | Kefir extract as an anti-cancer agent |
EP1309289A2 (en) | 2000-08-18 | 2003-05-14 | Atritech, Inc. | Expandable implant devices for filtering blood flow from atrial appendages |
US7544206B2 (en) | 2001-06-29 | 2009-06-09 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
US8771302B2 (en) | 2001-06-29 | 2014-07-08 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
US8623077B2 (en) | 2001-06-29 | 2014-01-07 | Medtronic, Inc. | Apparatus for replacing a cardiac valve |
FR2826863B1 (en) | 2001-07-04 | 2003-09-26 | Jacques Seguin | ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT |
FR2828091B1 (en) | 2001-07-31 | 2003-11-21 | Seguin Jacques | ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT |
US7097659B2 (en) | 2001-09-07 | 2006-08-29 | Medtronic, Inc. | Fixation band for affixing a prosthetic heart valve to tissue |
US20060292206A1 (en) | 2001-11-26 | 2006-12-28 | Kim Steven W | Devices and methods for treatment of vascular aneurysms |
US8721713B2 (en) | 2002-04-23 | 2014-05-13 | Medtronic, Inc. | System for implanting a replacement valve |
US7481821B2 (en) | 2002-11-12 | 2009-01-27 | Thomas J. Fogarty | Embolization device and a method of using the same |
US7766973B2 (en) * | 2005-01-19 | 2010-08-03 | Gi Dynamics, Inc. | Eversion resistant sleeves |
US20040260382A1 (en) * | 2003-02-12 | 2004-12-23 | Fogarty Thomas J. | Intravascular implants and methods of using the same |
CH696185A5 (en) * | 2003-03-21 | 2007-02-15 | Afksendiyos Kalangos | Intraparietal reinforcement for aortic valve and reinforced valve has rod inserted in biological tissue or organic prosthesis with strut fixed to one end |
AU2004253375B2 (en) * | 2003-07-08 | 2011-07-14 | Ventor Technologies Ltd. | Implantable prosthetic devices particularly for transarterial delivery in the treatment of aortic stenosis, and methods of implanting such devices |
US7201772B2 (en) * | 2003-07-08 | 2007-04-10 | Ventor Technologies, Ltd. | Fluid flow prosthetic device |
US20050015110A1 (en) | 2003-07-18 | 2005-01-20 | Fogarty Thomas J. | Embolization device and a method of using the same |
ATE442107T1 (en) * | 2003-07-21 | 2009-09-15 | Univ Pennsylvania | PERCUTANE HEART VALVE |
FR2858543B1 (en) | 2003-08-08 | 2006-02-03 | Assist Publ Hopitaux De Paris | AORTIC AND ANCILLARY RING FOR ITS INSTALLATION |
US7842084B2 (en) * | 2005-06-21 | 2010-11-30 | 3F Therapeutics, Inc. | Method and systems for sizing, folding, holding, and delivering a heart valve prosthesis |
US20050075718A1 (en) | 2003-10-06 | 2005-04-07 | Nguyen Tuoc Tan | Minimally invasive valve replacement system |
US10219899B2 (en) * | 2004-04-23 | 2019-03-05 | Medtronic 3F Therapeutics, Inc. | Cardiac valve replacement systems |
US20060259137A1 (en) | 2003-10-06 | 2006-11-16 | Jason Artof | Minimally invasive valve replacement system |
US7604650B2 (en) * | 2003-10-06 | 2009-10-20 | 3F Therapeutics, Inc. | Method and assembly for distal embolic protection |
US9579194B2 (en) | 2003-10-06 | 2017-02-28 | Medtronic ATS Medical, Inc. | Anchoring structure with concave landing zone |
US8915967B2 (en) * | 2003-12-19 | 2014-12-23 | Patrick Leahy | Anti reflux system |
US11278398B2 (en) | 2003-12-23 | 2022-03-22 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US8287584B2 (en) | 2005-11-14 | 2012-10-16 | Sadra Medical, Inc. | Medical implant deployment tool |
US7824443B2 (en) | 2003-12-23 | 2010-11-02 | Sadra Medical, Inc. | Medical implant delivery and deployment tool |
US8579962B2 (en) | 2003-12-23 | 2013-11-12 | Sadra Medical, Inc. | Methods and apparatus for performing valvuloplasty |
US7824442B2 (en) * | 2003-12-23 | 2010-11-02 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US20050137687A1 (en) | 2003-12-23 | 2005-06-23 | Sadra Medical | Heart valve anchor and method |
US20050137686A1 (en) * | 2003-12-23 | 2005-06-23 | Sadra Medical, A Delaware Corporation | Externally expandable heart valve anchor and method |
US7381219B2 (en) | 2003-12-23 | 2008-06-03 | Sadra Medical, Inc. | Low profile heart valve and delivery system |
US20120041550A1 (en) | 2003-12-23 | 2012-02-16 | Sadra Medical, Inc. | Methods and Apparatus for Endovascular Heart Valve Replacement Comprising Tissue Grasping Elements |
US7959666B2 (en) | 2003-12-23 | 2011-06-14 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US7329279B2 (en) | 2003-12-23 | 2008-02-12 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US8840663B2 (en) | 2003-12-23 | 2014-09-23 | Sadra Medical, Inc. | Repositionable heart valve method |
US8828078B2 (en) | 2003-12-23 | 2014-09-09 | Sadra Medical, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US9005273B2 (en) | 2003-12-23 | 2015-04-14 | Sadra Medical, Inc. | Assessing the location and performance of replacement heart valves |
US7445631B2 (en) | 2003-12-23 | 2008-11-04 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US20050137694A1 (en) * | 2003-12-23 | 2005-06-23 | Haug Ulrich R. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US8182528B2 (en) | 2003-12-23 | 2012-05-22 | Sadra Medical, Inc. | Locking heart valve anchor |
US8603160B2 (en) | 2003-12-23 | 2013-12-10 | Sadra Medical, Inc. | Method of using a retrievable heart valve anchor with a sheath |
US9526609B2 (en) | 2003-12-23 | 2016-12-27 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US7748389B2 (en) | 2003-12-23 | 2010-07-06 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
CN101947146B (en) | 2003-12-23 | 2014-08-06 | 萨德拉医学公司 | Relocatable heart valve |
US7780725B2 (en) | 2004-06-16 | 2010-08-24 | Sadra Medical, Inc. | Everting heart valve |
US8328868B2 (en) | 2004-11-05 | 2012-12-11 | Sadra Medical, Inc. | Medical devices and delivery systems for delivering medical devices |
US8343213B2 (en) | 2003-12-23 | 2013-01-01 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
CN102488572A (en) | 2004-02-27 | 2012-06-13 | 奥尔特克斯公司 | Prosthetic heart valve delivery systems and methods |
US20070073387A1 (en) * | 2004-02-27 | 2007-03-29 | Forster David C | Prosthetic Heart Valves, Support Structures And Systems And Methods For Implanting The Same |
WO2005087140A1 (en) | 2004-03-11 | 2005-09-22 | Percutaneous Cardiovascular Solutions Pty Limited | Percutaneous heart valve prosthesis |
US8349001B2 (en) | 2004-04-07 | 2013-01-08 | Medtronic, Inc. | Pharmacological delivery implement for use with cardiac repair devices |
EP1737390A1 (en) * | 2004-04-08 | 2007-01-03 | Cook Incorporated | Implantable medical device with optimized shape |
CN101052359A (en) | 2004-04-23 | 2007-10-10 | 3F医疗有限公司 | Implantable prosthetic valve |
US7276078B2 (en) * | 2004-06-30 | 2007-10-02 | Edwards Lifesciences Pvt | Paravalvular leak detection, sealing, and prevention |
FR2874813B1 (en) * | 2004-09-07 | 2007-06-22 | Perouse Soc Par Actions Simpli | VALVULAR PROSTHESIS |
US20060052867A1 (en) | 2004-09-07 | 2006-03-09 | Medtronic, Inc | Replacement prosthetic heart valve, system and method of implant |
CA2580053C (en) | 2004-09-14 | 2014-07-08 | Edwards Lifesciences Ag. | Device and method for treatment of heart valve regurgitation |
US7331010B2 (en) * | 2004-10-29 | 2008-02-12 | International Business Machines Corporation | System, method and storage medium for providing fault detection and correction in a memory subsystem |
US8562672B2 (en) | 2004-11-19 | 2013-10-22 | Medtronic, Inc. | Apparatus for treatment of cardiac valves and method of its manufacture |
US20060161248A1 (en) * | 2004-12-01 | 2006-07-20 | Case Brian C | Medical device with leak path |
US7758640B2 (en) * | 2004-12-16 | 2010-07-20 | Valvexchange Inc. | Cardiovascular valve assembly |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
US7331991B2 (en) * | 2005-02-25 | 2008-02-19 | California Institute Of Technology | Implantable small percutaneous valve and methods of delivery |
AU2005328535B2 (en) * | 2005-03-01 | 2011-09-22 | Leman Cardiovascular Sa | Intraparietal reinforcing device for biological cardiac prosthesis and reinforced biological heart valve prosthesis |
WO2006097931A2 (en) | 2005-03-17 | 2006-09-21 | Valtech Cardio, Ltd. | Mitral valve treatment techniques |
SE531468C2 (en) * | 2005-04-21 | 2009-04-14 | Edwards Lifesciences Ag | An apparatus for controlling blood flow |
US7962208B2 (en) | 2005-04-25 | 2011-06-14 | Cardiac Pacemakers, Inc. | Method and apparatus for pacing during revascularization |
US7914569B2 (en) | 2005-05-13 | 2011-03-29 | Medtronics Corevalve Llc | Heart valve prosthesis and methods of manufacture and use |
US9089423B2 (en) | 2010-05-10 | 2015-07-28 | Hlt, Inc. | Stentless support structure |
US8974523B2 (en) | 2005-05-27 | 2015-03-10 | Hlt, Inc. | Stentless support structure |
US7955372B2 (en) * | 2005-06-01 | 2011-06-07 | Board Of Trustees Of The Leland Stanford Junior University | Endoluminal delivery system |
US7780723B2 (en) * | 2005-06-13 | 2010-08-24 | Edwards Lifesciences Corporation | Heart valve delivery system |
US8951285B2 (en) | 2005-07-05 | 2015-02-10 | Mitralign, Inc. | Tissue anchor, anchoring system and methods of using the same |
WO2007016097A2 (en) * | 2005-07-27 | 2007-02-08 | Georgia Tech Research Corporation | Implantable prosthetic vascular valve |
US8790396B2 (en) * | 2005-07-27 | 2014-07-29 | Medtronic 3F Therapeutics, Inc. | Methods and systems for cardiac valve delivery |
US7455689B2 (en) * | 2005-08-25 | 2008-11-25 | Edwards Lifesciences Corporation | Four-leaflet stented mitral heart valve |
US7712606B2 (en) | 2005-09-13 | 2010-05-11 | Sadra Medical, Inc. | Two-part package for medical implant |
US20070078510A1 (en) | 2005-09-26 | 2007-04-05 | Ryan Timothy R | Prosthetic cardiac and venous valves |
US8167932B2 (en) | 2005-10-18 | 2012-05-01 | Edwards Lifesciences Corporation | Heart valve delivery system with valve catheter |
GB0521585D0 (en) * | 2005-10-22 | 2005-11-30 | Depuy Int Ltd | A spinal support rod |
GB0521582D0 (en) * | 2005-10-22 | 2005-11-30 | Depuy Int Ltd | An implant for supporting a spinal column |
EP3167847B1 (en) | 2005-11-10 | 2020-10-14 | Edwards Lifesciences CardiAQ LLC | Heart valve prosthesis |
US8764820B2 (en) | 2005-11-16 | 2014-07-01 | Edwards Lifesciences Corporation | Transapical heart valve delivery system and method |
WO2007100408A2 (en) * | 2005-12-15 | 2007-09-07 | Georgia Tech Research Corporation | Papillary muscle position control devices, systems & methods |
JP2009519784A (en) * | 2005-12-15 | 2009-05-21 | ジョージア テック リサーチ コーポレイション | System and method for controlling heart valve dimensions |
US8568473B2 (en) * | 2005-12-15 | 2013-10-29 | Georgia Tech Research Corporation | Systems and methods for enabling heart valve replacement |
US20070142907A1 (en) * | 2005-12-16 | 2007-06-21 | Micardia Corporation | Adjustable prosthetic valve implant |
US20070213813A1 (en) | 2005-12-22 | 2007-09-13 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
US9078781B2 (en) | 2006-01-11 | 2015-07-14 | Medtronic, Inc. | Sterile cover for compressible stents used in percutaneous device delivery systems |
GB0600662D0 (en) * | 2006-01-13 | 2006-02-22 | Depuy Int Ltd | Spinal support rod kit |
US8348952B2 (en) * | 2006-01-26 | 2013-01-08 | Depuy International Ltd. | System and method for cooling a spinal correction device comprising a shape memory material for corrective spinal surgery |
CN101415379B (en) | 2006-02-14 | 2012-06-20 | 萨德拉医学公司 | Systems for delivering a medical implant |
WO2008029296A2 (en) * | 2006-02-16 | 2008-03-13 | Endocor Pte Ltd. | Minimally invasive heart valve replacement |
US20080275550A1 (en) * | 2006-02-24 | 2008-11-06 | Arash Kheradvar | Implantable small percutaneous valve and methods of delivery |
US7780724B2 (en) * | 2006-02-24 | 2010-08-24 | California Institute Of Technology | Monolithic in situ forming valve system |
US8147541B2 (en) | 2006-02-27 | 2012-04-03 | Aortx, Inc. | Methods and devices for delivery of prosthetic heart valves and other prosthetics |
US8403981B2 (en) * | 2006-02-27 | 2013-03-26 | CardiacMC, Inc. | Methods and devices for delivery of prosthetic heart valves and other prosthetics |
EP2004095B1 (en) | 2006-03-28 | 2019-06-12 | Medtronic, Inc. | Prosthetic cardiac valve formed from pericardium material and methods of making same |
US7740655B2 (en) | 2006-04-06 | 2010-06-22 | Medtronic Vascular, Inc. | Reinforced surgical conduit for implantation of a stented valve therein |
US7591848B2 (en) * | 2006-04-06 | 2009-09-22 | Medtronic Vascular, Inc. | Riveted stent valve for percutaneous use |
US20070244544A1 (en) * | 2006-04-14 | 2007-10-18 | Medtronic Vascular, Inc. | Seal for Enhanced Stented Valve Fixation |
US8551161B2 (en) | 2006-04-25 | 2013-10-08 | Medtronic Vascular, Inc. | Cardiac valve annulus restraining device |
JP5016667B2 (en) | 2006-04-29 | 2012-09-05 | メドトロニック,インコーポレイテッド | Multi-membered prosthetic heart valve assembly, apparatus using the same, and method of using the same |
US8932348B2 (en) | 2006-05-18 | 2015-01-13 | Edwards Lifesciences Corporation | Device and method for improving heart valve function |
US8585594B2 (en) | 2006-05-24 | 2013-11-19 | Phoenix Biomedical, Inc. | Methods of assessing inner surfaces of body lumens or organs |
CN102283721B (en) | 2006-06-01 | 2015-08-26 | 爱德华兹生命科学公司 | For improving the prosthetic insert of heart valve function |
JP2009540954A (en) * | 2006-06-20 | 2009-11-26 | エーオーテックス, インコーポレイテッド | Prosthetic valve implantation site preparation technology |
JP2009540955A (en) | 2006-06-20 | 2009-11-26 | エーオーテックス, インコーポレイテッド | Artificial heart valves, support structures, and systems and methods for implanting them |
EP2035723A4 (en) | 2006-06-20 | 2011-11-30 | Aortx Inc | Torque shaft and torque drive |
AU2007260951A1 (en) * | 2006-06-21 | 2007-12-27 | Aortx, Inc. | Prosthetic valve implantation systems |
US20080004696A1 (en) * | 2006-06-29 | 2008-01-03 | Valvexchange Inc. | Cardiovascular valve assembly with resizable docking station |
US20080126131A1 (en) * | 2006-07-17 | 2008-05-29 | Walgreen Co. | Predictive Modeling And Risk Stratification Of A Medication Therapy Regimen |
US20090306768A1 (en) | 2006-07-28 | 2009-12-10 | Cardiaq Valve Technologies, Inc. | Percutaneous valve prosthesis and system and method for implanting same |
US9585743B2 (en) | 2006-07-31 | 2017-03-07 | Edwards Lifesciences Cardiaq Llc | Surgical implant devices and methods for their manufacture and use |
WO2008016578A2 (en) | 2006-07-31 | 2008-02-07 | Cartledge Richard G | Sealable endovascular implants and methods for their use |
US9408607B2 (en) | 2009-07-02 | 2016-08-09 | Edwards Lifesciences Cardiaq Llc | Surgical implant devices and methods for their manufacture and use |
GB0617219D0 (en) | 2006-08-31 | 2006-10-11 | Barts & London Nhs Trust | Blood vessel prosthesis and delivery apparatus |
ES2385296T3 (en) | 2006-09-08 | 2012-07-20 | Edwards Lifesciences Corporation | Integrated heart valve delivery system |
US11304800B2 (en) | 2006-09-19 | 2022-04-19 | Medtronic Ventor Technologies Ltd. | Sinus-engaging valve fixation member |
US8834564B2 (en) | 2006-09-19 | 2014-09-16 | Medtronic, Inc. | Sinus-engaging valve fixation member |
US8052750B2 (en) | 2006-09-19 | 2011-11-08 | Medtronic Ventor Technologies Ltd | Valve prosthesis fixation techniques using sandwiching |
WO2008046092A2 (en) * | 2006-10-13 | 2008-04-17 | Creighton University | Implantable valve prosthesis |
DK2083901T3 (en) | 2006-10-16 | 2018-02-26 | Medtronic Ventor Tech Ltd | TRANSAPICAL DELIVERY SYSTEM WITH VENTRICULO-ARTERIAL OVERFLOW BYPASS |
EP2083902B1 (en) * | 2006-10-18 | 2017-08-30 | Inspiremd Ltd. | Filter assemblies |
US9974653B2 (en) | 2006-12-05 | 2018-05-22 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US11259924B2 (en) | 2006-12-05 | 2022-03-01 | Valtech Cardio Ltd. | Implantation of repair devices in the heart |
JP5593545B2 (en) | 2006-12-06 | 2014-09-24 | メドトロニック シーブイ ルクセンブルク エス.アー.エール.エル. | System and method for transapical delivery of a self-expanding valve secured to an annulus |
US20100168844A1 (en) * | 2007-01-26 | 2010-07-01 | 3F Therapeutics, Inc. | Methods and systems for reducing paravalvular leakage in heart valves |
EP2129332B1 (en) | 2007-02-16 | 2019-01-23 | Medtronic, Inc. | Replacement prosthetic heart valves |
US8070802B2 (en) * | 2007-02-23 | 2011-12-06 | The Trustees Of The University Of Pennsylvania | Mitral valve system |
US7753949B2 (en) * | 2007-02-23 | 2010-07-13 | The Trustees Of The University Of Pennsylvania | Valve prosthesis systems and methods |
US11660190B2 (en) | 2007-03-13 | 2023-05-30 | Edwards Lifesciences Corporation | Tissue anchors, systems and methods, and devices |
US7896915B2 (en) * | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
FR2915087B1 (en) | 2007-04-20 | 2021-11-26 | Corevalve Inc | IMPLANT FOR TREATMENT OF A HEART VALVE, IN PARTICULAR OF A MITRAL VALVE, EQUIPMENT INCLUDING THIS IMPLANT AND MATERIAL FOR PLACING THIS IMPLANT. |
US20080294248A1 (en) * | 2007-05-25 | 2008-11-27 | Medical Entrepreneurs Ii, Inc. | Prosthetic Heart Valve |
US7815677B2 (en) * | 2007-07-09 | 2010-10-19 | Leman Cardiovascular Sa | Reinforcement device for a biological valve and reinforced biological valve |
US8663318B2 (en) * | 2007-07-23 | 2014-03-04 | Hocor Cardiovascular Technologies Llc | Method and apparatus for percutaneous aortic valve replacement |
US8663319B2 (en) | 2007-07-23 | 2014-03-04 | Hocor Cardiovascular Technologies Llc | Methods and apparatus for percutaneous aortic valve replacement |
US9814611B2 (en) | 2007-07-31 | 2017-11-14 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
US9566178B2 (en) | 2010-06-24 | 2017-02-14 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
US8747458B2 (en) | 2007-08-20 | 2014-06-10 | Medtronic Ventor Technologies Ltd. | Stent loading tool and method for use thereof |
EP3045147B8 (en) | 2007-08-21 | 2017-05-31 | Symetis SA | A replacement valve |
WO2009042196A2 (en) | 2007-09-26 | 2009-04-02 | St. Jude Medical, Inc. | Collapsible prosthetic heart valves |
US9532868B2 (en) | 2007-09-28 | 2017-01-03 | St. Jude Medical, Inc. | Collapsible-expandable prosthetic heart valves with structures for clamping native tissue |
WO2009045334A1 (en) | 2007-09-28 | 2009-04-09 | St. Jude Medical, Inc. | Collapsible/expandable prosthetic heart valves with native calcified leaflet retention features |
US10856970B2 (en) | 2007-10-10 | 2020-12-08 | Medtronic Ventor Technologies Ltd. | Prosthetic heart valve for transfemoral delivery |
WO2009052207A2 (en) | 2007-10-17 | 2009-04-23 | Hancock Jaffe Laboratories | Biological valve for venous valve insufficiency |
US20090105813A1 (en) * | 2007-10-17 | 2009-04-23 | Sean Chambers | Implantable valve device |
GB0720762D0 (en) | 2007-10-24 | 2007-12-05 | Depuy Spine Sorl | Assembly for orthopaedic surgery |
JP5603776B2 (en) | 2007-10-25 | 2014-10-08 | サイメティス エスアー | Stent, valved stent and method, and delivery system thereof |
US7846199B2 (en) * | 2007-11-19 | 2010-12-07 | Cook Incorporated | Remodelable prosthetic valve |
WO2009067432A1 (en) | 2007-11-19 | 2009-05-28 | Cook Incorporated | Valve frame |
PT3494930T (en) * | 2007-12-14 | 2020-02-06 | Edwards Lifesciences Corp | Leaflet attachment frame for a prosthetic valve |
GB2476451A (en) | 2009-11-19 | 2011-06-29 | Cook William Europ | Stent Graft |
US8574284B2 (en) | 2007-12-26 | 2013-11-05 | Cook Medical Technologies Llc | Low profile non-symmetrical bare alignment stents with graft |
US9226813B2 (en) | 2007-12-26 | 2016-01-05 | Cook Medical Technologies Llc | Low profile non-symmetrical stent |
US8728145B2 (en) * | 2008-12-11 | 2014-05-20 | Cook Medical Technologies Llc | Low profile non-symmetrical stents and stent-grafts |
US9180030B2 (en) | 2007-12-26 | 2015-11-10 | Cook Medical Technologies Llc | Low profile non-symmetrical stent |
US9089422B2 (en) | 2008-01-24 | 2015-07-28 | Medtronic, Inc. | Markers for prosthetic heart valves |
EP4378420A3 (en) * | 2008-01-24 | 2024-08-14 | Medtronic, Inc. | Stents for prosthetic heart valves |
CA2714062A1 (en) * | 2008-01-24 | 2009-07-30 | Medtronic, Inc. | Stents for prosthetic heart valves |
US9393115B2 (en) | 2008-01-24 | 2016-07-19 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
US9149358B2 (en) * | 2008-01-24 | 2015-10-06 | Medtronic, Inc. | Delivery systems for prosthetic heart valves |
WO2009104041A1 (en) * | 2008-02-21 | 2009-08-27 | Valerian Voinov | Implantable prosthetic valve stent |
GB0803302D0 (en) * | 2008-02-22 | 2008-04-02 | Barts & London Nhs Trust | Blood vessel prosthesis and delivery apparatus |
US9168130B2 (en) | 2008-02-26 | 2015-10-27 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
ES2903231T3 (en) | 2008-02-26 | 2022-03-31 | Jenavalve Tech Inc | Stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
WO2009108355A1 (en) | 2008-02-28 | 2009-09-03 | Medtronic, Inc. | Prosthetic heart valve systems |
DE102008012113A1 (en) | 2008-03-02 | 2009-09-03 | Transcatheter Technologies Gmbh | Implant e.g. heart-valve-carrying stent, for e.g. arresting blood vessel, has fiber by which section of implant is reducible according to increasing of implant at extended diameter by unfolding or expansion of diameter with expansion unit |
US8382829B1 (en) | 2008-03-10 | 2013-02-26 | Mitralign, Inc. | Method to reduce mitral regurgitation by cinching the commissure of the mitral valve |
US8696689B2 (en) * | 2008-03-18 | 2014-04-15 | Medtronic Ventor Technologies Ltd. | Medical suturing device and method for use thereof |
US8313525B2 (en) | 2008-03-18 | 2012-11-20 | Medtronic Ventor Technologies, Ltd. | Valve suturing and implantation procedures |
US8430927B2 (en) | 2008-04-08 | 2013-04-30 | Medtronic, Inc. | Multiple orifice implantable heart valve and methods of implantation |
US8312825B2 (en) | 2008-04-23 | 2012-11-20 | Medtronic, Inc. | Methods and apparatuses for assembly of a pericardial prosthetic heart valve |
US8696743B2 (en) | 2008-04-23 | 2014-04-15 | Medtronic, Inc. | Tissue attachment devices and methods for prosthetic heart valves |
US20090276040A1 (en) | 2008-05-01 | 2009-11-05 | Edwards Lifesciences Corporation | Device and method for replacing mitral valve |
US8197413B2 (en) * | 2008-06-06 | 2012-06-12 | Boston Scientific Scimed, Inc. | Transducers, devices and systems containing the transducers, and methods of manufacture |
LT3501455T (en) * | 2008-06-06 | 2020-01-27 | Edwards Lifesciences Corporation | Low profile transcatheter heart valve |
EP4176845A1 (en) | 2008-07-15 | 2023-05-10 | St. Jude Medical, LLC | Collapsible and re-expandable prosthetic heart valve cuff designs |
ES2421333T3 (en) * | 2008-07-17 | 2013-08-30 | Nvt Ag | Cardiac valve prosthesis system |
US8652202B2 (en) | 2008-08-22 | 2014-02-18 | Edwards Lifesciences Corporation | Prosthetic heart valve and delivery apparatus |
WO2010030859A1 (en) * | 2008-09-12 | 2010-03-18 | Valvexchange Inc. | Valve assembly with exchangeable valve member and a tool set for exchanging the valve member |
US8998981B2 (en) | 2008-09-15 | 2015-04-07 | Medtronic, Inc. | Prosthetic heart valve having identifiers for aiding in radiographic positioning |
US8721714B2 (en) | 2008-09-17 | 2014-05-13 | Medtronic Corevalve Llc | Delivery system for deployment of medical devices |
CA2749026C (en) | 2008-09-29 | 2018-01-09 | Impala, Inc. | Heart valve |
US8337541B2 (en) * | 2008-10-01 | 2012-12-25 | Cardiaq Valve Technologies, Inc. | Delivery system for vascular implant |
US8790387B2 (en) | 2008-10-10 | 2014-07-29 | Edwards Lifesciences Corporation | Expandable sheath for introducing an endovascular delivery device into a body |
US8137398B2 (en) | 2008-10-13 | 2012-03-20 | Medtronic Ventor Technologies Ltd | Prosthetic valve having tapered tip when compressed for delivery |
WO2010045477A2 (en) | 2008-10-16 | 2010-04-22 | Obalon Therapeutics, Inc. | Intragastric volume-occupying device and method for fabricating same |
US8986361B2 (en) | 2008-10-17 | 2015-03-24 | Medtronic Corevalve, Inc. | Delivery system for deployment of medical devices |
CN102438546B (en) | 2008-11-21 | 2015-07-15 | 经皮心血管解决方案公司 | Heart valve prosthesis |
US8926696B2 (en) | 2008-12-22 | 2015-01-06 | Valtech Cardio, Ltd. | Adjustable annuloplasty devices and adjustment mechanisms therefor |
US8241351B2 (en) | 2008-12-22 | 2012-08-14 | Valtech Cardio, Ltd. | Adjustable partial annuloplasty ring and mechanism therefor |
US8911494B2 (en) | 2009-05-04 | 2014-12-16 | Valtech Cardio, Ltd. | Deployment techniques for annuloplasty ring |
US8715342B2 (en) | 2009-05-07 | 2014-05-06 | Valtech Cardio, Ltd. | Annuloplasty ring with intra-ring anchoring |
US10517719B2 (en) | 2008-12-22 | 2019-12-31 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US9681950B2 (en) * | 2009-01-12 | 2017-06-20 | Valve Medical Ltd. | System and method for placing a percutaneous valve device |
US8353956B2 (en) | 2009-02-17 | 2013-01-15 | Valtech Cardio, Ltd. | Actively-engageable movement-restriction mechanism for use with an annuloplasty structure |
GB0905444D0 (en) | 2009-03-30 | 2009-05-13 | Ucl Business Plc | Heart valve prosthesis |
EP2413843B1 (en) | 2009-03-30 | 2020-04-22 | Suzhou Jiecheng Medical Technology Co. Ltd. | Sutureless valve prostheses and devices for delivery |
US8414644B2 (en) | 2009-04-15 | 2013-04-09 | Cardiaq Valve Technologies, Inc. | Vascular implant and delivery system |
US9968452B2 (en) | 2009-05-04 | 2018-05-15 | Valtech Cardio, Ltd. | Annuloplasty ring delivery cathethers |
WO2013069019A2 (en) | 2011-11-08 | 2013-05-16 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
JP5603934B2 (en) * | 2009-06-05 | 2014-10-08 | メドトロニック エイティーエス メディカル インコーポレイテッド | Flexible commissure structure for attaching a bioprosthetic valve |
US8439970B2 (en) | 2009-07-14 | 2013-05-14 | Edwards Lifesciences Corporation | Transapical delivery system for heart valves |
US20110077733A1 (en) * | 2009-09-25 | 2011-03-31 | Edwards Lifesciences Corporation | Leaflet contacting apparatus and method |
US20110313515A1 (en) | 2010-06-21 | 2011-12-22 | Arshad Quadri | Replacement heart valve |
US8652203B2 (en) | 2010-09-23 | 2014-02-18 | Cardiaq Valve Technologies, Inc. | Replacement heart valves, delivery devices and methods |
US9730790B2 (en) | 2009-09-29 | 2017-08-15 | Edwards Lifesciences Cardiaq Llc | Replacement valve and method |
US9180007B2 (en) | 2009-10-29 | 2015-11-10 | Valtech Cardio, Ltd. | Apparatus and method for guide-wire based advancement of an adjustable implant |
US10098737B2 (en) | 2009-10-29 | 2018-10-16 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
EP4406514A3 (en) * | 2009-11-02 | 2024-11-06 | Boston Scientific Medical Device Limited | Aortic bioprosthesis and systems for delivery thereof |
CA2779616A1 (en) * | 2009-11-03 | 2011-05-12 | Large Bore Closure, L.L.C. | Closure device |
US9757263B2 (en) | 2009-11-18 | 2017-09-12 | Cook Medical Technologies Llc | Stent graft and introducer assembly |
US8500775B2 (en) * | 2009-12-02 | 2013-08-06 | Surefire Medical, Inc. | Protection device and method against embolization agent reflux |
US9539081B2 (en) | 2009-12-02 | 2017-01-10 | Surefire Medical, Inc. | Method of operating a microvalve protection device |
EP2506777B1 (en) | 2009-12-02 | 2020-11-25 | Valtech Cardio, Ltd. | Combination of spool assembly coupled to a helical anchor and delivery tool for implantation thereof |
US8696698B2 (en) | 2009-12-02 | 2014-04-15 | Surefire Medical, Inc. | Microvalve protection device and method of use for protection against embolization agent reflux |
US8870950B2 (en) | 2009-12-08 | 2014-10-28 | Mitral Tech Ltd. | Rotation-based anchoring of an implant |
US9358109B2 (en) * | 2010-01-13 | 2016-06-07 | Vinay Badhwar | Transcorporeal delivery system and method |
DE102010008362A1 (en) | 2010-02-17 | 2011-08-18 | Transcatheter Technologies GmbH, 93053 | Medical implant which is expandable from a non-expanded state |
US9226826B2 (en) | 2010-02-24 | 2016-01-05 | Medtronic, Inc. | Transcatheter valve structure and methods for valve delivery |
US9522062B2 (en) | 2010-02-24 | 2016-12-20 | Medtronic Ventor Technologies, Ltd. | Mitral prosthesis and methods for implantation |
US8795354B2 (en) | 2010-03-05 | 2014-08-05 | Edwards Lifesciences Corporation | Low-profile heart valve and delivery system |
US20110224785A1 (en) | 2010-03-10 | 2011-09-15 | Hacohen Gil | Prosthetic mitral valve with tissue anchors |
US8652204B2 (en) | 2010-04-01 | 2014-02-18 | Medtronic, Inc. | Transcatheter valve with torsion spring fixation and related systems and methods |
US9545306B2 (en) | 2010-04-21 | 2017-01-17 | Medtronic, Inc. | Prosthetic valve with sealing members and methods of use thereof |
US8623075B2 (en) | 2010-04-21 | 2014-01-07 | Medtronic, Inc. | Transcatheter prosthetic heart valve delivery system and method with controlled expansion of prosthetic heart valve |
US8876892B2 (en) | 2010-04-21 | 2014-11-04 | Medtronic, Inc. | Prosthetic heart valve delivery system with spacing |
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
BR112012029896A2 (en) | 2010-05-25 | 2017-06-20 | Jenavalve Tech Inc | prosthetic heart valve for stent graft and stent graft |
WO2012004679A2 (en) | 2010-07-09 | 2012-01-12 | Highlife Sas | Transcatheter atrio-ventricular valve prosthesis |
US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
US8992604B2 (en) | 2010-07-21 | 2015-03-31 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US9132009B2 (en) | 2010-07-21 | 2015-09-15 | Mitraltech Ltd. | Guide wires with commissural anchors to advance a prosthetic valve |
US9763657B2 (en) | 2010-07-21 | 2017-09-19 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
WO2012012761A2 (en) * | 2010-07-23 | 2012-01-26 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic valves |
US8696737B2 (en) | 2010-08-11 | 2014-04-15 | Hlt, Inc. | Reinforced commissural support structure |
EP2611388B1 (en) | 2010-09-01 | 2022-04-27 | Medtronic Vascular Galway | Prosthetic valve support structure |
CN103108611B (en) | 2010-09-10 | 2016-08-31 | 西美蒂斯股份公司 | Valve replacement device |
EP4042974B1 (en) | 2010-10-05 | 2024-10-23 | Edwards Lifesciences Corporation | Prosthetic heart valve |
US9770319B2 (en) | 2010-12-01 | 2017-09-26 | Surefire Medical, Inc. | Closed tip dynamic microvalve protection device |
US9579197B2 (en) * | 2010-12-15 | 2017-02-28 | Medtronic Vascular, Inc. | Systems and methods for positioning a heart valve using visual markers |
DE102010061371A1 (en) * | 2010-12-20 | 2012-06-21 | Transcatheter Technologies Gmbh | Individual shaft fiber device and kit for folding or deploying a medical implant and method |
US9421098B2 (en) | 2010-12-23 | 2016-08-23 | Twelve, Inc. | System for mitral valve repair and replacement |
BR112013018254B1 (en) | 2011-01-21 | 2020-07-07 | Obalon Therapeutics, Inc. | system for inflating intragastric balloon |
US9155619B2 (en) | 2011-02-25 | 2015-10-13 | Edwards Lifesciences Corporation | Prosthetic heart valve delivery apparatus |
EP2688516B1 (en) | 2011-03-21 | 2022-08-17 | Cephea Valve Technologies, Inc. | Disk-based valve apparatus |
US9381082B2 (en) | 2011-04-22 | 2016-07-05 | Edwards Lifesciences Corporation | Devices, systems and methods for accurate positioning of a prosthetic valve |
US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
US8840659B2 (en) * | 2011-04-28 | 2014-09-23 | Cook Medical Technologies Llc | Stent and stent-graft designs |
US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
EP2520251A1 (en) | 2011-05-05 | 2012-11-07 | Symetis SA | Method and Apparatus for Compressing Stent-Valves |
US8840664B2 (en) * | 2011-06-15 | 2014-09-23 | Edwards Lifesciences Corporation | Heart valve prosthesis anchoring device and methods |
CN107647939A (en) | 2011-06-21 | 2018-02-02 | 托尔福公司 | Artificial heart valve film device and related system |
US9918840B2 (en) | 2011-06-23 | 2018-03-20 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
US10792152B2 (en) | 2011-06-23 | 2020-10-06 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
EP2731550B1 (en) | 2011-07-12 | 2016-02-24 | Boston Scientific Scimed, Inc. | Coupling system for a replacement valve |
US8795357B2 (en) | 2011-07-15 | 2014-08-05 | Edwards Lifesciences Corporation | Perivalvular sealing for transcatheter heart valve |
EP3424468A1 (en) | 2011-07-21 | 2019-01-09 | 4Tech Inc. | Apparatus for tricuspid valve repair using tension |
US9119716B2 (en) | 2011-07-27 | 2015-09-01 | Edwards Lifesciences Corporation | Delivery systems for prosthetic heart valve |
WO2013021374A2 (en) | 2011-08-05 | 2013-02-14 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
EP2739214B1 (en) | 2011-08-05 | 2018-10-10 | Cardiovalve Ltd | Percutaneous mitral valve replacement and sealing |
US20140324164A1 (en) | 2011-08-05 | 2014-10-30 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US8852272B2 (en) | 2011-08-05 | 2014-10-07 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US9089668B2 (en) | 2011-09-28 | 2015-07-28 | Surefire Medical, Inc. | Flow directional infusion device |
US9655722B2 (en) | 2011-10-19 | 2017-05-23 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
EA201400481A1 (en) | 2011-10-19 | 2014-10-30 | Твелв, Инк. | ARTIFICIAL HEART VALVE DEVICES, ARTIFICIAL MITRAL VALVES AND RELATED SYSTEMS AND METHODS |
US9763780B2 (en) | 2011-10-19 | 2017-09-19 | Twelve, Inc. | Devices, systems and methods for heart valve replacement |
US11202704B2 (en) | 2011-10-19 | 2021-12-21 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US9039757B2 (en) | 2011-10-19 | 2015-05-26 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
EP4252714A3 (en) | 2011-10-19 | 2023-12-20 | Twelve, Inc. | Device for heart valve replacement |
CA2852369A1 (en) | 2011-10-21 | 2013-04-25 | Jenavalve Technology Inc. | Catheter system for introducing an expandable heart valve stent into the body of a patient, insertion system with a catheter system and medical device for treatment of a heart valve defect |
US9827093B2 (en) | 2011-10-21 | 2017-11-28 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
US8858623B2 (en) | 2011-11-04 | 2014-10-14 | Valtech Cardio, Ltd. | Implant having multiple rotational assemblies |
US9131926B2 (en) | 2011-11-10 | 2015-09-15 | Boston Scientific Scimed, Inc. | Direct connect flush system |
US8940014B2 (en) | 2011-11-15 | 2015-01-27 | Boston Scientific Scimed, Inc. | Bond between components of a medical device |
US8951243B2 (en) | 2011-12-03 | 2015-02-10 | Boston Scientific Scimed, Inc. | Medical device handle |
EP2787926B1 (en) | 2011-12-09 | 2022-07-06 | Edwards Lifesciences Corporation | Prosthetic heart valve improved commissure supports |
EP2886084B1 (en) | 2011-12-12 | 2018-02-14 | David Alon | Heart valve repair device |
US8652145B2 (en) | 2011-12-14 | 2014-02-18 | Edwards Lifesciences Corporation | System and method for crimping a prosthetic valve |
US9510945B2 (en) | 2011-12-20 | 2016-12-06 | Boston Scientific Scimed Inc. | Medical device handle |
US9277993B2 (en) | 2011-12-20 | 2016-03-08 | Boston Scientific Scimed, Inc. | Medical device delivery systems |
US10172708B2 (en) | 2012-01-25 | 2019-01-08 | Boston Scientific Scimed, Inc. | Valve assembly with a bioabsorbable gasket and a replaceable valve implant |
EP3424469A1 (en) | 2012-02-22 | 2019-01-09 | Syntheon TAVR, LLC | Actively controllable stent, stent graft and heart valve |
US9089341B2 (en) | 2012-02-28 | 2015-07-28 | Surefire Medical, Inc. | Renal nerve neuromodulation device |
US20130304197A1 (en) * | 2012-02-28 | 2013-11-14 | Mvalve Technologies Ltd. | Cardiac valve modification device |
WO2013128432A1 (en) | 2012-02-28 | 2013-09-06 | Mvalve Technologies Ltd. | Cardiac valve support structure |
US9579198B2 (en) | 2012-03-01 | 2017-02-28 | Twelve, Inc. | Hydraulic delivery systems for prosthetic heart valve devices and associated methods |
US20130274873A1 (en) | 2012-03-22 | 2013-10-17 | Symetis Sa | Transcatheter Stent-Valves and Methods, Systems and Devices for Addressing Para-Valve Leakage |
US11207176B2 (en) | 2012-03-22 | 2021-12-28 | Boston Scientific Scimed, Inc. | Transcatheter stent-valves and methods, systems and devices for addressing para-valve leakage |
US9427315B2 (en) | 2012-04-19 | 2016-08-30 | Caisson Interventional, LLC | Valve replacement systems and methods |
US9011515B2 (en) | 2012-04-19 | 2015-04-21 | Caisson Interventional, LLC | Heart valve assembly systems and methods |
CN104487022B (en) * | 2012-05-09 | 2017-03-29 | 波士顿科学国际有限公司 | The valve of the reduction profile with locking member |
CA2873838C (en) * | 2012-05-15 | 2018-11-27 | Valve Medical Ltd. | System and method for assembling a folded percutaneous valve |
CN104470471B (en) | 2012-05-16 | 2017-05-31 | 耶拿阀门科技有限责任公司 | Catheter delivery system for introducing an expandable heart valve prosthesis and medical device for treating a heart valve defect |
US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
US8961594B2 (en) | 2012-05-31 | 2015-02-24 | 4Tech Inc. | Heart valve repair system |
US9883941B2 (en) | 2012-06-19 | 2018-02-06 | Boston Scientific Scimed, Inc. | Replacement heart valve |
US20140005776A1 (en) | 2012-06-29 | 2014-01-02 | St. Jude Medical, Cardiology Division, Inc. | Leaflet attachment for function in various shapes and sizes |
US20140018902A1 (en) * | 2012-07-12 | 2014-01-16 | Makor Issues And Rights Ltd. | Tailor-made stent graft and procedure for minimally invasive aneurysm repair with novel tailor-made balloon, novel guidewire, and novel capsulated bioglue |
US9232995B2 (en) | 2013-01-08 | 2016-01-12 | Medtronic, Inc. | Valve prosthesis and method for delivery |
US10206775B2 (en) | 2012-08-13 | 2019-02-19 | Medtronic, Inc. | Heart valve prosthesis |
US9387080B2 (en) | 2012-09-27 | 2016-07-12 | Elwha Llc | Artificial joint components including synovial fluid deflecting structures |
US8845739B2 (en) | 2012-09-27 | 2014-09-30 | Elwha Llc | Artificial joint components including mechanized synovial fluid deflecting structures |
US8845741B2 (en) | 2012-09-27 | 2014-09-30 | Seavete LLC | Artificial joint components including integral magnetic fields configured to deflect wear debris particles |
US8828081B2 (en) | 2012-09-27 | 2014-09-09 | Elwha Llc | Artificial joint components including synovial fluid deflecting structures |
CA2885354A1 (en) | 2012-09-29 | 2014-04-03 | Mitralign, Inc. | Plication lock delivery system and method of use thereof |
EP3730066A1 (en) | 2012-10-23 | 2020-10-28 | Valtech Cardio, Ltd. | Percutaneous tissue anchor techniques |
EP3517052A1 (en) | 2012-10-23 | 2019-07-31 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
US8628571B1 (en) | 2012-11-13 | 2014-01-14 | Mitraltech Ltd. | Percutaneously-deliverable mechanical valve |
US20140155993A1 (en) * | 2012-12-04 | 2014-06-05 | The Cleveland Clinic Foundation | Device for mitigating or preventing paravalvular leaks |
WO2014087402A1 (en) | 2012-12-06 | 2014-06-12 | Valtech Cardio, Ltd. | Techniques for guide-wire based advancement of a tool |
US9066801B2 (en) | 2013-01-08 | 2015-06-30 | Medtronic, Inc. | Valve prosthesis and method for delivery |
US20140200662A1 (en) * | 2013-01-16 | 2014-07-17 | Mvalve Technologies Ltd. | Anchoring elements for intracardiac devices |
US20150351906A1 (en) | 2013-01-24 | 2015-12-10 | Mitraltech Ltd. | Ventricularly-anchored prosthetic valves |
US9724084B2 (en) | 2013-02-26 | 2017-08-08 | Mitralign, Inc. | Devices and methods for percutaneous tricuspid valve repair |
US10583002B2 (en) | 2013-03-11 | 2020-03-10 | Neovasc Tiara Inc. | Prosthetic valve with anti-pivoting mechanism |
CN105163687B (en) | 2013-03-14 | 2019-08-13 | 心肺医疗股份有限公司 | Embolus protection device and application method |
US9730791B2 (en) | 2013-03-14 | 2017-08-15 | Edwards Lifesciences Cardiaq Llc | Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery |
US9681951B2 (en) | 2013-03-14 | 2017-06-20 | Edwards Lifesciences Cardiaq Llc | Prosthesis with outer skirt and anchors |
US11259923B2 (en) | 2013-03-14 | 2022-03-01 | Jc Medical, Inc. | Methods and devices for delivery of a prosthetic valve |
US11406497B2 (en) | 2013-03-14 | 2022-08-09 | Jc Medical, Inc. | Heart valve prosthesis |
US20140277427A1 (en) | 2013-03-14 | 2014-09-18 | Cardiaq Valve Technologies, Inc. | Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery |
AU2014261117B2 (en) * | 2013-03-14 | 2017-03-30 | Valve Medical Ltd. | Temporary valve and valve-filter |
US10449333B2 (en) | 2013-03-14 | 2019-10-22 | Valtech Cardio, Ltd. | Guidewire feeder |
US10149757B2 (en) | 2013-03-15 | 2018-12-11 | Edwards Lifesciences Corporation | System and method for transaortic delivery of a prosthetic heart valve |
CN105283214B (en) | 2013-03-15 | 2018-10-16 | 北京泰德制药股份有限公司 | Translate conduit, system and its application method |
CN105208973B (en) | 2013-03-15 | 2018-04-03 | Hlt股份有限公司 | Low profile prosthetic valve structures |
US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
US10219724B2 (en) | 2013-05-02 | 2019-03-05 | VS Medtech, Inc. | Systems and methods for measuring and characterizing interior surfaces of luminal structures |
WO2014179763A1 (en) | 2013-05-03 | 2014-11-06 | Medtronic Inc. | Valve delivery tool |
CN105246431B (en) | 2013-05-20 | 2018-04-06 | 托尔福公司 | Implantable cardiac valve device, mitral valve repair device and related system and method |
MX361339B (en) | 2013-05-20 | 2018-12-04 | Edwards Lifesciences Corp | Prosthetic heart valve delivery apparatus. |
US11076952B2 (en) * | 2013-06-14 | 2021-08-03 | The Regents Of The University Of California | Collapsible atrioventricular valve prosthesis |
US10524904B2 (en) * | 2013-07-11 | 2020-01-07 | Medtronic, Inc. | Valve positioning device |
US8870948B1 (en) | 2013-07-17 | 2014-10-28 | Cephea Valve Technologies, Inc. | System and method for cardiac valve repair and replacement |
WO2015013666A1 (en) | 2013-07-26 | 2015-01-29 | Cardiaq Valve Technologies, Inc. | Systems and methods for sealing openings in an anatomical wall |
SG10202103500PA (en) | 2013-08-12 | 2021-05-28 | Mitral Valve Tech Sarl | Apparatus and methods for implanting a replacement heart valve |
EP4098226A1 (en) | 2013-08-30 | 2022-12-07 | JenaValve Technology, Inc. | Endoprosthesis comprising a radially collapsible frame and a prosthetic valve |
US10070857B2 (en) | 2013-08-31 | 2018-09-11 | Mitralign, Inc. | Devices and methods for locating and implanting tissue anchors at mitral valve commissure |
US10117742B2 (en) | 2013-09-12 | 2018-11-06 | St. Jude Medical, Cardiology Division, Inc. | Stent designs for prosthetic heart valves |
US10299793B2 (en) | 2013-10-23 | 2019-05-28 | Valtech Cardio, Ltd. | Anchor magazine |
US9050188B2 (en) | 2013-10-23 | 2015-06-09 | Caisson Interventional, LLC | Methods and systems for heart valve therapy |
US9662202B2 (en) | 2013-10-24 | 2017-05-30 | Medtronic, Inc. | Heart valve prosthesis |
US10052095B2 (en) | 2013-10-30 | 2018-08-21 | 4Tech Inc. | Multiple anchoring-point tension system |
US10039643B2 (en) | 2013-10-30 | 2018-08-07 | 4Tech Inc. | Multiple anchoring-point tension system |
US10022114B2 (en) | 2013-10-30 | 2018-07-17 | 4Tech Inc. | Percutaneous tether locking |
US9913715B2 (en) | 2013-11-06 | 2018-03-13 | St. Jude Medical, Cardiology Division, Inc. | Paravalvular leak sealing mechanism |
CN106456320B (en) | 2013-11-11 | 2020-01-21 | 爱德华兹生命科学卡迪尔克有限责任公司 | System and method for manufacturing stent frames |
EP3071149B1 (en) | 2013-11-19 | 2022-06-01 | St. Jude Medical, Cardiology Division, Inc. | Sealing structures for paravalvular leak protection |
US10098734B2 (en) | 2013-12-05 | 2018-10-16 | Edwards Lifesciences Corporation | Prosthetic heart valve and delivery apparatus |
US9610162B2 (en) | 2013-12-26 | 2017-04-04 | Valtech Cardio, Ltd. | Implantation of flexible implant |
US20150209141A1 (en) * | 2014-01-24 | 2015-07-30 | St. Jude Medical, Cardiology Division, Inc. | Stationary intra-annular halo designs for paravalvular leak (pvl) reduction-passive channel filling cuff designs |
US9820852B2 (en) | 2014-01-24 | 2017-11-21 | St. Jude Medical, Cardiology Division, Inc. | Stationary intra-annular halo designs for paravalvular leak (PVL) reduction—active channel filling cuff designs |
CA2910087C (en) | 2014-02-18 | 2022-06-07 | Edwards Lifesciences Corporation | Flexible commissure frame |
US10004599B2 (en) | 2014-02-21 | 2018-06-26 | Edwards Lifesciences Cardiaq Llc | Prosthesis, delivery device and methods of use |
USD755384S1 (en) | 2014-03-05 | 2016-05-03 | Edwards Lifesciences Cardiaq Llc | Stent |
US9968740B2 (en) | 2014-03-25 | 2018-05-15 | Surefire Medical, Inc. | Closed tip dynamic microvalve protection device |
US9889031B1 (en) | 2014-03-25 | 2018-02-13 | Surefire Medical, Inc. | Method of gastric artery embolization |
EP3125826B1 (en) | 2014-03-31 | 2020-10-07 | St. Jude Medical, Cardiology Division, Inc. | Paravalvular sealing via extended cuff mechanisms |
US10154904B2 (en) | 2014-04-28 | 2018-12-18 | Edwards Lifesciences Corporation | Intravascular introducer devices |
WO2015171743A2 (en) | 2014-05-07 | 2015-11-12 | Baylor College Of Medicine | Artificial, flexible valves and methods of fabricating and serially expanding the same |
US10195025B2 (en) | 2014-05-12 | 2019-02-05 | Edwards Lifesciences Corporation | Prosthetic heart valve |
CA3161000A1 (en) | 2014-05-19 | 2015-11-26 | Edwards Lifesciences Cardiaq Llc | Replacement mitral valve with annular flap |
EP3134033B1 (en) | 2014-05-29 | 2018-04-04 | Edwards Lifesciences CardiAQ LLC | Prosthesis and delivery device |
US9532870B2 (en) | 2014-06-06 | 2017-01-03 | Edwards Lifesciences Corporation | Prosthetic valve for replacing a mitral valve |
US9974647B2 (en) | 2014-06-12 | 2018-05-22 | Caisson Interventional, LLC | Two stage anchor and mitral valve assembly |
EP3157607B1 (en) | 2014-06-19 | 2019-08-07 | 4Tech Inc. | Cardiac tissue cinching |
EP3166512B1 (en) | 2014-07-08 | 2020-08-19 | Avinger, Inc. | High speed chronic total occlusion crossing devices |
EP4066786A1 (en) | 2014-07-30 | 2022-10-05 | Cardiovalve Ltd. | Articulatable prosthetic valve |
US10016272B2 (en) | 2014-09-12 | 2018-07-10 | Mitral Valve Technologies Sarl | Mitral repair and replacement devices and methods |
US20160095701A1 (en) * | 2014-10-07 | 2016-04-07 | St. Jude Medical, Cardiology Division, Inc. | Bi-Leaflet Mitral Valve Design |
EP4331503A3 (en) | 2014-10-14 | 2024-06-05 | Edwards Lifesciences Innovation (Israel) Ltd. | Leaflet-restraining techniques |
US9750607B2 (en) | 2014-10-23 | 2017-09-05 | Caisson Interventional, LLC | Systems and methods for heart valve therapy |
US9750605B2 (en) | 2014-10-23 | 2017-09-05 | Caisson Interventional, LLC | Systems and methods for heart valve therapy |
US9901445B2 (en) | 2014-11-21 | 2018-02-27 | Boston Scientific Scimed, Inc. | Valve locking mechanism |
CN106999178B (en) | 2014-12-02 | 2019-12-24 | 4科技有限公司 | Eccentric tissue anchor |
EP3229736B1 (en) | 2014-12-09 | 2024-01-10 | Cephea Valve Technologies, Inc. | Replacement cardiac valves and method of manufacture |
EP3037064B1 (en) | 2014-12-23 | 2018-03-14 | Venus MedTech (HangZhou), Inc. | Minimally invasive mitral valve replacement with brim |
US10449043B2 (en) | 2015-01-16 | 2019-10-22 | Boston Scientific Scimed, Inc. | Displacement based lock and release mechanism |
US9861477B2 (en) | 2015-01-26 | 2018-01-09 | Boston Scientific Scimed Inc. | Prosthetic heart valve square leaflet-leaflet stitch |
US9788942B2 (en) | 2015-02-03 | 2017-10-17 | Boston Scientific Scimed Inc. | Prosthetic heart valve having tubular seal |
WO2016126524A1 (en) | 2015-02-03 | 2016-08-11 | Boston Scientific Scimed, Inc. | Prosthetic heart valve having tubular seal |
US9974651B2 (en) | 2015-02-05 | 2018-05-22 | Mitral Tech Ltd. | Prosthetic valve with axially-sliding frames |
ES2978714T3 (en) | 2015-02-05 | 2024-09-18 | Cardiovalve Ltd | Prosthetic valve with axial sliding frames |
US20160256269A1 (en) | 2015-03-05 | 2016-09-08 | Mitralign, Inc. | Devices for treating paravalvular leakage and methods use thereof |
US10285809B2 (en) | 2015-03-06 | 2019-05-14 | Boston Scientific Scimed Inc. | TAVI anchoring assist device |
US10426617B2 (en) | 2015-03-06 | 2019-10-01 | Boston Scientific Scimed, Inc. | Low profile valve locking mechanism and commissure assembly |
US10080652B2 (en) | 2015-03-13 | 2018-09-25 | Boston Scientific Scimed, Inc. | Prosthetic heart valve having an improved tubular seal |
JP6785786B2 (en) | 2015-03-19 | 2020-11-18 | ケーソン・インターヴェンショナル・エルエルシー | Systems and methods for heart valve treatment |
CN107405198B (en) | 2015-03-20 | 2021-04-20 | 耶拿阀门科技股份有限公司 | Heart valve prosthesis delivery system and method of delivering a heart valve prosthesis with an introducer sheath |
US20160287839A1 (en) | 2015-03-31 | 2016-10-06 | Surefire Medical, Inc. | Apparatus and Method for Infusing an Immunotherapy Agent to a Solid Tumor for Treatment |
US10327896B2 (en) | 2015-04-10 | 2019-06-25 | Edwards Lifesciences Corporation | Expandable sheath with elastomeric cross sectional portions |
US10792471B2 (en) | 2015-04-10 | 2020-10-06 | Edwards Lifesciences Corporation | Expandable sheath |
US10441416B2 (en) | 2015-04-21 | 2019-10-15 | Edwards Lifesciences Corporation | Percutaneous mitral valve replacement device |
KR101588310B1 (en) * | 2015-04-22 | 2016-01-25 | (주)태웅메디칼 | Artificial heart valves using the pericardial and manufacturing method |
CR20170480A (en) | 2015-04-30 | 2018-02-21 | Valtech Cardio Ltd | Annuloplasty technologies |
US10376363B2 (en) | 2015-04-30 | 2019-08-13 | Edwards Lifesciences Cardiaq Llc | Replacement mitral valve, delivery system for replacement mitral valve and methods of use |
EP4403138A3 (en) | 2015-05-01 | 2024-10-09 | JenaValve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
WO2016183526A1 (en) | 2015-05-14 | 2016-11-17 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US10849746B2 (en) | 2015-05-14 | 2020-12-01 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices and systems |
US10016273B2 (en) | 2015-06-05 | 2018-07-10 | Medtronic, Inc. | Filtered sealing components for a transcatheter valve prosthesis |
US10226335B2 (en) | 2015-06-22 | 2019-03-12 | Edwards Lifesciences Cardiaq Llc | Actively controllable heart valve implant and method of controlling same |
US10092400B2 (en) | 2015-06-23 | 2018-10-09 | Edwards Lifesciences Cardiaq Llc | Systems and methods for anchoring and sealing a prosthetic heart valve |
US10195392B2 (en) | 2015-07-02 | 2019-02-05 | Boston Scientific Scimed, Inc. | Clip-on catheter |
US10335277B2 (en) | 2015-07-02 | 2019-07-02 | Boston Scientific Scimed Inc. | Adjustable nosecone |
US9974650B2 (en) | 2015-07-14 | 2018-05-22 | Edwards Lifesciences Corporation | Prosthetic heart valve |
US10136991B2 (en) | 2015-08-12 | 2018-11-27 | Boston Scientific Scimed Inc. | Replacement heart valve implant |
US10179041B2 (en) | 2015-08-12 | 2019-01-15 | Boston Scientific Scimed Icn. | Pinless release mechanism |
WO2017035002A1 (en) | 2015-08-21 | 2017-03-02 | Twelve Inc. | Implantable heart valve devices, mitral valve repair devices and associated systems and methods |
US10575951B2 (en) | 2015-08-26 | 2020-03-03 | Edwards Lifesciences Cardiaq Llc | Delivery device and methods of use for transapical delivery of replacement mitral valve |
US10117744B2 (en) | 2015-08-26 | 2018-11-06 | Edwards Lifesciences Cardiaq Llc | Replacement heart valves and methods of delivery |
US10350066B2 (en) | 2015-08-28 | 2019-07-16 | Edwards Lifesciences Cardiaq Llc | Steerable delivery system for replacement mitral valve and methods of use |
US10350047B2 (en) | 2015-09-02 | 2019-07-16 | Edwards Lifesciences Corporation | Method and system for packaging and preparing a prosthetic heart valve and associated delivery system |
US10779940B2 (en) | 2015-09-03 | 2020-09-22 | Boston Scientific Scimed, Inc. | Medical device handle |
US10314703B2 (en) | 2015-09-21 | 2019-06-11 | Edwards Lifesciences Corporation | Cylindrical implant and balloon |
CN109172045B (en) | 2015-11-06 | 2021-04-06 | 麦克尔有限公司 | Mitral valve prosthesis |
US10321996B2 (en) | 2015-11-11 | 2019-06-18 | Edwards Lifesciences Corporation | Prosthetic valve delivery apparatus having clutch mechanism |
US11033387B2 (en) | 2015-11-23 | 2021-06-15 | Edwards Lifesciences Corporation | Methods for controlled heart valve delivery |
US10265169B2 (en) | 2015-11-23 | 2019-04-23 | Edwards Lifesciences Corporation | Apparatus for controlled heart valve delivery |
US10357351B2 (en) | 2015-12-04 | 2019-07-23 | Edwards Lifesciences Corporation | Storage assembly for prosthetic valve |
US9931204B2 (en) | 2015-12-10 | 2018-04-03 | Medtronic, Inc. | Transcatheter heart valve replacement systems, heart valve prostheses, and methods for percutaneous heart valve replacement |
WO2017100927A1 (en) | 2015-12-15 | 2017-06-22 | Neovasc Tiara Inc. | Transseptal delivery system |
US10537453B2 (en) | 2015-12-16 | 2020-01-21 | Obalon Therapeutics, Inc. | Intragastric device with expandable portions |
US10751182B2 (en) | 2015-12-30 | 2020-08-25 | Edwards Lifesciences Corporation | System and method for reshaping right heart |
US10828160B2 (en) | 2015-12-30 | 2020-11-10 | Edwards Lifesciences Corporation | System and method for reducing tricuspid regurgitation |
AU2016380345B2 (en) | 2015-12-30 | 2021-10-28 | Caisson Interventional, LLC | Systems and methods for heart valve therapy |
CA3007670A1 (en) | 2016-01-29 | 2017-08-03 | Neovasc Tiara Inc. | Prosthetic valve for avoiding obstruction of outflow |
US10342660B2 (en) | 2016-02-02 | 2019-07-09 | Boston Scientific Inc. | Tensioned sheathing aids |
US10363130B2 (en) | 2016-02-05 | 2019-07-30 | Edwards Lifesciences Corporation | Devices and systems for docking a heart valve |
US10179043B2 (en) | 2016-02-12 | 2019-01-15 | Edwards Lifesciences Corporation | Prosthetic heart valve having multi-level sealing member |
US10531866B2 (en) | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
WO2017160823A1 (en) | 2016-03-14 | 2017-09-21 | Medtronic Vascular Inc. | Stented prosthetic heart valve having a wrap and delivery devices |
US10398549B2 (en) | 2016-03-15 | 2019-09-03 | Abbott Cardiovascular Systems Inc. | System and method for transcatheter heart valve platform |
CA3216740A1 (en) | 2016-03-24 | 2017-09-28 | Edwards Lifesciences Corporation | Delivery system for prosthetic heart valve |
USD815744S1 (en) | 2016-04-28 | 2018-04-17 | Edwards Lifesciences Cardiaq Llc | Valve frame for a delivery system |
EP3448316B1 (en) | 2016-04-29 | 2023-03-29 | Medtronic Vascular Inc. | Prosthetic heart valve devices with tethered anchors |
US10583005B2 (en) | 2016-05-13 | 2020-03-10 | Boston Scientific Scimed, Inc. | Medical device handle |
US10245136B2 (en) | 2016-05-13 | 2019-04-02 | Boston Scientific Scimed Inc. | Containment vessel with implant sheathing guide |
JP7081749B2 (en) | 2016-05-13 | 2022-06-07 | イエナバルブ テクノロジー インク | Heart valve prosthesis delivery system |
US10201416B2 (en) | 2016-05-16 | 2019-02-12 | Boston Scientific Scimed, Inc. | Replacement heart valve implant with invertible leaflets |
US10702274B2 (en) | 2016-05-26 | 2020-07-07 | Edwards Lifesciences Corporation | Method and system for closing left atrial appendage |
US11331187B2 (en) | 2016-06-17 | 2022-05-17 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices and systems |
GB201611910D0 (en) | 2016-07-08 | 2016-08-24 | Valtech Cardio Ltd | Adjustable annuloplasty device with alternating peaks and troughs |
US10350062B2 (en) | 2016-07-21 | 2019-07-16 | Edwards Lifesciences Corporation | Replacement heart valve prosthesis |
US11096781B2 (en) | 2016-08-01 | 2021-08-24 | Edwards Lifesciences Corporation | Prosthetic heart valve |
GB201613219D0 (en) | 2016-08-01 | 2016-09-14 | Mitraltech Ltd | Minimally-invasive delivery systems |
USD800908S1 (en) | 2016-08-10 | 2017-10-24 | Mitraltech Ltd. | Prosthetic valve element |
WO2018029680A1 (en) | 2016-08-10 | 2018-02-15 | Mitraltech Ltd. | Prosthetic valve with concentric frames |
US10828152B2 (en) | 2016-08-11 | 2020-11-10 | 4C Medical Technologies, Inc. | Heart chamber prosthetic valve implant with base, spring and dome sections with single chamber anchoring for preservation, supplementation and/or replacement of native valve function |
US10646340B2 (en) | 2016-08-19 | 2020-05-12 | Edwards Lifesciences Corporation | Steerable delivery system for replacement mitral valve |
CA3034006A1 (en) | 2016-08-26 | 2018-03-01 | Edwards Lifesciences Corporation | Multi-portion replacement heart valve prosthesis |
US11400263B1 (en) | 2016-09-19 | 2022-08-02 | Trisalus Life Sciences, Inc. | System and method for selective pressure-controlled therapeutic delivery |
US10780250B1 (en) | 2016-09-19 | 2020-09-22 | Surefire Medical, Inc. | System and method for selective pressure-controlled therapeutic delivery |
US10575944B2 (en) | 2016-09-22 | 2020-03-03 | Edwards Lifesciences Corporation | Prosthetic heart valve with reduced stitching |
WO2018081252A1 (en) * | 2016-10-26 | 2018-05-03 | Medtronic Vascular Inc. | Stented prosthetic heart valve having a paravalvular sealing wrap |
US10758348B2 (en) | 2016-11-02 | 2020-09-01 | Edwards Lifesciences Corporation | Supra and sub-annular mitral valve delivery system |
US10973631B2 (en) | 2016-11-17 | 2021-04-13 | Edwards Lifesciences Corporation | Crimping accessory device for a prosthetic valve |
US10463484B2 (en) | 2016-11-17 | 2019-11-05 | Edwards Lifesciences Corporation | Prosthetic heart valve having leaflet inflow below frame |
AU2017361296B2 (en) | 2016-11-21 | 2022-09-29 | Neovasc Tiara Inc. | Methods and systems for rapid retraction of a transcatheter heart valve delivery system |
US10603165B2 (en) | 2016-12-06 | 2020-03-31 | Edwards Lifesciences Corporation | Mechanically expanding heart valve and delivery apparatus therefor |
US10813749B2 (en) | 2016-12-20 | 2020-10-27 | Edwards Lifesciences Corporation | Docking device made with 3D woven fabric |
US10653523B2 (en) | 2017-01-19 | 2020-05-19 | 4C Medical Technologies, Inc. | Systems, methods and devices for delivery systems, methods and devices for implanting prosthetic heart valves |
US10433993B2 (en) | 2017-01-20 | 2019-10-08 | Medtronic Vascular, Inc. | Valve prosthesis having a radially-expandable sleeve integrated thereon for delivery and prevention of paravalvular leakage |
US11013600B2 (en) | 2017-01-23 | 2021-05-25 | Edwards Lifesciences Corporation | Covered prosthetic heart valve |
US11654023B2 (en) | 2017-01-23 | 2023-05-23 | Edwards Lifesciences Corporation | Covered prosthetic heart valve |
EP4209196A1 (en) | 2017-01-23 | 2023-07-12 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US11185406B2 (en) | 2017-01-23 | 2021-11-30 | Edwards Lifesciences Corporation | Covered prosthetic heart valve |
JP7046078B2 (en) | 2017-01-23 | 2022-04-01 | セフィア・バルブ・テクノロジーズ,インコーポレイテッド | Replacement mitral valve |
US10561495B2 (en) | 2017-01-24 | 2020-02-18 | 4C Medical Technologies, Inc. | Systems, methods and devices for two-step delivery and implantation of prosthetic heart valve |
WO2018138658A1 (en) | 2017-01-27 | 2018-08-02 | Jenavalve Technology, Inc. | Heart valve mimicry |
USD867595S1 (en) | 2017-02-01 | 2019-11-19 | Edwards Lifesciences Corporation | Stent |
US12029647B2 (en) | 2017-03-07 | 2024-07-09 | 4C Medical Technologies, Inc. | Systems, methods and devices for prosthetic heart valve with single valve leaflet |
US10588636B2 (en) | 2017-03-20 | 2020-03-17 | Surefire Medical, Inc. | Dynamic reconfigurable microvalve protection device |
US10575950B2 (en) | 2017-04-18 | 2020-03-03 | Twelve, Inc. | Hydraulic systems for delivering prosthetic heart valve devices and associated methods |
US10433961B2 (en) | 2017-04-18 | 2019-10-08 | Twelve, Inc. | Delivery systems with tethers for prosthetic heart valve devices and associated methods |
US10702378B2 (en) | 2017-04-18 | 2020-07-07 | Twelve, Inc. | Prosthetic heart valve device and associated systems and methods |
US11045627B2 (en) | 2017-04-18 | 2021-06-29 | Edwards Lifesciences Corporation | Catheter system with linear actuation control mechanism |
US10959846B2 (en) | 2017-05-10 | 2021-03-30 | Edwards Lifesciences Corporation | Mitral valve spacer device |
US10792151B2 (en) | 2017-05-11 | 2020-10-06 | Twelve, Inc. | Delivery systems for delivering prosthetic heart valve devices and associated methods |
US10842619B2 (en) | 2017-05-12 | 2020-11-24 | Edwards Lifesciences Corporation | Prosthetic heart valve docking assembly |
US11135056B2 (en) | 2017-05-15 | 2021-10-05 | Edwards Lifesciences Corporation | Devices and methods of commissure formation for prosthetic heart valve |
EP3630013B1 (en) | 2017-05-22 | 2024-04-24 | Edwards Lifesciences Corporation | Valve anchor |
US12064341B2 (en) | 2017-05-31 | 2024-08-20 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
US10646338B2 (en) | 2017-06-02 | 2020-05-12 | Twelve, Inc. | Delivery systems with telescoping capsules for deploying prosthetic heart valve devices and associated methods |
US10869759B2 (en) | 2017-06-05 | 2020-12-22 | Edwards Lifesciences Corporation | Mechanically expandable heart valve |
US11026785B2 (en) | 2017-06-05 | 2021-06-08 | Edwards Lifesciences Corporation | Mechanically expandable heart valve |
US10709591B2 (en) | 2017-06-06 | 2020-07-14 | Twelve, Inc. | Crimping device and method for loading stents and prosthetic heart valves |
WO2018226915A1 (en) | 2017-06-08 | 2018-12-13 | Boston Scientific Scimed, Inc. | Heart valve implant commissure support structure |
US12036113B2 (en) | 2017-06-14 | 2024-07-16 | 4C Medical Technologies, Inc. | Delivery of heart chamber prosthetic valve implant |
US10729541B2 (en) | 2017-07-06 | 2020-08-04 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
CN114748212A (en) | 2017-07-06 | 2022-07-15 | 爱德华兹生命科学公司 | Steerable rail delivery system |
US10786352B2 (en) | 2017-07-06 | 2020-09-29 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US10918473B2 (en) | 2017-07-18 | 2021-02-16 | Edwards Lifesciences Corporation | Transcatheter heart valve storage container and crimping mechanism |
US10898325B2 (en) | 2017-08-01 | 2021-01-26 | Boston Scientific Scimed, Inc. | Medical implant locking mechanism |
US10575948B2 (en) | 2017-08-03 | 2020-03-03 | Cardiovalve Ltd. | Prosthetic heart valve |
US11246704B2 (en) | 2017-08-03 | 2022-02-15 | Cardiovalve Ltd. | Prosthetic heart valve |
US12064347B2 (en) | 2017-08-03 | 2024-08-20 | Cardiovalve Ltd. | Prosthetic heart valve |
US10888421B2 (en) | 2017-09-19 | 2021-01-12 | Cardiovalve Ltd. | Prosthetic heart valve with pouch |
US10537426B2 (en) | 2017-08-03 | 2020-01-21 | Cardiovalve Ltd. | Prosthetic heart valve |
US11793633B2 (en) | 2017-08-03 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic heart valve |
IL314778A (en) | 2017-08-11 | 2024-10-01 | Edwards Lifesciences Corp | Sealing element for prosthetic heart valve |
US11083575B2 (en) | 2017-08-14 | 2021-08-10 | Edwards Lifesciences Corporation | Heart valve frame design with non-uniform struts |
US10932903B2 (en) | 2017-08-15 | 2021-03-02 | Edwards Lifesciences Corporation | Skirt assembly for implantable prosthetic valve |
EP3668449A1 (en) | 2017-08-16 | 2020-06-24 | Boston Scientific Scimed, Inc. | Replacement heart valve commissure assembly |
US10898319B2 (en) | 2017-08-17 | 2021-01-26 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
US10973628B2 (en) | 2017-08-18 | 2021-04-13 | Edwards Lifesciences Corporation | Pericardial sealing member for prosthetic heart valve |
US10722353B2 (en) | 2017-08-21 | 2020-07-28 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
US10856984B2 (en) | 2017-08-25 | 2020-12-08 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
US10973629B2 (en) | 2017-09-06 | 2021-04-13 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
US11147667B2 (en) | 2017-09-08 | 2021-10-19 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
US11304804B2 (en) | 2017-09-19 | 2022-04-19 | Cardiovalve, Ltd. | Prosthetic valve with connecting struts of variable size and tissue anchoring legs of variable size that extend from junctions |
US10835221B2 (en) | 2017-11-02 | 2020-11-17 | Valtech Cardio, Ltd. | Implant-cinching devices and systems |
JP2021503341A (en) * | 2017-11-16 | 2021-02-12 | ザ チルドレンズ メディカル センター コーポレーション | Geometrically compatible heart valve replacement device |
US11135062B2 (en) | 2017-11-20 | 2021-10-05 | Valtech Cardio Ltd. | Cinching of dilated heart muscle |
GB201720803D0 (en) | 2017-12-13 | 2018-01-24 | Mitraltech Ltd | Prosthetic Valve and delivery tool therefor |
US11020226B2 (en) | 2018-01-07 | 2021-06-01 | Jc Medical, Inc. | Prosthetic heart valve delivery system |
CN210697903U (en) | 2018-01-07 | 2020-06-09 | 苏州杰成医疗科技有限公司 | Heart valve prosthesis |
GB201800399D0 (en) | 2018-01-10 | 2018-02-21 | Mitraltech Ltd | Temperature-control during crimping of an implant |
WO2019144069A2 (en) | 2018-01-19 | 2019-07-25 | Boston Scientific Scimed, Inc. | Inductance mode deployment sensors for transcatheter valve system |
US11246625B2 (en) | 2018-01-19 | 2022-02-15 | Boston Scientific Scimed, Inc. | Medical device delivery system with feedback loop |
WO2019144121A1 (en) | 2018-01-22 | 2019-07-25 | Edwards Lifesciences Corporation | Heart shape preserving anchor |
WO2019145947A1 (en) | 2018-01-24 | 2019-08-01 | Valtech Cardio, Ltd. | Contraction of an annuloplasty structure |
WO2019147846A2 (en) | 2018-01-25 | 2019-08-01 | Edwards Lifesciences Corporation | Delivery system for aided replacement valve recapture and repositioning post- deployment |
EP4248904A3 (en) | 2018-01-26 | 2023-11-29 | Edwards Lifesciences Innovation (Israel) Ltd. | Techniques for facilitating heart valve tethering and chord replacement |
EP3749252A1 (en) | 2018-02-07 | 2020-12-16 | Boston Scientific Scimed, Inc. | Medical device delivery system with alignment feature |
EP3758651B1 (en) | 2018-02-26 | 2022-12-07 | Boston Scientific Scimed, Inc. | Embedded radiopaque marker in adaptive seal |
US11051934B2 (en) | 2018-02-28 | 2021-07-06 | Edwards Lifesciences Corporation | Prosthetic mitral valve with improved anchors and seal |
WO2019183372A1 (en) * | 2018-03-21 | 2019-09-26 | Cornell University | Mitral valves with integrated cutting features |
US11318011B2 (en) | 2018-04-27 | 2022-05-03 | Edwards Lifesciences Corporation | Mechanically expandable heart valve with leaflet clamps |
CN116269937A (en) * | 2018-04-30 | 2023-06-23 | 爱德华兹生命科学公司 | Push-on sheath style |
GB2574576B (en) * | 2018-05-01 | 2022-07-20 | The David J Wheatley Discretionary Trust | Heart valve |
WO2019222367A1 (en) | 2018-05-15 | 2019-11-21 | Boston Scientific Scimed, Inc. | Replacement heart valve commissure assembly |
US11241310B2 (en) | 2018-06-13 | 2022-02-08 | Boston Scientific Scimed, Inc. | Replacement heart valve delivery device |
SG11202013066PA (en) | 2018-07-12 | 2021-01-28 | Valtech Cardio Ltd | Annuloplasty systems and locking tools therefor |
US11850398B2 (en) | 2018-08-01 | 2023-12-26 | Trisalus Life Sciences, Inc. | Systems and methods for pressure-facilitated therapeutic agent delivery |
US11857441B2 (en) | 2018-09-04 | 2024-01-02 | 4C Medical Technologies, Inc. | Stent loading device |
US11338117B2 (en) | 2018-10-08 | 2022-05-24 | Trisalus Life Sciences, Inc. | Implantable dual pathway therapeutic agent delivery port |
EP3866731B1 (en) | 2018-10-19 | 2024-08-28 | Edwards Lifesciences Corporation | Prosthetic heart valve having non-cylindrical frame |
JP7260930B2 (en) | 2018-11-08 | 2023-04-19 | ニオバスク ティアラ インコーポレイテッド | Ventricular deployment of a transcatheter mitral valve prosthesis |
CN109350307B (en) * | 2018-12-03 | 2023-08-29 | 宁波健世科技股份有限公司 | Transcatheter prosthetic valve replacement system |
WO2020123486A1 (en) | 2018-12-10 | 2020-06-18 | Boston Scientific Scimed, Inc. | Medical device delivery system including a resistance member |
JP2022517423A (en) | 2019-01-17 | 2022-03-08 | エドワーズ ライフサイエンシーズ コーポレイション | Frame for artificial valve |
US11304792B2 (en) * | 2019-02-13 | 2022-04-19 | Emboline, Inc. | Catheter with integrated embolic protection device |
AU2020233892A1 (en) | 2019-03-08 | 2021-11-04 | Neovasc Tiara Inc. | Retrievable prosthesis delivery system |
CN113873973B (en) | 2019-03-26 | 2023-12-22 | 爱德华兹生命科学公司 | prosthetic heart valve |
JP7438236B2 (en) | 2019-04-01 | 2024-02-26 | ニオバスク ティアラ インコーポレイテッド | Controllably deployable prosthetic valve |
CA3136334A1 (en) | 2019-04-10 | 2020-10-15 | Neovasc Tiara Inc. | Prosthetic valve with natural blood flow |
US11439504B2 (en) | 2019-05-10 | 2022-09-13 | Boston Scientific Scimed, Inc. | Replacement heart valve with improved cusp washout and reduced loading |
WO2020236931A1 (en) | 2019-05-20 | 2020-11-26 | Neovasc Tiara Inc. | Introducer with hemostasis mechanism |
US11311376B2 (en) | 2019-06-20 | 2022-04-26 | Neovase Tiara Inc. | Low profile prosthetic mitral valve |
EP4051182B1 (en) | 2019-10-29 | 2024-08-21 | Edwards Lifesciences Innovation (Israel) Ltd. | Annuloplasty and tissue anchor technologies |
US11801131B2 (en) | 2019-12-20 | 2023-10-31 | Medtronic Vascular, Inc. | Elliptical heart valve prostheses, delivery systems, and methods of use |
CN115003255A (en) | 2020-01-10 | 2022-09-02 | 爱德华兹生命科学公司 | Method of assembling prosthetic heart valve leaflets |
US11931253B2 (en) | 2020-01-31 | 2024-03-19 | 4C Medical Technologies, Inc. | Prosthetic heart valve delivery system: ball-slide attachment |
US12053375B2 (en) | 2020-03-05 | 2024-08-06 | 4C Medical Technologies, Inc. | Prosthetic mitral valve with improved atrial and/or annular apposition and paravalvular leakage mitigation |
US11992403B2 (en) | 2020-03-06 | 2024-05-28 | 4C Medical Technologies, Inc. | Devices, systems and methods for improving recapture of prosthetic heart valve device with stent frame having valve support with inwardly stent cells |
US12023247B2 (en) | 2020-05-20 | 2024-07-02 | Edwards Lifesciences Corporation | Reducing the diameter of a cardiac valve annulus with independent control over each of the anchors that are launched into the annulus |
WO2021257774A1 (en) | 2020-06-18 | 2021-12-23 | Edwards Lifesciences Corporation | Crimping methods |
CN111772882B (en) * | 2020-08-17 | 2021-07-13 | 四川大学 | Pulmonary artery support and pulmonary valve replacement device convenient to control |
WO2022103747A1 (en) | 2020-11-10 | 2022-05-19 | Edwards Lifesciences Corporation | Prosthetic heart valves with hermetic layers or valvular structures to reduce thrombosis risk |
CN114681126A (en) * | 2020-12-28 | 2022-07-01 | 杭州德晋医疗科技有限公司 | Multi-stent valve dilator and valve dilation system |
WO2022159431A1 (en) * | 2021-01-20 | 2022-07-28 | Edwards Lifesciences Corporation | Mechanically expandable bi-caval docking device |
CN116981432A (en) | 2021-01-20 | 2023-10-31 | 爱德华兹生命科学公司 | Connection skirt for attaching leaflets to a frame of a prosthetic heart valve |
EP4312883A1 (en) | 2021-03-23 | 2024-02-07 | Edwards Lifesciences Corporation | Prosthetic heart valve having elongated sealing member |
WO2023161766A1 (en) * | 2022-02-25 | 2023-08-31 | Medtronic, Inc. | Prosthetic heart valve |
WO2024030237A1 (en) | 2022-08-03 | 2024-02-08 | The Children's Medical Center Corporation | Geometrically-accommodating heart valve replacement device |
WO2024112523A1 (en) * | 2022-11-21 | 2024-05-30 | St. Jude Medical, Cardiology Division, Inc. | Transcatheter prosthetic atrioventricular valve with stiffening structure |
Citations (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3657744A (en) * | 1970-05-08 | 1972-04-25 | Univ Minnesota | Method for fixing prosthetic implants in a living body |
US3714671A (en) * | 1970-11-30 | 1973-02-06 | Cutter Lab | Tissue-type heart valve with a graft support ring or stent |
US4680031A (en) * | 1982-11-29 | 1987-07-14 | Tascon Medical Technology Corporation | Heart valve prosthesis |
US5411552A (en) * | 1990-05-18 | 1995-05-02 | Andersen; Henning R. | Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis |
US5500014A (en) * | 1989-05-31 | 1996-03-19 | Baxter International Inc. | Biological valvular prothesis |
US5840081A (en) * | 1990-05-18 | 1998-11-24 | Andersen; Henning Rud | System and method for implanting cardiac valves |
US5855601A (en) * | 1996-06-21 | 1999-01-05 | The Trustees Of Columbia University In The City Of New York | Artificial heart valve and method and device for implanting the same |
US20010007956A1 (en) * | 1996-12-31 | 2001-07-12 | Brice Letac | Valve prosthesis for implantation in body channels |
US20010011017A1 (en) * | 1995-09-29 | 2001-08-02 | Rolf Biedermann | Cordless telecommunication system with backup interoperability of cordless telecommunication applications, in particular of a gap-specific dect system |
US20020052651A1 (en) * | 2000-01-27 | 2002-05-02 | Keith Myers | Prosthetic heart valve |
US6425916B1 (en) * | 1999-02-10 | 2002-07-30 | Michi E. Garrison | Methods and devices for implanting cardiac valves |
US6454799B1 (en) * | 2000-04-06 | 2002-09-24 | Edwards Lifesciences Corporation | Minimally-invasive heart valves and methods of use |
US6494909B2 (en) * | 2000-12-01 | 2002-12-17 | Prodesco, Inc. | Endovascular valve |
US6503272B2 (en) * | 2001-03-21 | 2003-01-07 | Cordis Corporation | Stent-based venous valves |
US20030040792A1 (en) * | 2000-09-12 | 2003-02-27 | Shlomo Gabbay | Heart valve prosthesis and sutureless implantation of a heart valve prosthesis |
US6530952B2 (en) * | 1997-12-29 | 2003-03-11 | The Cleveland Clinic Foundation | Bioprosthetic cardiovascular valve system |
US20030060875A1 (en) * | 2000-01-17 | 2003-03-27 | Wittens Cornelis Hendrikus Anna | Implant valve for implantation in a blood vessel |
US20030130729A1 (en) * | 2002-01-04 | 2003-07-10 | David Paniagua | Percutaneously implantable replacement heart valve device and method of making same |
US20030153974A1 (en) * | 2001-10-11 | 2003-08-14 | Benjamin Spenser | Implantable prosthetic valve |
US6658418B2 (en) * | 1996-02-27 | 2003-12-02 | Datamize Llc | Authoring system for computer-based information delivery system |
US6733525B2 (en) * | 2001-03-23 | 2004-05-11 | Edwards Lifesciences Corporation | Rolled minimally-invasive heart valves and methods of use |
US20040093060A1 (en) * | 1999-11-17 | 2004-05-13 | Jacques Seguin | Prosthetic valve for transluminal delivery |
US20040210306A1 (en) * | 2003-04-17 | 2004-10-21 | Quijano Rodolfo C. | Device for reduction of pressure effects of cardiac tricuspid valve regurgitation |
US20050043790A1 (en) * | 2001-07-04 | 2005-02-24 | Jacques Seguin | Kit enabling a prosthetic valve to be placed in a body enabling a prosthetic valve to be put into place in a duct in the body |
Family Cites Families (89)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US411552A (en) * | 1889-09-24 | The worcester fire | ||
US682559A (en) * | 1901-03-08 | 1901-09-10 | Harry C Mack | Bobbin. |
US3571815A (en) * | 1968-09-19 | 1971-03-23 | John V Somyk | Suture ring for heart valve |
US4768523A (en) | 1981-04-29 | 1988-09-06 | Lifecore Biomedical, Inc. | Hydrogel adhesive |
US4626255A (en) * | 1983-09-23 | 1986-12-02 | Christian Weinhold | Heart valve bioprothesis |
US5225196A (en) | 1983-11-14 | 1993-07-06 | Columbia Laboratories, Inc. | Bioadhesive compositions and methods of treatment therewith |
DE3622642A1 (en) | 1986-07-05 | 1988-01-14 | Behringwerke Ag | ONE-COMPONENT TISSUE ADHESIVE AND METHOD FOR THE PRODUCTION THEREOF |
US4725274A (en) * | 1986-10-24 | 1988-02-16 | Baxter Travenol Laboratories, Inc. | Prosthetic heart valve |
US5936035A (en) | 1988-11-21 | 1999-08-10 | Cohesion Technologies, Inc. | Biocompatible adhesive compositions |
US4994077A (en) * | 1989-04-21 | 1991-02-19 | Dobben Richard L | Artificial heart valve for implantation in a blood vessel |
AU5549590A (en) | 1989-05-11 | 1990-11-29 | Landec Labs, Inc. | Temperature-activated adhesive assemblies |
US5156911A (en) | 1989-05-11 | 1992-10-20 | Landec Labs Inc. | Skin-activated temperature-sensitive adhesive assemblies |
US5648167A (en) | 1990-03-29 | 1997-07-15 | Smith & Nephew Plc | Adhesive compositions |
US5037434A (en) * | 1990-04-11 | 1991-08-06 | Carbomedics, Inc. | Bioprosthetic heart valve with elastic commissures |
US5147391A (en) * | 1990-04-11 | 1992-09-15 | Carbomedics, Inc. | Bioprosthetic heart valve with semi-permeable commissure posts and deformable leaflets |
US5066709A (en) | 1990-09-20 | 1991-11-19 | Gaf Chemicals Corporation | Bioadhesive composition |
US5055046A (en) | 1990-09-20 | 1991-10-08 | Isp Investments Inc. | Bioadhesive composition |
US5197973A (en) | 1990-12-14 | 1993-03-30 | Creative Biomolecules, Inc. | Synthetic bioadhesive |
US5370685A (en) * | 1991-07-16 | 1994-12-06 | Stanford Surgical Technologies, Inc. | Endovascular aortic valve replacement |
US5267554A (en) * | 1991-11-15 | 1993-12-07 | Wilk Peter J | Spreadable laparoscopic retractor and associated method of use |
US5163953A (en) * | 1992-02-10 | 1992-11-17 | Vince Dennis J | Toroidal artificial heart valve stent |
US5509900A (en) * | 1992-03-02 | 1996-04-23 | Kirkman; Thomas R. | Apparatus and method for retaining a catheter in a blood vessel in a fixed position |
JPH07508975A (en) | 1992-04-23 | 1995-10-05 | バーレックス ラボラトリーズ インコーポレイテッド | Bioadhesive aqueous mineral oil emulsion ointment base, topical pharmaceutical compositions comprising it and its use in wound healing |
CN1091315A (en) | 1992-10-08 | 1994-08-31 | E·R·斯奎布父子公司 | Fibrin sealant compositions and using method thereof |
GB2274995B (en) | 1993-02-15 | 1996-10-09 | John Mccune Anderson | Biomedical electrode device |
US6010531A (en) * | 1993-02-22 | 2000-01-04 | Heartport, Inc. | Less-invasive devices and methods for cardiac valve surgery |
US5549904A (en) | 1993-06-03 | 1996-08-27 | Orthogene, Inc. | Biological adhesive composition and method of promoting adhesion between tissue surfaces |
EP0667133B1 (en) * | 1993-12-14 | 2001-03-07 | Sante Camilli | A percutaneous implantable valve for the use in blood vessels |
WO1995022316A1 (en) | 1994-02-17 | 1995-08-24 | New York Blood Center, Inc. | Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use |
US5474065A (en) | 1994-04-04 | 1995-12-12 | Graphic Controls Corporation | Non-invasive fetal probe |
US5752522A (en) * | 1995-05-04 | 1998-05-19 | Cardiovascular Concepts, Inc. | Lesion diameter measurement catheter and method |
US5716417A (en) * | 1995-06-07 | 1998-02-10 | St. Jude Medical, Inc. | Integral supporting structure for bioprosthetic heart valve |
US5769882A (en) * | 1995-09-08 | 1998-06-23 | Medtronic, Inc. | Methods and apparatus for conformably sealing prostheses within body lumens |
US6287315B1 (en) * | 1995-10-30 | 2001-09-11 | World Medical Manufacturing Corporation | Apparatus for delivering an endoluminal prosthesis |
US6533805B1 (en) | 1996-04-01 | 2003-03-18 | General Surgical Innovations, Inc. | Prosthesis and method for deployment within a body lumen |
EP0914096B1 (en) | 1996-05-17 | 2003-08-13 | Elan Drug Delivery Limited | Microparticles and their use in wound therapy |
NL1004827C2 (en) * | 1996-12-18 | 1998-06-19 | Surgical Innovations Vof | Device for regulating blood circulation. |
US5957949A (en) * | 1997-05-01 | 1999-09-28 | World Medical Manufacturing Corp. | Percutaneous placement valve stent |
US6245102B1 (en) * | 1997-05-07 | 2001-06-12 | Iowa-India Investments Company Ltd. | Stent, stent graft and stent valve |
US5925063A (en) * | 1997-09-26 | 1999-07-20 | Khosravi; Farhad | Coiled sheet valve, filter or occlusive device and methods of use |
US5980515A (en) | 1997-12-19 | 1999-11-09 | Irvine Biomedical, Inc. | Devices and methods for lead extraction |
US6159178A (en) | 1998-01-23 | 2000-12-12 | Heartport, Inc. | Methods and devices for occluding the ascending aorta and maintaining circulation of oxygenated blood in the patient when the patient's heart is arrested |
US6102943A (en) * | 1998-01-26 | 2000-08-15 | Ave Connaught | Endoluminal stents and their manufacture |
US6074418A (en) * | 1998-04-20 | 2000-06-13 | St. Jude Medical, Inc. | Driver tool for heart valve prosthesis fasteners |
US7452371B2 (en) * | 1999-06-02 | 2008-11-18 | Cook Incorporated | Implantable vascular device |
US6254636B1 (en) * | 1998-06-26 | 2001-07-03 | St. Jude Medical, Inc. | Single suture biological tissue aortic stentless valve |
US6267781B1 (en) * | 1998-08-31 | 2001-07-31 | Quantum Therapeutics Corp. | Medical device and methods for treating valvular annulus |
US6033402A (en) | 1998-09-28 | 2000-03-07 | Irvine Biomedical, Inc. | Ablation device for lead extraction and methods thereof |
US6241692B1 (en) | 1998-10-06 | 2001-06-05 | Irvine Biomedical, Inc. | Ultrasonic ablation device and methods for lead extraction |
US6558418B2 (en) | 1999-01-26 | 2003-05-06 | Edwards Lifesciences Corporation | Flexible heart valve |
US6736845B2 (en) * | 1999-01-26 | 2004-05-18 | Edwards Lifesciences Corporation | Holder for flexible heart valve |
US6896690B1 (en) * | 2000-01-27 | 2005-05-24 | Viacor, Inc. | Cardiac valve procedure methods and devices |
AU764886B2 (en) | 1999-01-27 | 2003-09-04 | Viacor Incorporated | Cardiac valve procedure methods and devices |
US6638717B2 (en) | 1999-05-19 | 2003-10-28 | Aventis Pharmaceuticals, Inc. | Microarray-based subtractive hybridzation |
US6299637B1 (en) * | 1999-08-20 | 2001-10-09 | Samuel M. Shaolian | Transluminally implantable venous valve |
FR2800984B1 (en) * | 1999-11-17 | 2001-12-14 | Jacques Seguin | DEVICE FOR REPLACING A HEART VALVE PERCUTANEOUSLY |
FR2815844B1 (en) | 2000-10-31 | 2003-01-17 | Jacques Seguin | TUBULAR SUPPORT FOR THE PERCUTANEOUS POSITIONING OF A REPLACEMENT HEART VALVE |
US6458153B1 (en) * | 1999-12-31 | 2002-10-01 | Abps Venture One, Ltd. | Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof |
US7749245B2 (en) * | 2000-01-27 | 2010-07-06 | Medtronic, Inc. | Cardiac valve procedure methods and devices |
DE10010074B4 (en) | 2000-02-28 | 2005-04-14 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Device for fastening and anchoring heart valve prostheses |
US6566649B1 (en) | 2000-05-26 | 2003-05-20 | Precision Drilling Technology Services Group Inc. | Standoff compensation for nuclear measurements |
US6485501B1 (en) | 2000-08-11 | 2002-11-26 | Cordis Corporation | Vascular filter system with guidewire and capture mechanism |
US6893459B1 (en) * | 2000-09-20 | 2005-05-17 | Ample Medical, Inc. | Heart valve annulus device and method of using same |
WO2002026168A2 (en) * | 2000-09-29 | 2002-04-04 | Tricardia, Llc | Venous valvuloplasty device |
US6974476B2 (en) * | 2003-05-05 | 2005-12-13 | Rex Medical, L.P. | Percutaneous aortic valve |
US6752829B2 (en) * | 2001-01-30 | 2004-06-22 | Scimed Life Systems, Inc. | Stent with channel(s) for containing and delivering a biologically active material and method for manufacturing the same |
NL1017275C2 (en) * | 2001-02-02 | 2002-08-05 | Univ Eindhoven Tech | Heart valve prosthesis has through passage with wall at least partly formed by flexible valve components with free outer ends and movable radially for opening and closing through passage |
US7556646B2 (en) * | 2001-09-13 | 2009-07-07 | Edwards Lifesciences Corporation | Methods and apparatuses for deploying minimally-invasive heart valves |
US20040193253A1 (en) * | 2001-04-30 | 2004-09-30 | Thorpe Patricia E | Replacement venous valve |
US6605056B2 (en) | 2001-07-11 | 2003-08-12 | Scimed Life Systems, Inc. | Conformable balloon |
FR2828091B1 (en) * | 2001-07-31 | 2003-11-21 | Seguin Jacques | ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT |
US7097659B2 (en) * | 2001-09-07 | 2006-08-29 | Medtronic, Inc. | Fixation band for affixing a prosthetic heart valve to tissue |
US7192441B2 (en) * | 2001-10-16 | 2007-03-20 | Scimed Life Systems, Inc. | Aortic artery aneurysm endovascular prosthesis |
US6755857B2 (en) * | 2001-12-12 | 2004-06-29 | Sulzer Carbomedics Inc. | Polymer heart valve with perforated stent and sewing cuff |
US6716241B2 (en) * | 2002-03-05 | 2004-04-06 | John G. Wilder | Venous valve and graft combination |
US20030199971A1 (en) * | 2002-04-23 | 2003-10-23 | Numed, Inc. | Biological replacement valve assembly |
US6733526B2 (en) * | 2002-04-25 | 2004-05-11 | Advanced Medical Optics, Inc. | Method of improving adherence and centering of intra-corneal implants on corneal bed |
WO2003092554A1 (en) * | 2002-05-03 | 2003-11-13 | The General Hospital Corporation | Involuted endovascular valve and method of construction |
AU2003225291A1 (en) * | 2002-05-10 | 2003-11-11 | Cordis Corporation | Method of making a medical device having a thin wall tubular membrane over a structural frame |
US7351256B2 (en) | 2002-05-10 | 2008-04-01 | Cordis Corporation | Frame based unidirectional flow prosthetic implant |
US20040059412A1 (en) * | 2002-09-25 | 2004-03-25 | Lytle Thomas William | Heart valve holder |
US6682462B1 (en) * | 2003-02-21 | 2004-01-27 | Sunny Lee | Dual-purpose exerciser operable in pedaling and rowing modes |
US7399315B2 (en) * | 2003-03-18 | 2008-07-15 | Edwards Lifescience Corporation | Minimally-invasive heart valve with cusp positioners |
EP1615595B1 (en) * | 2003-04-24 | 2009-10-21 | Cook Incorporated | Artificial valve prosthesis with improved flow dynamics |
DE602004018059D1 (en) * | 2003-04-30 | 2009-01-15 | Medtronic Vascular Inc | Perivascular repair system for leaks |
US20050075718A1 (en) | 2003-10-06 | 2005-04-07 | Nguyen Tuoc Tan | Minimally invasive valve replacement system |
CA2545874C (en) | 2003-10-06 | 2012-02-21 | 3F Therapeutics, Inc. | Minimally invasive valve replacement system |
CN101052359A (en) | 2004-04-23 | 2007-10-10 | 3F医疗有限公司 | Implantable prosthetic valve |
KR20230029317A (en) | 2021-08-24 | 2023-03-03 | 엘지디스플레이 주식회사 | Display device, data driving circuit and display driving method |
-
2003
- 2003-10-06 US US10/680,716 patent/US20050075718A1/en not_active Abandoned
- 2003-10-06 US US10/680,567 patent/US20050096738A1/en not_active Abandoned
- 2003-10-06 US US10/680,070 patent/US20050075730A1/en not_active Abandoned
- 2003-10-06 US US10/680,560 patent/US20050075717A1/en not_active Abandoned
- 2003-10-06 US US10/680,562 patent/US20050075724A1/en not_active Abandoned
- 2003-10-06 US US10/680,733 patent/US20050075584A1/en not_active Abandoned
- 2003-10-06 US US10/680,068 patent/US7044966B2/en not_active Expired - Lifetime
- 2003-10-06 US US10/680,075 patent/US20050075728A1/en not_active Abandoned
- 2003-10-06 US US10/680,717 patent/US20050075719A1/en not_active Abandoned
- 2003-10-06 US US10/680,071 patent/US7101396B2/en not_active Expired - Lifetime
- 2003-10-06 US US10/680,069 patent/US20050075729A1/en not_active Abandoned
- 2003-10-06 US US10/680,732 patent/US20050075720A1/en not_active Abandoned
- 2003-10-06 US US10/680,719 patent/US20050075712A1/en not_active Abandoned
- 2003-10-06 US US10/680,728 patent/US20050075713A1/en not_active Abandoned
-
2004
- 2004-10-06 EP EP14163073.1A patent/EP2789314B1/en not_active Expired - Lifetime
Patent Citations (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3657744A (en) * | 1970-05-08 | 1972-04-25 | Univ Minnesota | Method for fixing prosthetic implants in a living body |
US3714671A (en) * | 1970-11-30 | 1973-02-06 | Cutter Lab | Tissue-type heart valve with a graft support ring or stent |
US4680031A (en) * | 1982-11-29 | 1987-07-14 | Tascon Medical Technology Corporation | Heart valve prosthesis |
US5500014A (en) * | 1989-05-31 | 1996-03-19 | Baxter International Inc. | Biological valvular prothesis |
US6582462B1 (en) * | 1990-05-18 | 2003-06-24 | Heartport, Inc. | Valve prosthesis for implantation in the body and a catheter for implanting such valve prosthesis |
US5411552A (en) * | 1990-05-18 | 1995-05-02 | Andersen; Henning R. | Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis |
US5840081A (en) * | 1990-05-18 | 1998-11-24 | Andersen; Henning Rud | System and method for implanting cardiac valves |
US6168614B1 (en) * | 1990-05-18 | 2001-01-02 | Heartport, Inc. | Valve prosthesis for implantation in the body |
US20010011017A1 (en) * | 1995-09-29 | 2001-08-02 | Rolf Biedermann | Cordless telecommunication system with backup interoperability of cordless telecommunication applications, in particular of a gap-specific dect system |
US6658418B2 (en) * | 1996-02-27 | 2003-12-02 | Datamize Llc | Authoring system for computer-based information delivery system |
US5855601A (en) * | 1996-06-21 | 1999-01-05 | The Trustees Of Columbia University In The City Of New York | Artificial heart valve and method and device for implanting the same |
US20010007956A1 (en) * | 1996-12-31 | 2001-07-12 | Brice Letac | Valve prosthesis for implantation in body channels |
US20030014104A1 (en) * | 1996-12-31 | 2003-01-16 | Alain Cribier | Value prosthesis for implantation in body channels |
US20030109924A1 (en) * | 1996-12-31 | 2003-06-12 | Alain Cribier | Implanting a valve prosthesis in body channels |
US6530952B2 (en) * | 1997-12-29 | 2003-03-11 | The Cleveland Clinic Foundation | Bioprosthetic cardiovascular valve system |
US6425916B1 (en) * | 1999-02-10 | 2002-07-30 | Michi E. Garrison | Methods and devices for implanting cardiac valves |
US20040093060A1 (en) * | 1999-11-17 | 2004-05-13 | Jacques Seguin | Prosthetic valve for transluminal delivery |
US20030060875A1 (en) * | 2000-01-17 | 2003-03-27 | Wittens Cornelis Hendrikus Anna | Implant valve for implantation in a blood vessel |
US6682559B2 (en) * | 2000-01-27 | 2004-01-27 | 3F Therapeutics, Inc. | Prosthetic heart valve |
US20020052651A1 (en) * | 2000-01-27 | 2002-05-02 | Keith Myers | Prosthetic heart valve |
US6767362B2 (en) * | 2000-04-06 | 2004-07-27 | Edwards Lifesciences Corporation | Minimally-invasive heart valves and methods of use |
US6454799B1 (en) * | 2000-04-06 | 2002-09-24 | Edwards Lifesciences Corporation | Minimally-invasive heart valves and methods of use |
US20030040792A1 (en) * | 2000-09-12 | 2003-02-27 | Shlomo Gabbay | Heart valve prosthesis and sutureless implantation of a heart valve prosthesis |
US6494909B2 (en) * | 2000-12-01 | 2002-12-17 | Prodesco, Inc. | Endovascular valve |
US6503272B2 (en) * | 2001-03-21 | 2003-01-07 | Cordis Corporation | Stent-based venous valves |
US6733525B2 (en) * | 2001-03-23 | 2004-05-11 | Edwards Lifesciences Corporation | Rolled minimally-invasive heart valves and methods of use |
US20050043790A1 (en) * | 2001-07-04 | 2005-02-24 | Jacques Seguin | Kit enabling a prosthetic valve to be placed in a body enabling a prosthetic valve to be put into place in a duct in the body |
US6730118B2 (en) * | 2001-10-11 | 2004-05-04 | Percutaneous Valve Technologies, Inc. | Implantable prosthetic valve |
US20030153974A1 (en) * | 2001-10-11 | 2003-08-14 | Benjamin Spenser | Implantable prosthetic valve |
US20030130729A1 (en) * | 2002-01-04 | 2003-07-10 | David Paniagua | Percutaneously implantable replacement heart valve device and method of making same |
US20040210306A1 (en) * | 2003-04-17 | 2004-10-21 | Quijano Rodolfo C. | Device for reduction of pressure effects of cardiac tricuspid valve regurgitation |
Cited By (293)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10238486B2 (en) | 2000-06-01 | 2019-03-26 | Edwards Lifesciences Corporation | Heart valve with integrated stent and sewing ring |
US9439762B2 (en) | 2000-06-01 | 2016-09-13 | Edwards Lifesciences Corporation | Methods of implant of a heart valve with a convertible sewing ring |
US7819915B2 (en) | 2000-07-27 | 2010-10-26 | Edwards Lifesciences Corporation | Heart valve holders and handling clips therefor |
US7776053B2 (en) | 2000-10-26 | 2010-08-17 | Boston Scientific Scimed, Inc. | Implantable valve system |
US8038708B2 (en) | 2001-02-05 | 2011-10-18 | Cook Medical Technologies Llc | Implantable device with remodelable material and covering material |
US7972377B2 (en) | 2001-12-27 | 2011-07-05 | Medtronic, Inc. | Bioprosthetic heart valve |
US7682385B2 (en) | 2002-04-03 | 2010-03-23 | Boston Scientific Corporation | Artificial valve |
US20040215333A1 (en) * | 2002-04-16 | 2004-10-28 | Carlos Duran | Sigmoid valve and method for its percutaneous implantation |
US7125418B2 (en) * | 2002-04-16 | 2006-10-24 | The International Heart Institute Of Montana Foundation | Sigmoid valve and method for its percutaneous implantation |
US7806920B2 (en) * | 2002-04-16 | 2010-10-05 | The International Heart Institute Of Montana Foundation | Sigmoid valve and method for its percutaneous implantation |
US20070016290A1 (en) * | 2002-04-16 | 2007-01-18 | Carlos Duran | Sigmoid valve and method for its percutaneous implantation |
US7959674B2 (en) | 2002-07-16 | 2011-06-14 | Medtronic, Inc. | Suture locking assembly and method of use |
US8349003B2 (en) | 2002-07-16 | 2013-01-08 | Medtronic, Inc. | Suture locking assembly and method of use |
US9333078B2 (en) | 2002-12-20 | 2016-05-10 | Medtronic, Inc. | Heart valve assemblies |
US8025695B2 (en) | 2002-12-20 | 2011-09-27 | Medtronic, Inc. | Biologically implantable heart valve system |
US8460373B2 (en) | 2002-12-20 | 2013-06-11 | Medtronic, Inc. | Method for implanting a heart valve within an annulus of a patient |
US8623080B2 (en) | 2002-12-20 | 2014-01-07 | Medtronic, Inc. | Biologically implantable prosthesis and methods of using the same |
US7981153B2 (en) | 2002-12-20 | 2011-07-19 | Medtronic, Inc. | Biologically implantable prosthesis methods of using |
US10595991B2 (en) | 2002-12-20 | 2020-03-24 | Medtronic, Inc. | Heart valve assemblies |
US8551162B2 (en) | 2002-12-20 | 2013-10-08 | Medtronic, Inc. | Biologically implantable prosthesis |
US7780627B2 (en) | 2002-12-30 | 2010-08-24 | Boston Scientific Scimed, Inc. | Valve treatment catheter and methods |
US8221492B2 (en) | 2003-04-24 | 2012-07-17 | Cook Medical Technologies | Artificial valve prosthesis with improved flow dynamics |
US7658759B2 (en) * | 2003-04-24 | 2010-02-09 | Cook Incorporated | Intralumenally implantable frames |
US7625399B2 (en) * | 2003-04-24 | 2009-12-01 | Cook Incorporated | Intralumenally-implantable frames |
US20070021826A1 (en) * | 2003-04-24 | 2007-01-25 | Cook Incorporated | Intralumenally implantable frames |
US8771338B2 (en) | 2003-04-24 | 2014-07-08 | Cook Medical Technologies Llc | Intralumenally-implantable frames |
US9421096B2 (en) | 2003-04-24 | 2016-08-23 | Cook Medical Technologies Llc | Artificial valve prosthesis with improved flow dynamics |
US20100114296A1 (en) * | 2003-04-24 | 2010-05-06 | Cook Incorporated | Intralumenally-implantable frames |
US7717952B2 (en) * | 2003-04-24 | 2010-05-18 | Cook Incorporated | Artificial prostheses with preferred geometries |
US8470020B2 (en) | 2003-04-24 | 2013-06-25 | Cook Medical Technologies Llc | Intralumenally-implantable frames |
US20070038291A1 (en) * | 2003-04-24 | 2007-02-15 | Cook Incorporated | Intralumenally-implantable frames |
US9326871B2 (en) | 2003-04-24 | 2016-05-03 | Cook Medical Technologies Llc | Intralumenally-implantable frames |
US8157857B2 (en) * | 2003-04-24 | 2012-04-17 | Cook Medical Technologies Llc | Intralumenally-implantable frames |
US20070100435A1 (en) * | 2003-04-24 | 2007-05-03 | Cook Incorporated | Artificial prostheses with preferred geometries |
US8021421B2 (en) | 2003-08-22 | 2011-09-20 | Medtronic, Inc. | Prosthesis heart valve fixturing device |
US8747463B2 (en) | 2003-08-22 | 2014-06-10 | Medtronic, Inc. | Methods of using a prosthesis fixturing device |
US8603161B2 (en) | 2003-10-08 | 2013-12-10 | Medtronic, Inc. | Attachment device and methods of using the same |
US9301843B2 (en) | 2003-12-19 | 2016-04-05 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US10869764B2 (en) | 2003-12-19 | 2020-12-22 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US8721717B2 (en) | 2003-12-19 | 2014-05-13 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US8128681B2 (en) | 2003-12-19 | 2012-03-06 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7854761B2 (en) | 2003-12-19 | 2010-12-21 | Boston Scientific Scimed, Inc. | Methods for venous valve replacement with a catheter |
US9155617B2 (en) | 2004-01-23 | 2015-10-13 | Edwards Lifesciences Corporation | Prosthetic mitral valve |
US10085836B2 (en) | 2004-01-23 | 2018-10-02 | Edwards Lifesciences Corporation | Prosthetic mitral valve |
US9730794B2 (en) | 2004-01-23 | 2017-08-15 | Edwards Lifesciences Corporation | Prosthetic mitral valve |
US10342661B2 (en) | 2004-01-23 | 2019-07-09 | Edwards Lifesciences Corporation | Prosthetic mitral valve |
US9867695B2 (en) | 2004-03-03 | 2018-01-16 | Sorin Group Italia S.R.L. | Minimally-invasive cardiac-valve prosthesis |
US8109996B2 (en) | 2004-03-03 | 2012-02-07 | Sorin Biomedica Cardio, S.R.L. | Minimally-invasive cardiac-valve prosthesis |
US20050197695A1 (en) * | 2004-03-03 | 2005-09-08 | Sorin Biomedica Cardio S.R.L. | Minimally-invasive cardiac-valve prosthesis |
US8535373B2 (en) | 2004-03-03 | 2013-09-17 | Sorin Group Italia S.R.L. | Minimally-invasive cardiac-valve prosthesis |
US20050228494A1 (en) * | 2004-03-29 | 2005-10-13 | Salvador Marquez | Controlled separation heart valve frame |
US20060122692A1 (en) * | 2004-05-10 | 2006-06-08 | Ran Gilad | Stent valve and method of using same |
US20060122686A1 (en) * | 2004-05-10 | 2006-06-08 | Ran Gilad | Stent and method of manufacturing same |
US20060122693A1 (en) * | 2004-05-10 | 2006-06-08 | Youssef Biadillah | Stent valve and method of manufacturing same |
US8002824B2 (en) | 2004-09-02 | 2011-08-23 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
US9918834B2 (en) | 2004-09-02 | 2018-03-20 | Boston Scientific Scimed, Inc. | Cardiac valve, system and method |
US8932349B2 (en) | 2004-09-02 | 2015-01-13 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
US7744642B2 (en) * | 2004-11-19 | 2010-06-29 | Biomedical Research Associates, Inc. | Prosthetic venous valves |
US20060111773A1 (en) * | 2004-11-19 | 2006-05-25 | Biomedical Research Associates, Inc. | Prosthetic venous valves |
US7854755B2 (en) | 2005-02-01 | 2010-12-21 | Boston Scientific Scimed, Inc. | Vascular catheter, system, and method |
US9622859B2 (en) | 2005-02-01 | 2017-04-18 | Boston Scientific Scimed, Inc. | Filter system and method |
US7878966B2 (en) | 2005-02-04 | 2011-02-01 | Boston Scientific Scimed, Inc. | Ventricular assist and support device |
US7780722B2 (en) | 2005-02-07 | 2010-08-24 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7670368B2 (en) | 2005-02-07 | 2010-03-02 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US20100063363A1 (en) * | 2005-02-10 | 2010-03-11 | Hamman Baron L | System, device, and method for providing access in a cardiovascular environment |
US8920492B2 (en) | 2005-02-10 | 2014-12-30 | Sorin Group Italia S.R.L. | Cardiac valve prosthesis |
US9895223B2 (en) | 2005-02-10 | 2018-02-20 | Sorin Group Italia S.R.L. | Cardiac valve prosthesis |
US8540768B2 (en) | 2005-02-10 | 2013-09-24 | Sorin Group Italia S.R.L. | Cardiac valve prosthesis |
US8574257B2 (en) | 2005-02-10 | 2013-11-05 | Edwards Lifesciences Corporation | System, device, and method for providing access in a cardiovascular environment |
US7857845B2 (en) | 2005-02-10 | 2010-12-28 | Sorin Biomedica Cardio S.R.L. | Cardiac-valve prosthesis |
US9486313B2 (en) | 2005-02-10 | 2016-11-08 | Sorin Group Italia S.R.L. | Cardiac valve prosthesis |
US20080249619A1 (en) * | 2005-02-10 | 2008-10-09 | Sorin Biomedica Cardio S.R.L. | Cardiac-valve prosthesis |
US8539662B2 (en) | 2005-02-10 | 2013-09-24 | Sorin Group Italia S.R.L. | Cardiac-valve prosthesis |
US9808341B2 (en) | 2005-02-23 | 2017-11-07 | Boston Scientific Scimed Inc. | Valve apparatus, system and method |
US9370419B2 (en) | 2005-02-23 | 2016-06-21 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US7951197B2 (en) | 2005-04-08 | 2011-05-31 | Medtronic, Inc. | Two-piece prosthetic valves with snap-in connection and methods for use |
US8500802B2 (en) | 2005-04-08 | 2013-08-06 | Medtronic, Inc. | Two-piece prosthetic valves with snap-in connection and methods for use |
US8512399B2 (en) | 2005-04-15 | 2013-08-20 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US9861473B2 (en) | 2005-04-15 | 2018-01-09 | Boston Scientific Scimed Inc. | Valve apparatus, system and method |
US7722666B2 (en) | 2005-04-15 | 2010-05-25 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US10912546B2 (en) | 2005-04-22 | 2021-02-09 | Laurent Schaller | Catheter-based tissue remodeling devices and methods |
US10966696B2 (en) | 2005-04-22 | 2021-04-06 | Laurent Schaller | Catheter-based tissue remodeling devices and methods |
US20060287717A1 (en) * | 2005-05-24 | 2006-12-21 | Rowe Stanton J | Methods for rapid deployment of prosthetic heart valves |
US8911493B2 (en) | 2005-05-24 | 2014-12-16 | Edwards Lifesciences Corporation | Rapid deployment prosthetic heart valves |
US20060287719A1 (en) * | 2005-05-24 | 2006-12-21 | Rowe Stanton J | Rapid deployment prosthetic heart valve |
US11284998B2 (en) | 2005-05-24 | 2022-03-29 | Edwards Lifesciences Corporation | Surgical methods of replacing prosthetic heart valves |
US8500798B2 (en) | 2005-05-24 | 2013-08-06 | Edwards Lifesciences Corporation | Rapid deployment prosthetic heart valve |
US10456251B2 (en) | 2005-05-24 | 2019-10-29 | Edwards Lifesciences Corporation | Surgical methods of replacing prosthetic heart valves |
US7708775B2 (en) | 2005-05-24 | 2010-05-04 | Edwards Lifesciences Corporation | Methods for rapid deployment of prosthetic heart valves |
US9554903B2 (en) | 2005-05-24 | 2017-01-31 | Edwards Lifesciences Corporation | Rapid deployment prosthetic heart valve |
US10130468B2 (en) | 2005-05-24 | 2018-11-20 | Edwards Lifesciences Corporation | Replacement prosthetic heart valves |
US8211169B2 (en) | 2005-05-27 | 2012-07-03 | Medtronic, Inc. | Gasket with collar for prosthetic heart valves and methods for using them |
US11337812B2 (en) | 2005-06-10 | 2022-05-24 | Boston Scientific Scimed, Inc. | Venous valve, system and method |
US8012198B2 (en) | 2005-06-10 | 2011-09-06 | Boston Scientific Scimed, Inc. | Venous valve, system, and method |
US9028542B2 (en) | 2005-06-10 | 2015-05-12 | Boston Scientific Scimed, Inc. | Venous valve, system, and method |
US8506625B2 (en) | 2005-07-13 | 2013-08-13 | Edwards Lifesciences Corporation | Contoured sewing ring for a prosthetic mitral heart valve |
US20110054598A1 (en) * | 2005-07-13 | 2011-03-03 | Edwards Lifesciences Corporation | Contoured Sewing Ring for a Prosthetic Mitral Heart Valve |
US8672997B2 (en) | 2005-09-21 | 2014-03-18 | Boston Scientific Scimed, Inc. | Valve with sinus |
US10548734B2 (en) | 2005-09-21 | 2020-02-04 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US7951189B2 (en) | 2005-09-21 | 2011-05-31 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US8460365B2 (en) | 2005-09-21 | 2013-06-11 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US9474609B2 (en) | 2005-09-21 | 2016-10-25 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US7799038B2 (en) | 2006-01-20 | 2010-09-21 | Boston Scientific Scimed, Inc. | Translumenal apparatus, system, and method |
US7967857B2 (en) | 2006-01-27 | 2011-06-28 | Medtronic, Inc. | Gasket with spring collar for prosthetic heart valves and methods for making and using them |
US8821569B2 (en) | 2006-04-29 | 2014-09-02 | Medtronic, Inc. | Multiple component prosthetic heart valve assemblies and methods for delivering them |
US8021161B2 (en) | 2006-05-01 | 2011-09-20 | Edwards Lifesciences Corporation | Simulated heart valve root for training and testing |
US20070254273A1 (en) * | 2006-05-01 | 2007-11-01 | Hugues Lafrance | Simulated heart valve root for training and testing |
US8057539B2 (en) | 2006-12-19 | 2011-11-15 | Sorin Biomedica Cardio S.R.L. | System for in situ positioning of cardiac valve prostheses without occluding blood flow |
US9056008B2 (en) | 2006-12-19 | 2015-06-16 | Sorin Group Italia S.R.L. | Instrument and method for in situ development of cardiac valve prostheses |
US8470024B2 (en) | 2006-12-19 | 2013-06-25 | Sorin Group Italia S.R.L. | Device for in situ positioning of cardiac valve prosthesis |
US20080147182A1 (en) * | 2006-12-19 | 2008-06-19 | Sorin Biomedica Cardio S.R.L. | Instrument and method for in situ deployment of cardiac valve prostheses |
US20080262507A1 (en) * | 2006-12-19 | 2008-10-23 | Sorin Biomedica Cardio S.R.L. | Instrument and method for in situ deployment of cardiac valve prostheses |
US8070799B2 (en) | 2006-12-19 | 2011-12-06 | Sorin Biomedica Cardio S.R.L. | Instrument and method for in situ deployment of cardiac valve prostheses |
US7993392B2 (en) | 2006-12-19 | 2011-08-09 | Sorin Biomedica Cardio S.R.L. | Instrument and method for in situ deployment of cardiac valve prostheses |
US8348999B2 (en) | 2007-01-08 | 2013-01-08 | California Institute Of Technology | In-situ formation of a valve |
US20100249920A1 (en) * | 2007-01-08 | 2010-09-30 | Millipede Llc | Reconfiguring heart features |
US8133270B2 (en) | 2007-01-08 | 2012-03-13 | California Institute Of Technology | In-situ formation of a valve |
US9192471B2 (en) | 2007-01-08 | 2015-11-24 | Millipede, Inc. | Device for translumenal reshaping of a mitral valve annulus |
US8470023B2 (en) | 2007-02-05 | 2013-06-25 | Boston Scientific Scimed, Inc. | Percutaneous valve, system, and method |
US9421083B2 (en) | 2007-02-05 | 2016-08-23 | Boston Scientific Scimed Inc. | Percutaneous valve, system and method |
US10226344B2 (en) | 2007-02-05 | 2019-03-12 | Boston Scientific Scimed, Inc. | Percutaneous valve, system and method |
US11504239B2 (en) | 2007-02-05 | 2022-11-22 | Boston Scientific Scimed, Inc. | Percutaneous valve, system and method |
US7967853B2 (en) | 2007-02-05 | 2011-06-28 | Boston Scientific Scimed, Inc. | Percutaneous valve, system and method |
US20090030506A1 (en) * | 2007-07-24 | 2009-01-29 | Biotronik Vi Patent Ag | Endoprosthesis and method for manufacturing same |
US8828079B2 (en) | 2007-07-26 | 2014-09-09 | Boston Scientific Scimed, Inc. | Circulatory valve, system and method |
US8808367B2 (en) | 2007-09-07 | 2014-08-19 | Sorin Group Italia S.R.L. | Prosthetic valve delivery system including retrograde/antegrade approach |
US8114154B2 (en) | 2007-09-07 | 2012-02-14 | Sorin Biomedica Cardio S.R.L. | Fluid-filled delivery system for in situ deployment of cardiac valve prostheses |
US8475521B2 (en) | 2007-09-07 | 2013-07-02 | Sorin Group Italia S.R.L. | Streamlined delivery system for in situ deployment of cardiac valve prostheses |
US8486137B2 (en) | 2007-09-07 | 2013-07-16 | Sorin Group Italia S.R.L. | Streamlined, apical delivery system for in situ deployment of cardiac valve prostheses |
US9848981B2 (en) | 2007-10-12 | 2017-12-26 | Mayo Foundation For Medical Education And Research | Expandable valve prosthesis with sealing mechanism |
US20090099653A1 (en) * | 2007-10-12 | 2009-04-16 | Sorin Biomedica Cardio S.R.L. | Expandable valve prosthesis with sealing mechanism |
US10966823B2 (en) | 2007-10-12 | 2021-04-06 | Sorin Group Italia S.R.L. | Expandable valve prosthesis with sealing mechanism |
US7892276B2 (en) | 2007-12-21 | 2011-02-22 | Boston Scientific Scimed, Inc. | Valve with delayed leaflet deployment |
US8137394B2 (en) | 2007-12-21 | 2012-03-20 | Boston Scientific Scimed, Inc. | Valve with delayed leaflet deployment |
US8414641B2 (en) | 2007-12-21 | 2013-04-09 | Boston Scientific Scimed, Inc. | Valve with delayed leaflet deployment |
US9333100B2 (en) | 2008-01-24 | 2016-05-10 | Medtronic, Inc. | Stents for prosthetic heart valves |
US20090292350A1 (en) * | 2008-01-24 | 2009-11-26 | Medtronic, Inc. | Stents for Prosthetic Heart Valves |
US11607311B2 (en) * | 2008-01-24 | 2023-03-21 | Medtronic, Inc. | Stents for prosthetic heart valves |
US10758343B2 (en) * | 2008-01-24 | 2020-09-01 | Medtronic, Inc. | Stent for prosthetic heart valves |
US20160296327A1 (en) * | 2008-01-24 | 2016-10-13 | Medtronic, Inc. | Stent for Prosthetic Heart Valves |
US8628566B2 (en) * | 2008-01-24 | 2014-01-14 | Medtronic, Inc. | Stents for prosthetic heart valves |
US20210322161A1 (en) * | 2008-01-24 | 2021-10-21 | Medtronic, Inc. | Stents for Prosthetic Heart Valves |
US8840661B2 (en) | 2008-05-16 | 2014-09-23 | Sorin Group Italia S.R.L. | Atraumatic prosthetic heart valve prosthesis |
US9314334B2 (en) | 2008-11-25 | 2016-04-19 | Edwards Lifesciences Corporation | Conformal expansion of prosthetic devices to anatomical shapes |
US10667906B2 (en) | 2008-11-25 | 2020-06-02 | Edwards Lifesciences Corporation | Methods of conformal expansion of prosthetic heart valves |
US8308798B2 (en) | 2008-12-19 | 2012-11-13 | Edwards Lifesciences Corporation | Quick-connect prosthetic heart valve and methods |
US11504232B2 (en) | 2008-12-19 | 2022-11-22 | Edwards Lifesciences Corporation | Rapid implant prosthetic heart valve system |
US9005278B2 (en) | 2008-12-19 | 2015-04-14 | Edwards Lifesciences Corporation | Quick-connect prosthetic heart valve |
US10182909B2 (en) | 2008-12-19 | 2019-01-22 | Edwards Lifesciences Corporation | Methods for quickly implanting a prosthetic heart valve |
US10799346B2 (en) | 2008-12-19 | 2020-10-13 | Edwards Lifesciences Corporation | Methods for quickly implanting a prosthetic heart valve |
US9561100B2 (en) | 2008-12-19 | 2017-02-07 | Edwards Lifesciences Corporation | Systems for quickly delivering a prosthetic heart valve |
US12011350B2 (en) | 2008-12-19 | 2024-06-18 | Edwards Lifesciences Corporation | Rapid implant prosthetic heart valve system |
US10098733B2 (en) | 2008-12-23 | 2018-10-16 | Sorin Group Italia S.R.L. | Expandable prosthetic valve having anchoring appendages |
US8834563B2 (en) | 2008-12-23 | 2014-09-16 | Sorin Group Italia S.R.L. | Expandable prosthetic valve having anchoring appendages |
US20100249894A1 (en) * | 2009-03-31 | 2010-09-30 | Edwards Lifesciences Corporation | Prosthetic heart valve system |
US9931207B2 (en) | 2009-03-31 | 2018-04-03 | Edwards Lifesciences Corporation | Methods of implanting a heart valve at an aortic annulus |
US9248016B2 (en) | 2009-03-31 | 2016-02-02 | Edwards Lifesciences Corporation | Prosthetic heart valve system |
US10842623B2 (en) | 2009-03-31 | 2020-11-24 | Edwards Lifesciences Corporation | Methods of implanting prosthetic heart valve using position markers |
US9980818B2 (en) | 2009-03-31 | 2018-05-29 | Edwards Lifesciences Corporation | Prosthetic heart valve system with positioning markers |
US20100249908A1 (en) * | 2009-03-31 | 2010-09-30 | Edwards Lifesciences Corporation | Prosthetic heart valve system with positioning markers |
US8512397B2 (en) | 2009-04-27 | 2013-08-20 | Sorin Group Italia S.R.L. | Prosthetic vascular conduit |
US20100292782A1 (en) * | 2009-05-13 | 2010-11-18 | Sorin Biomedica Cardio S.R.L. | Device for the in situ delivery of heart valves |
US8353953B2 (en) | 2009-05-13 | 2013-01-15 | Sorin Biomedica Cardio, S.R.L. | Device for the in situ delivery of heart valves |
US20100292783A1 (en) * | 2009-05-13 | 2010-11-18 | Sorin Biomedica Cardio S.R.L. | Device for surgical interventions |
US9168105B2 (en) | 2009-05-13 | 2015-10-27 | Sorin Group Italia S.R.L. | Device for surgical interventions |
US20100292784A1 (en) * | 2009-05-13 | 2010-11-18 | Sorin Biomedica Cardio S.r. I. | Device for the in situ delivery of heart valves |
US8403982B2 (en) | 2009-05-13 | 2013-03-26 | Sorin Group Italia S.R.L. | Device for the in situ delivery of heart valves |
US8696742B2 (en) | 2009-06-26 | 2014-04-15 | Edwards Lifesciences Corporation | Unitary quick-connect prosthetic heart valve deployment methods |
US10555810B2 (en) | 2009-06-26 | 2020-02-11 | Edwards Lifesciences Corporation | Prosthetic heart valve deployment systems |
US9005277B2 (en) | 2009-06-26 | 2015-04-14 | Edwards Lifesciences Corporation | Unitary quick-connect prosthetic heart valve deployment system |
US8348998B2 (en) | 2009-06-26 | 2013-01-08 | Edwards Lifesciences Corporation | Unitary quick connect prosthetic heart valve and deployment system and methods |
US8808369B2 (en) | 2009-10-05 | 2014-08-19 | Mayo Foundation For Medical Education And Research | Minimally invasive aortic valve replacement |
US20110098602A1 (en) * | 2009-10-27 | 2011-04-28 | Edwards Lifesciences Corporation | Apparatus and Method for Measuring Body Orifice |
US10231646B2 (en) | 2009-10-27 | 2019-03-19 | Edwards Lifesciences Corporation | Device for measuring an aortic valve annulus in an expanded condition |
US11412954B2 (en) | 2009-10-27 | 2022-08-16 | Edwards Lifesciences Corporation | Device for measuring an aortic valve annulus in an expanded condition |
US8449625B2 (en) | 2009-10-27 | 2013-05-28 | Edwards Lifesciences Corporation | Methods of measuring heart valve annuluses for valve replacement |
US9603553B2 (en) | 2009-10-27 | 2017-03-28 | Edwards Lifesciences Corporation | Methods of measuring heart valve annuluses for valve replacement |
US10433963B2 (en) | 2010-01-22 | 2019-10-08 | 4Tech Inc. | Tissue anchor and delivery tool |
US10058323B2 (en) | 2010-01-22 | 2018-08-28 | 4 Tech Inc. | Tricuspid valve repair using tension |
US20130046380A1 (en) * | 2010-01-22 | 2013-02-21 | 4Tech Inc. | Tricuspid valve repair using tension |
US20150073543A1 (en) * | 2010-03-26 | 2015-03-12 | Thubrikar Aortic Valve, Inc. | Valve component, frame component and prosthetic valve device including the same for implantation in a body lumen |
US9549814B2 (en) * | 2010-03-26 | 2017-01-24 | Thubrikar Aortic Valve, Inc. | Valve component, frame component and prosthetic valve device including the same for implantation in a body lumen |
US11571299B2 (en) | 2010-05-10 | 2023-02-07 | Edwards Lifesciences Corporation | Methods for manufacturing resilient prosthetic surgical heart valves |
US10702383B2 (en) | 2010-05-10 | 2020-07-07 | Edwards Lifesciences Corporation | Methods of delivering and implanting resilient prosthetic surgical heart valves |
US8986374B2 (en) | 2010-05-10 | 2015-03-24 | Edwards Lifesciences Corporation | Prosthetic heart valve |
EP2568925A4 (en) * | 2010-05-12 | 2015-10-21 | Edwards Lifesciences Corp | Low gradient prosthetic heart valve |
US10463480B2 (en) | 2010-05-12 | 2019-11-05 | Edwards Lifesciences Corporation | Leaflet for low gradient prosthetic heart valve |
US11266497B2 (en) | 2010-05-12 | 2022-03-08 | Edwards Lifesciences Corporation | Low gradient prosthetic heart valves |
US9554901B2 (en) | 2010-05-12 | 2017-01-31 | Edwards Lifesciences Corporation | Low gradient prosthetic heart valve |
US9248017B2 (en) | 2010-05-21 | 2016-02-02 | Sorin Group Italia S.R.L. | Support device for valve prostheses and corresponding kit |
US9795480B2 (en) | 2010-08-24 | 2017-10-24 | Millipede, Inc. | Reconfiguring tissue features of a heart annulus |
CN103237523A (en) * | 2010-09-01 | 2013-08-07 | M阀门技术有限公司 | Cardiac valve support structure |
US9301836B2 (en) | 2010-09-01 | 2016-04-05 | Mvalve Technologies Ltd. | Cardiac valve support structure |
US10105224B2 (en) | 2010-09-01 | 2018-10-23 | Mvalve Technologies Ltd. | Cardiac valve support structure |
US9504563B2 (en) | 2010-09-10 | 2016-11-29 | Edwards Lifesciences Corporation | Rapidly deployable surgical heart valves |
US10039641B2 (en) | 2010-09-10 | 2018-08-07 | Edwards Lifesciences Corporation | Methods of rapidly deployable surgical heart valves |
US10548728B2 (en) | 2010-09-10 | 2020-02-04 | Edwards Lifesciences Corporation | Safety systems for expansion of prosthetic heart valves |
US9125741B2 (en) | 2010-09-10 | 2015-09-08 | Edwards Lifesciences Corporation | Systems and methods for ensuring safe and rapid deployment of prosthetic heart valves |
US9968450B2 (en) | 2010-09-10 | 2018-05-15 | Edwards Lifesciences Corporation | Methods for ensuring safe and rapid deployment of prosthetic heart valves |
US9370418B2 (en) | 2010-09-10 | 2016-06-21 | Edwards Lifesciences Corporation | Rapidly deployable surgical heart valves |
US11471279B2 (en) | 2010-09-10 | 2022-10-18 | Edwards Lifesciences Corporation | Systems for rapidly deployable surgical heart valves |
US12053377B2 (en) | 2010-09-10 | 2024-08-06 | Edwards Lifesciences Corporation | Methods for rapidly deployable surgical heart valves |
US11775613B2 (en) | 2010-09-10 | 2023-10-03 | Edwards Lifesciences Corporation | Methods of safely expanding prosthetic heart valves |
US8641757B2 (en) | 2010-09-10 | 2014-02-04 | Edwards Lifesciences Corporation | Systems for rapidly deploying surgical heart valves |
US11197757B2 (en) | 2010-09-10 | 2021-12-14 | Edwards Lifesciences Corporation | Methods of safely expanding prosthetic heart valves |
US10722358B2 (en) | 2010-09-10 | 2020-07-28 | Edwards Lifesciences Corporation | Systems for rapidly deployable surgical heart valves |
US10736741B2 (en) | 2010-09-27 | 2020-08-11 | Edwards Lifesciences Corporation | Methods of delivery of heart valves |
US11207178B2 (en) | 2010-09-27 | 2021-12-28 | Edwards Lifesciences Corporation | Collapsible-expandable heart valves |
US8845720B2 (en) | 2010-09-27 | 2014-09-30 | Edwards Lifesciences Corporation | Prosthetic heart valve frame with flexible commissures |
US9861479B2 (en) | 2010-09-27 | 2018-01-09 | Edwards Lifesciences Corporation | Methods of delivery of flexible heart valves |
US9161836B2 (en) | 2011-02-14 | 2015-10-20 | Sorin Group Italia S.R.L. | Sutureless anchoring device for cardiac valve prostheses |
US9289289B2 (en) | 2011-02-14 | 2016-03-22 | Sorin Group Italia S.R.L. | Sutureless anchoring device for cardiac valve prostheses |
US11517426B2 (en) | 2011-05-20 | 2022-12-06 | Edwards Lifesciences Corporation | Encapsulated heart valves |
US10543080B2 (en) | 2011-05-20 | 2020-01-28 | Edwards Lifesciences Corporation | Methods of making encapsulated heart valves |
US10058313B2 (en) | 2011-05-24 | 2018-08-28 | Sorin Group Italia S.R.L. | Transapical valve replacement |
US9668859B2 (en) | 2011-08-05 | 2017-06-06 | California Institute Of Technology | Percutaneous heart valve delivery systems |
US10238489B2 (en) | 2011-12-21 | 2019-03-26 | Edwards Lifesciences Corporation | Anchoring device and method for replacing or repairing a heart valve |
US10849752B2 (en) | 2011-12-21 | 2020-12-01 | Edwards Lifesciences Corporation | Methods for anchoring a device at a native heart valve annulus |
US9078747B2 (en) | 2011-12-21 | 2015-07-14 | Edwards Lifesciences Corporation | Anchoring device for replacing or repairing a heart valve |
US11452602B2 (en) | 2011-12-21 | 2022-09-27 | Edwards Lifesciences Corporation | Anchoring device for replacing or repairing a native heart valve annulus |
US9138314B2 (en) | 2011-12-29 | 2015-09-22 | Sorin Group Italia S.R.L. | Prosthetic vascular conduit and assembly method |
US8685084B2 (en) | 2011-12-29 | 2014-04-01 | Sorin Group Italia S.R.L. | Prosthetic vascular conduit and assembly method |
US10940167B2 (en) | 2012-02-10 | 2021-03-09 | Cvdevices, Llc | Methods and uses of biological tissues for various stent and other medical applications |
US10543088B2 (en) | 2012-09-14 | 2020-01-28 | Boston Scientific Scimed, Inc. | Mitral valve inversion prostheses |
US10849755B2 (en) | 2012-09-14 | 2020-12-01 | Boston Scientific Scimed, Inc. | Mitral valve inversion prostheses |
US10449050B2 (en) | 2013-01-09 | 2019-10-22 | 4 Tech Inc. | Soft tissue depth-finding tool |
US11406495B2 (en) | 2013-02-11 | 2022-08-09 | Cook Medical Technologies Llc | Expandable support frame and medical device |
US9907681B2 (en) | 2013-03-14 | 2018-03-06 | 4Tech Inc. | Stent with tether interface |
US10058425B2 (en) | 2013-03-15 | 2018-08-28 | Edwards Lifesciences Corporation | Methods of assembling a valved aortic conduit |
US9744037B2 (en) | 2013-03-15 | 2017-08-29 | California Institute Of Technology | Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves |
US11007058B2 (en) | 2013-03-15 | 2021-05-18 | Edwards Lifesciences Corporation | Valved aortic conduits |
US11648116B2 (en) | 2013-03-15 | 2023-05-16 | Edwards Lifesciences Corporation | Methods of assembling valved aortic conduits |
US11464633B2 (en) | 2013-06-12 | 2022-10-11 | Edwards Lifesciences Corporation | Heart valve implants with side slits |
US10314706B2 (en) | 2013-06-12 | 2019-06-11 | Edwards Lifesciences Corporation | Methods of implanting a cardiac implant with integrated suture fasteners |
US9468527B2 (en) | 2013-06-12 | 2016-10-18 | Edwards Lifesciences Corporation | Cardiac implant with integrated suture fasteners |
US9968451B2 (en) | 2013-06-12 | 2018-05-15 | Edwards Lifesciences Corporation | Cardiac implant with integrated suture fasteners |
US10702680B2 (en) | 2013-08-28 | 2020-07-07 | Edwards Lifesciences Corporation | Method of operating an integrated balloon catheter inflation system |
US9919137B2 (en) | 2013-08-28 | 2018-03-20 | Edwards Lifesciences Corporation | Integrated balloon catheter inflation system |
US11266499B2 (en) | 2013-09-20 | 2022-03-08 | Edwards Lifesciences Corporation | Heart valves with increased effective orifice area |
US10441415B2 (en) | 2013-09-20 | 2019-10-15 | Edwards Lifesciences Corporation | Heart valves with increased effective orifice area |
US10722316B2 (en) | 2013-11-06 | 2020-07-28 | Edwards Lifesciences Corporation | Bioprosthetic heart valves having adaptive seals to minimize paravalvular leakage |
US12089971B2 (en) | 2013-11-06 | 2024-09-17 | Edwards Lifesciences Corporation | Bioprosthetic heart valves having adaptive seals to minimize perivalvular leakage |
US9956384B2 (en) | 2014-01-24 | 2018-05-01 | Cook Medical Technologies Llc | Articulating balloon catheter and method for using the same |
US9549816B2 (en) | 2014-04-03 | 2017-01-24 | Edwards Lifesciences Corporation | Method for manufacturing high durability heart valve |
US11376122B2 (en) | 2014-04-30 | 2022-07-05 | Edwards Lifesciences Corporation | Holder and deployment system for surgical heart valves |
US9585752B2 (en) | 2014-04-30 | 2017-03-07 | Edwards Lifesciences Corporation | Holder and deployment system for surgical heart valves |
US11980544B2 (en) | 2014-04-30 | 2024-05-14 | Edwards Lifesciences Corporation | Holder and deployment system for prosthetic heart valves |
US10307249B2 (en) | 2014-04-30 | 2019-06-04 | Edwards Lifesciences Corporation | Holder and deployment system for surgical heart valves |
US9504566B2 (en) | 2014-06-20 | 2016-11-29 | Edwards Lifesciences Corporation | Surgical heart valves identifiable post-implant |
US11154394B2 (en) | 2014-06-20 | 2021-10-26 | Edwards Lifesciences Corporation | Methods of identifying and replacing implanted heart valves |
US10130469B2 (en) | 2014-06-20 | 2018-11-20 | Edwards Lifesciences Corporation | Expandable surgical heart valve indicators |
US12023235B2 (en) | 2014-07-17 | 2024-07-02 | Boston Scientific Scimed, Inc. | Adjustable endolumenal implant for reshaping the mitral valve annulus |
US9615926B2 (en) | 2014-07-17 | 2017-04-11 | Millipede, Inc. | Adjustable endolumenal implant for reshaping the mitral valve annulus |
US9622862B2 (en) | 2014-07-17 | 2017-04-18 | Millipede, Inc. | Prosthetic mitral valve with adjustable support |
US9180005B1 (en) | 2014-07-17 | 2015-11-10 | Millipede, Inc. | Adjustable endolumenal mitral valve ring |
US9913706B2 (en) | 2014-07-17 | 2018-03-13 | Millipede, Inc. | Adjustable endolumenal implant for reshaping the mitral valve annulus |
US10136985B2 (en) | 2014-07-17 | 2018-11-27 | Millipede, Inc. | Method of reconfiguring a mitral valve annulus |
US10695160B2 (en) | 2014-07-17 | 2020-06-30 | Boston Scientific Scimed, Inc. | Adjustable endolumenal implant for reshaping the mitral valve annulus |
US9848983B2 (en) | 2015-02-13 | 2017-12-26 | Millipede, Inc. | Valve replacement using rotational anchors |
US10258466B2 (en) | 2015-02-13 | 2019-04-16 | Millipede, Inc. | Valve replacement using moveable restrains and angled struts |
US11918462B2 (en) | 2015-02-13 | 2024-03-05 | Boston Scientific Scimed, Inc. | Valve replacement using moveable restraints and angled struts |
USD867594S1 (en) | 2015-06-19 | 2019-11-19 | Edwards Lifesciences Corporation | Prosthetic heart valve |
USD893031S1 (en) | 2015-06-19 | 2020-08-11 | Edwards Lifesciences Corporation | Prosthetic heart valve |
US11690714B2 (en) | 2015-07-02 | 2023-07-04 | Edwards Lifesciences Corporation | Hybrid heart valves adapted for post-implant expansion |
US10695170B2 (en) | 2015-07-02 | 2020-06-30 | Edwards Lifesciences Corporation | Hybrid heart valves adapted for post-implant expansion |
US11654020B2 (en) | 2015-07-02 | 2023-05-23 | Edwards Lifesciences Corporation | Hybrid heart valves |
US10456246B2 (en) | 2015-07-02 | 2019-10-29 | Edwards Lifesciences Corporation | Integrated hybrid heart valves |
US11690709B2 (en) | 2015-09-02 | 2023-07-04 | Edwards Lifesciences Corporation | Methods for securing a transcatheter valve to a bioprosthetic cardiac structure |
US10751174B2 (en) | 2015-09-10 | 2020-08-25 | Edwards Lifesciences Corporation | Limited expansion heart valve |
US11806232B2 (en) | 2015-09-10 | 2023-11-07 | Edwards Lifesciences Corporation | Limited expansion valve-in-valve procedures |
US10080653B2 (en) | 2015-09-10 | 2018-09-25 | Edwards Lifesciences Corporation | Limited expansion heart valve |
US10335275B2 (en) | 2015-09-29 | 2019-07-02 | Millipede, Inc. | Methods for delivery of heart valve devices using intravascular ultrasound imaging |
US10555813B2 (en) | 2015-11-17 | 2020-02-11 | Boston Scientific Scimed, Inc. | Implantable device and delivery system for reshaping a heart valve annulus |
US11471275B2 (en) | 2016-03-08 | 2022-10-18 | Edwards Lifesciences Corporation | Valve implant with integrated sensor and transmitter |
US10667904B2 (en) | 2016-03-08 | 2020-06-02 | Edwards Lifesciences Corporation | Valve implant with integrated sensor and transmitter |
US10456245B2 (en) | 2016-05-16 | 2019-10-29 | Edwards Lifesciences Corporation | System and method for applying material to a stent |
USD846122S1 (en) | 2016-12-16 | 2019-04-16 | Edwards Lifesciences Corporation | Heart valve sizer |
US10548731B2 (en) | 2017-02-10 | 2020-02-04 | Boston Scientific Scimed, Inc. | Implantable device and delivery system for reshaping a heart valve annulus |
US10463485B2 (en) | 2017-04-06 | 2019-11-05 | Edwards Lifesciences Corporation | Prosthetic valve holders with automatic deploying mechanisms |
US11376125B2 (en) | 2017-04-06 | 2022-07-05 | Edwards Lifesciences Corporation | Prosthetic valve holders with automatic deploying mechanisms |
US10799353B2 (en) | 2017-04-28 | 2020-10-13 | Edwards Lifesciences Corporation | Prosthetic heart valve with collapsible holder |
US11911273B2 (en) | 2017-04-28 | 2024-02-27 | Edwards Lifesciences Corporation | Prosthetic heart valve with collapsible holder |
US11135057B2 (en) | 2017-06-21 | 2021-10-05 | Edwards Lifesciences Corporation | Dual-wireform limited expansion heart valves |
US20230233325A1 (en) * | 2017-07-06 | 2023-07-27 | Raghuveer Basude | Tissue grasping devices and related methods |
US11648118B2 (en) * | 2017-07-06 | 2023-05-16 | Raghuveer Basude | Tissue grasping devices and related methods |
US11337805B2 (en) | 2018-01-23 | 2022-05-24 | Edwards Lifesciences Corporation | Prosthetic valve holders, systems, and methods |
US11969341B2 (en) | 2018-05-23 | 2024-04-30 | Corcym S.R.L. | Cardiac valve prosthesis |
US11504231B2 (en) | 2018-05-23 | 2022-11-22 | Corcym S.R.L. | Cardiac valve prosthesis |
USD995774S1 (en) | 2018-07-11 | 2023-08-15 | Edwards Lifesciences Corporation | Collapsible heart valve sizer |
USD908874S1 (en) | 2018-07-11 | 2021-01-26 | Edwards Lifesciences Corporation | Collapsible heart valve sizer |
USD952143S1 (en) | 2018-07-11 | 2022-05-17 | Edwards Lifesciences Corporation | Collapsible heart valve sizer |
US11554012B2 (en) | 2019-12-16 | 2023-01-17 | Edwards Lifesciences Corporation | Valve holder assembly with suture looping protection |
US11951006B2 (en) | 2019-12-16 | 2024-04-09 | Edwards Lifesciences Corporation | Valve holder assembly with suture looping protection |
Also Published As
Publication number | Publication date |
---|---|
US20050075719A1 (en) | 2005-04-07 |
US20050075730A1 (en) | 2005-04-07 |
US20050075718A1 (en) | 2005-04-07 |
US20050096738A1 (en) | 2005-05-05 |
EP2789314A2 (en) | 2014-10-15 |
US20050075724A1 (en) | 2005-04-07 |
US20050075584A1 (en) | 2005-04-07 |
US20050075720A1 (en) | 2005-04-07 |
US20050075717A1 (en) | 2005-04-07 |
US7101396B2 (en) | 2006-09-05 |
EP2789314A3 (en) | 2014-10-22 |
US7044966B2 (en) | 2006-05-16 |
US20050075729A1 (en) | 2005-04-07 |
EP2789314B1 (en) | 2018-04-25 |
US20050075731A1 (en) | 2005-04-07 |
US20050075728A1 (en) | 2005-04-07 |
US20050075726A1 (en) | 2005-04-07 |
US20050075712A1 (en) | 2005-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7101396B2 (en) | Minimally invasive valve replacement system | |
EP1684671B1 (en) | Minimally invasive valve replacement system | |
EP2040645B1 (en) | Minimally invasive valve replacement system | |
JP6559730B2 (en) | Cardiovascular prosthetic valve and system having the cardiovascular prosthetic valve | |
CN109199639B (en) | Prosthetic heart valve devices, prosthetic mitral valves, and associated systems and methods | |
KR101146035B1 (en) | Stent-valves for valve replacement and associated methods for surgery | |
JP2016519973A (en) | Implantable heart valve device, mitral valve repair device, and related systems and methods | |
JP2009520535A (en) | Valve replacement stent valves and related surgical methods and systems | |
WO2008092101A9 (en) | Methods and systems for reducing paravalvular leakage in heart valves | |
US20230079043A1 (en) | Tip assemblies, systems, and methods for fracturing a frame of a deployed prosthesis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |